BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer. 2005;5:845-856. [PMID: 16239904 DOI: 10.1038/nrc1739] [Cited by in Crossref: 1100] [Cited by in F6Publishing: 977] [Article Influence: 73.3] [Reference Citation Analysis]
Number Citing Articles
1 Powers TW, Holst S, Wuhrer M, Mehta AS, Drake RR. Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry. Biomolecules 2015;5:2554-72. [PMID: 26501333 DOI: 10.3390/biom5042554] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 11.0] [Reference Citation Analysis]
2 Metzenmacher M, Váraljai R, Hegedüs B, Cima I, Forster J, Schramm A, Scheffler B, Horn PA, Klein CA, Szarvas T, Reis H, Bielefeld N, Roesch A, Aigner C, Kunzmann V, Wiesweg M, Siveke JT, Schuler M, Lueong SS. Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of Cancer. Cancers (Basel) 2020;12:E353. [PMID: 32033141 DOI: 10.3390/cancers12020353] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
3 Scott DA, Drake RR. Glycosylation and its implications in breast cancer. Expert Rev Proteomics 2019;16:665-80. [PMID: 31314995 DOI: 10.1080/14789450.2019.1645604] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
4 Dobson L, Conway C, Hanley A, Johnson A, Costello S, O'Grady A, Connolly Y, Magee H, O'Shea D, Jeffers M, Kay E. Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretation. Histopathology 2010;57:27-38. [PMID: 20584089 DOI: 10.1111/j.1365-2559.2010.03577.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
5 Fanayan S, Smith JT, Lee LY, Yan F, Snyder M, Hancock WS, Nice E. Proteogenomic analysis of human colon carcinoma cell lines LIM1215, LIM1899, and LIM2405. J Proteome Res. 2013;12:1732-1742. [PMID: 23458625 DOI: 10.1021/pr3010869] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
6 Shi Y, Chen Z, Gao J, Wu S, Gao H, Feng G. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma. Oncol Rep 2018;40:2014-22. [PMID: 30106437 DOI: 10.3892/or.2018.6623] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
7 Hashimoto R, Fujitani N, Takegawa Y, Kurogochi M, Matsushita T, Naruchi K, Ohyabu N, Hinou H, Gao XD, Manri N, Satake H, Kaneko A, Sakamoto T, Nishimura S. An Efficient Approach for the Characterization of Mucin-Type Glycopeptides: The Effect of O-Glycosylation on the Conformation of Synthetic Mucin Peptides. Chem Eur J 2011;17:2393-404. [DOI: 10.1002/chem.201002754] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
8 Larijani B, Goodarzi P, Sheikh Hosseini M, M. Nejad S, Alavi-moghadam S, Sarvari M, Abedi M, Arabi M, Rahim F, Foroughi Heravani N, Hadavandkhani M, Payab M. OMICs Profiling of Cancer Cells. In: Arjmand B, editor. Genomics, Proteomics, and Metabolomics. Cham: Springer International Publishing; 2019. pp. 141-57. [DOI: 10.1007/978-3-030-27727-7_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Simon E. Biological and chemical sensors for cancer diagnosis. Meas Sci Technol 2010;21:112002. [DOI: 10.1088/0957-0233/21/11/112002] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
10 Birnbaum J, Gadi VK, Markowitz E, Etzioni R. The Effect of Treatment Advances on the Mortality Results of Breast Cancer Screening Trials: A Microsimulation Model. Ann Intern Med 2016;164:236-43. [PMID: 26756332 DOI: 10.7326/M15-0754] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
11 Wang J, Chen G, Jiang H, Li Z, Wang X. Advances in nano-scaled biosensors for biomedical applications. Analyst 2013;138:4427. [DOI: 10.1039/c3an00438d] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
12 Hu F, Xu S, Liu B. Photosensitizers with Aggregation-Induced Emission: Materials and Biomedical Applications. Adv Mater 2018;30:1801350. [DOI: 10.1002/adma.201801350] [Cited by in Crossref: 290] [Cited by in F6Publishing: 232] [Article Influence: 96.7] [Reference Citation Analysis]
13 Martínez-Mancera FD, García-López P, Hernández-López JL. Pre-clinical validation study of a miniaturized electrochemical immunoassay based on square wave voltammetry for early detection of carcinoembryonic antigen in human serum. Clin Chim Acta 2015;444:199-205. [PMID: 25689793 DOI: 10.1016/j.cca.2015.02.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
14 Rusling JF. Steps along the road to electrochemical devices for early cancer diagnosis. Bioanalysis 2010;2:847-50. [PMID: 20606724 DOI: 10.4155/bio.10.26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
15 Matsushita T, Sadamoto R, Ohyabu N, Nakata H, Fumoto M, Fujitani N, Takegawa Y, Sakamoto T, Kurogochi M, Hinou H, Shimizu H, Ito T, Naruchi K, Togame H, Takemoto H, Kondo H, Nishimura S. Functional Neoglycopeptides: Synthesis and Characterization of a New Class of MUC1 Glycoprotein Models Having Core 2-Based O -Glycan and Complex-Type N -Glycan Chains. Biochemistry 2009;48:11117-33. [DOI: 10.1021/bi901557a] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
16 Ward TH, Cummings J, Dean E, Greystoke A, Hou JM, Backen A, Ranson M, Dive C. Biomarkers of apoptosis. Br J Cancer 2008;99:841-6. [PMID: 19238626 DOI: 10.1038/sj.bjc.6604519] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 5.2] [Reference Citation Analysis]
17 Urooj T, Wasim B, Mushtaq S, Shah SNN, Shah M. Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects. Curr Cancer Drug Targets 2020;20:168-86. [PMID: 31858911 DOI: 10.2174/1568009620666191220151856] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
18 Kuan JC, Wu CC, Sun CA, Chu CM, Lin FG, Hsu CH, Kan PC, Lin SC, Yang T, Chou YC. DNA methylation combinations in adjacent normal colon tissue predict cancer recurrence: evidence from a clinical cohort study. PLoS One. 2015;10:e0123396. [PMID: 25815725 DOI: 10.1371/journal.pone.0123396] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
19 Munoz D, Near AM, van Ravesteyn NT, Lee SJ, Schechter CB, Alagoz O, Berry DA, Burnside ES, Chang Y, Chisholm G, de Koning HJ, Ali Ergun M, Heijnsdijk EA, Huang H, Stout NK, Sprague BL, Trentham-Dietz A, Mandelblatt JS, Plevritis SK. Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality. J Natl Cancer Inst 2014;106:dju289. [PMID: 25255803 DOI: 10.1093/jnci/dju289] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 10.3] [Reference Citation Analysis]
20 Fu-Jun L, Shao-Hua J, Xiao-Fang S. Differential proteomic analysis of pathway biomarkers in human breast cancer by integrated bioinformatics. Oncol Lett 2012;4:1097-103. [PMID: 23162659 DOI: 10.3892/ol.2012.881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
21 Dudas SP, Chatterjee M, Tainsky MA. Usage of cancer associated autoantibodies in the detection of disease. Cancer Biomark 2010;6:257-70. [PMID: 20938086 DOI: 10.3233/CBM-2009-0138] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
22 Zhu J, Djukovic D, Deng L, Gu H, Himmati F, Abu Zaid M, Chiorean EG, Raftery D. Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring. Anal Bioanal Chem 2015;407:7857-63. [PMID: 26342311 DOI: 10.1007/s00216-015-8984-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 6.7] [Reference Citation Analysis]
23 Paulitschke V, Kunstfeld R, Mohr T, Slany A, Micksche M, Drach J, Zielinski C, Pehamberger H, Gerner C. Entering a New Era of Rational Biomarker Discovery for Early Detection of Melanoma Metastases: Secretome Analysis of Associated Stroma Cells. J Proteome Res 2009;8:2501-10. [DOI: 10.1021/pr8010827] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
24 Mccaffery I, Fitzpatrick VD, Wang SW, Rossi JM, Bao H, Suggs SV, Ferbas J, Patterson SD. Translation of Protein Biomarkers for Clinical Development. In: Van Eyk JE, Dunn MJ, editors. Clinical Proteomics. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2007. pp. 633-51. [DOI: 10.1002/9783527622153.ch34] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
25 Clark AD, Oldenbroek M, Boyer TG. Mediator kinase module and human tumorigenesis. Crit Rev Biochem Mol Biol 2015;50:393-426. [PMID: 26182352 DOI: 10.3109/10409238.2015.1064854] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
26 Guzman VB, Silva ID, Brenna SM, Carvalho CR, Ribalta JC, Gerbase-Delima M. High levels of granzyme B expression in invasive cervical carcinoma correlates to poor response to treatment. Cancer Invest 2008;26:499-503. [PMID: 18568772 DOI: 10.1080/07357900701805678] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
27 Zhou X, Gladstein S, Almassalha LM, Li Y, Eshein A, Cherkezyan L, Viswanathan P, Subramanian H, Szleifer I, Backman V. Preservation of cellular nano-architecture by the process of chemical fixation for nanopathology. PLoS One 2019;14:e0219006. [PMID: 31329606 DOI: 10.1371/journal.pone.0219006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Horgan D, Ciliberto G, Conte P, Baldwin D, Seijo L, Montuenga LM, Paz-Ares L, Garassino M, Penault-Llorca F, Galli F, Ray-Coquard I, Querleu D, Capoluongo E, Banerjee S, Riegman P, Kerr K, Horbach B, Büttner R, Van Poppel H, Bjartell A, Codacci-Pisanelli G, Westphalen B, Calvo F, Koeva-Balabanova J, Hall S, Paradiso A, Kalra D, Cobbaert C, Varea Menendez R, Maravic Z, Fotaki V, Bennouna J, Cauchin E, Malats N, Gutiérrez-Ibarluzea I, Gannon B, Mastris K, Bernini C, Gallagher W, Buglioni S, Kent A, Munzone E, Belina I, Van Meerbeeck J, Duffy M, Sarnowska E, Jagielska B, Mee S, Curigliano G. Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology. Biomed Hub 2020;5:182-223. [PMID: 33564664 DOI: 10.1159/000511209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Wang L, Yao L, Zheng YZ, Xu Q, Liu XP, Hu X, Wang P, Shao ZM. Expression of autophagy-related proteins ATG5 and FIP200 predicts favorable disease-free survival in patients with breast cancer. Biochem Biophys Res Commun 2015;458:816-22. [PMID: 25689718 DOI: 10.1016/j.bbrc.2015.02.037] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
30 Cao HH, Zhang SY, Shen JH, Wu ZY, Wu JY, Wang SH, Li EM, Xu LY. A three-protein signature and clinical outcome in esophageal squamous cell carcinoma. Oncotarget. 2015;6:5435-5448. [PMID: 25605255 DOI: 10.18632/oncotarget.3102] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
31 Dutta G, Lillehoj PB. An ultrasensitive enzyme-free electrochemical immunosensor based on redox cycling amplification using methylene blue. Analyst 2017;142:3492-9. [PMID: 28831485 DOI: 10.1039/c7an00789b] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
32 Jin T, Nguyen ND, Talos F, Wang D. ECMarker: interpretable machine learning model identifies gene expression biomarkers predicting clinical outcomes and reveals molecular mechanisms of human disease in early stages. Bioinformatics 2021;37:1115-24. [PMID: 33305308 DOI: 10.1093/bioinformatics/btaa935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Hu C, Yue W, Yang M. Nanoparticle-based signal generation and amplification in microfluidic devices for bioanalysis. Analyst 2013;138:6709-20. [PMID: 24067742 DOI: 10.1039/c3an01321a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
34 Herr AE. Disruptive by design: a perspective on engineering in analytical chemistry. Anal Chem 2013;85:7622-8. [PMID: 23924345 DOI: 10.1021/ac4010887] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
35 Grade M, Hörmann P, Becker S, Hummon AB, Wangsa D, Varma S, Simon R, Liersch T, Becker H, Difilippantonio MJ, Ghadimi BM, Ried T. Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas. Cancer Res 2007;67:41-56. [PMID: 17210682 DOI: 10.1158/0008-5472.CAN-06-1514] [Cited by in Crossref: 82] [Cited by in F6Publishing: 58] [Article Influence: 5.9] [Reference Citation Analysis]
36 Tinelli A, Vergara D, Martignago R, Leo G, Pisanò M, Malvasi A. An outlook on ovarian cancer and borderline ovarian tumors: focus on genomic and proteomic findings. Curr Genomics 2009;10:240-9. [PMID: 19949545 DOI: 10.2174/138920209788488553] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
37 Kirwan A, Utratna M, O'Dwyer ME, Joshi L, Kilcoyne M. Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics. Biomed Res Int 2015;2015:490531. [PMID: 26509158 DOI: 10.1155/2015/490531] [Cited by in Crossref: 93] [Cited by in F6Publishing: 81] [Article Influence: 15.5] [Reference Citation Analysis]
38 Cummings J, Ward TH, Greystoke A, Ranson M, Dive C. Biomarker method validation in anticancer drug development. Br J Pharmacol 2008;153:646-56. [PMID: 17876307 DOI: 10.1038/sj.bjp.0707441] [Cited by in Crossref: 99] [Cited by in F6Publishing: 84] [Article Influence: 7.1] [Reference Citation Analysis]
39 Fan Y, Feng M, Wang R. Application of Radiomics in Central Nervous System Diseases: a Systematic literature review. Clinical Neurology and Neurosurgery 2019;187:105565. [DOI: 10.1016/j.clineuro.2019.105565] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
40 Svarovsky SA, Joshi L. Cancer glycan biomarkers and their detection – past, present and future. Anal Methods 2014;6:3918-36. [DOI: 10.1039/c3ay42243g] [Cited by in Crossref: 49] [Article Influence: 7.0] [Reference Citation Analysis]
41 Feichtinger J, McFarlane RJ, Larcombe LD. CancerEST: a web-based tool for automatic meta-analysis of public EST data. Database (Oxford) 2014;2014:bau024. [PMID: 24715218 DOI: 10.1093/database/bau024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Khatayevich D, Page T, Gresswell C, Hayamizu Y, Grady W, Sarikaya M. Selective detection of target proteins by peptide-enabled graphene biosensor. Small 2014;10:1505-13, 1504. [PMID: 24677773 DOI: 10.1002/smll.201302188] [Cited by in Crossref: 82] [Cited by in F6Publishing: 64] [Article Influence: 11.7] [Reference Citation Analysis]
43 Ehsani M, Chaichi MJ, Nezammeddin Hosseini S. Comparison of CuO nanoparticle and CuO/MWCNT nanocomposite for amplification of chemiluminescence immunoassay for detection of the hepatitis B surface antigen in biological samples. Sensors and Actuators B: Chemical 2017;247:319-28. [DOI: 10.1016/j.snb.2017.02.019] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
44 Ardito F, Giuliani M, Perrone D, Troiano G, Lo Muzio L. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review). Int J Mol Med 2017;40:271-80. [PMID: 28656226 DOI: 10.3892/ijmm.2017.3036] [Cited by in Crossref: 323] [Cited by in F6Publishing: 265] [Article Influence: 80.8] [Reference Citation Analysis]
45 Hunter SA, Lawrie SM. Imaging and Genetic Biomarkers Predicting Transition to Psychosis. Curr Top Behav Neurosci 2018;40:353-88. [PMID: 29626338 DOI: 10.1007/7854_2018_46] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
46 Baum BJ, Yates JR, Srivastava S, Wong DT, Melvin JE. Scientific frontiers: emerging technologies for salivary diagnostics. Adv Dent Res. 2011;23:360-368. [PMID: 21917746 DOI: 10.1177/0022034511420433] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
47 Wang M, Bai J, Tan Y, Wang S, Tian Y, Gong W, Zhou Y, Gao Y, Zhou J, Zhang Z. Genetic variant in PSCA predicts survival of diffuse-type gastric cancer in a Chinese population. Int J Cancer 2011;129:1207-13. [PMID: 21064099 DOI: 10.1002/ijc.25740] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
48 Dai C, Cazares LH, Wang L, Chu Y, Wang SL, Troyer DA, Semmes OJ, Drake RR, Wang B. Using boronolectin in MALDI-MS imaging for the histological analysis of cancer tissue expressing the sialyl Lewis X antigen. Chem Commun (Camb) 2011;47:10338-40. [PMID: 21853197 DOI: 10.1039/c1cc11814e] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
49 Novell A, Martínez-alonso M, Mira M, Tarragona J, Salud A, Matias-guiu X. Prognostic value of c-FLIPL/s, HIF-1α, and NF-κβ in stage II and III rectal cancer. Virchows Arch 2014;464:645-54. [DOI: 10.1007/s00428-014-1572-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
50 Nair KK, Pramod GV, Chaudhuri K, Ashok L. Estimation of Serum Butyryl Cholinesterase in Patients with Oral Squamous Cell Carcinoma: A Cross-Sectional Study. J Clin Diagn Res 2017;11:ZC59-62. [PMID: 28893045 DOI: 10.7860/JCDR/2017/27127.10207] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Chen F, Gao S, Wang F, Ma J, Zhang M, Lv M, Zhou Q, Fu Z, Lu C, Yin H. Comprehensive profiling of biological processes reveals two major prognostic subtypes in breast cancer. Tumour Biol 2016;37:3365-70. [PMID: 26446459 DOI: 10.1007/s13277-015-4173-9] [Reference Citation Analysis]
52 Zhu J, Wang F, Chen R, Cheng K, Xu B, Guo Z, Liang X, Ye M, Zou H. Centrifugation Assisted Microreactor Enables Facile Integration of Trypsin Digestion, Hydrophilic Interaction Chromatography Enrichment, and On-Column Deglycosylation for Rapid and Sensitive N-Glycoproteome Analysis. Anal Chem 2012;84:5146-53. [DOI: 10.1021/ac3000732] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 9.1] [Reference Citation Analysis]
53 Chao TC, Hansmeier N. Microfluidic devices for high-throughput proteome analyses. Proteomics 2013;13:467-79. [PMID: 23135952 DOI: 10.1002/pmic.201200411] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
54 Zhu Q, Chai Y, Yuan R, Zhuo Y. Simultaneous detection of four biomarkers with one sensing surface based on redox probe tagging strategy. Analytica Chimica Acta 2013;800:22-8. [DOI: 10.1016/j.aca.2013.08.039] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
55 Mohammadniaei M, Nguyen HV, Tieu MV, Lee MH. 2D Materials in Development of Electrochemical Point-of-Care Cancer Screening Devices. Micromachines (Basel) 2019;10:E662. [PMID: 31575012 DOI: 10.3390/mi10100662] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
56 Hudler P, Kocevar N, Komel R. Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics. ScientificWorldJournal. 2014;2014:260348. [PMID: 24550697 DOI: 10.1155/2014/260348] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
57 Pan S, Chen R, Tamura Y, Crispin DA, Lai LA, May DH, McIntosh MW, Goodlett DR, Brentnall TA. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma. J Proteome Res. 2014;13:1293-1306. [PMID: 24471499 DOI: 10.1021/pr4010184] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
58 Wang CH, Liu LL, Liao DZ, Zhang MF, Fu J, Lu SX, Chen SL, Wang H, Cai SH, Zhang CZ, Zhang HZ, Yun JP. PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma. Cancer Manag Res 2018;10:2241-8. [PMID: 30100755 DOI: 10.2147/CMAR.S166789] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
59 Eiro N, Cid S, Aguado N, Fraile M, de Pablo N, Fernández B, Domínguez F, González LO, Vizoso FJ. MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts. Int J Mol Sci 2020;22:E371. [PMID: 33396463 DOI: 10.3390/ijms22010371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Wang S, Tian Y, Wu D, Zhu H, Luo D, Gong W, Zhou Y, Zhou J, Zhang Z. Genetic variation of CTNNB1 gene is associated with susceptibility and prognosis of gastric cancer in a Chinese population. Mutagenesis. 2012;27:623-630. [PMID: 22848100 DOI: 10.1093/mutage/ges027] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
61 Guzzetta AA, Pisanic Ii TR, Sharma P, Yi JM, Stark A, Wang TH, Ahuja N. The promise of methylation on beads for cancer detection and treatment. Expert Rev Mol Diagn 2014;14:845-52. [PMID: 25136840 DOI: 10.1586/14737159.2014.943665] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
62 Han Y, Jia C, Cong X, Yu F, Cai H, Fang S, Cai L, Yang H, Sun Y, Li D, Liu J, Xie R, Yuan X, Zhong X, Li M, Wei Q, Lv Z, Fu D, Ma Y. Increased Expression of TGFβR2 Is Associated with the Clinical Outcome of Non-Small Cell Lung Cancer Patients Treated with Chemotherapy. PLoS One 2015;10:e0134682. [PMID: 26252213 DOI: 10.1371/journal.pone.0134682] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
63 Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008;13:48-57. [PMID: 18167339 DOI: 10.1016/j.ccr.2007.12.008] [Cited by in Crossref: 585] [Cited by in F6Publishing: 552] [Article Influence: 45.0] [Reference Citation Analysis]
64 Hatami Z, Jalali F, Amouzadeh Tabrizi M, Shamsipur M. Application of metal-organic framework as redox probe in an electrochemical aptasensor for sensitive detection of MUC1. Biosens Bioelectron 2019;141:111433. [PMID: 31212196 DOI: 10.1016/j.bios.2019.111433] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
65 de Graaf G, Postmus D, Westerink J, Buskens E. The early economic evaluation of novel biomarkers to accelerate their translation into clinical applications. Cost Eff Resour Alloc 2018;16:23. [PMID: 29946228 DOI: 10.1186/s12962-018-0105-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Cristoni S, Molin L, Lai A, Bernardi LR, Pucciarelli S, Agostini M, Bedin C, Nitti D, Seraglia R, Repetto O, Dibari VF, Orlandi R, Sinues PM, Traldi P. MALDI-MS-NIST library approach for colorectal cancer diagnosis: Letter to the Editor. Rapid Commun Mass Spectrom 2009;23:2839-45. [DOI: 10.1002/rcm.4180] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
67 Meehan J, Gray M, Martínez-Pérez C, Kay C, Pang LY, Fraser JA, Poole AV, Kunkler IH, Langdon SP, Argyle D, Turnbull AK. Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer. Front Oncol 2020;10:628. [PMID: 32391281 DOI: 10.3389/fonc.2020.00628] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
68 Kondo T. Inconvenient truth: cancer biomarker development by using proteomics. Biochim Biophys Acta 2014;1844:861-5. [PMID: 23896458 DOI: 10.1016/j.bbapap.2013.07.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
69 Hajji I, Serra M, Geremie L, Ferrante I, Renault R, Viovy J, Descroix S, Ferraro D. Droplet microfluidic platform for fast and continuous-flow RT-qPCR analysis devoted to cancer diagnosis application. Sensors and Actuators B: Chemical 2020;303:127171. [DOI: 10.1016/j.snb.2019.127171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
70 Opstal-van Winden AW, Rodenburg W, Pennings JL, van Oostrom CT, Beijnen JH, Peeters PH, van Gils CH, de Vries A. A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum. Int J Mol Sci 2012;13:13587-604. [PMID: 23202969 DOI: 10.3390/ijms131013587] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
71 Luk VN, Fiddes LK, Luk VM, Kumacheva E, Wheeler AR. Digital microfluidic hydrogel microreactors for proteomics. Proteomics 2012;12:1310-8. [PMID: 22589180 DOI: 10.1002/pmic.201100608] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
72 Solomon M, Liu Y, Berezin MY, Achilefu S. Optical imaging in cancer research: basic principles, tumor detection, and therapeutic monitoring. Med Princ Pract 2011;20:397-415. [PMID: 21757928 DOI: 10.1159/000327655] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
73 Raphael I, Webb J, Stuve O, Haskins W, Forsthuber T. Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future. Expert Rev Clin Immunol 2015;11:69-91. [PMID: 25523168 DOI: 10.1586/1744666X.2015.991315] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
74 Molitoris BA, Melnikov VY, Okusa MD, Himmelfarb J. Technology Insight: biomarker development in acute kidney injury--what can we anticipate? Nat Clin Pract Nephrol. 2008;4:154-165. [PMID: 18227821 DOI: 10.1038/ncpneph0723] [Cited by in Crossref: 57] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
75 Ravalli A, Voccia D, Palchetti I, Marrazza G. Electrochemical, Electrochemiluminescence, and Photoelectrochemical Aptamer-Based Nanostructured Sensors for Biomarker Analysis. Biosensors (Basel) 2016;6:E39. [PMID: 27490578 DOI: 10.3390/bios6030039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
76 Ulmschneider MB, Searson PC. Mathematical models of the steps involved in the systemic delivery of a chemotherapeutic to a solid tumor: From circulation to survival. J Control Release 2015;212:78-84. [PMID: 26103439 DOI: 10.1016/j.jconrel.2015.06.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
77 Feng LN, Bian ZP, Peng J, Jiang F, Yang GH, Zhu YD, Yang D, Jiang LP, Zhu JJ. Ultrasensitive multianalyte electrochemical immunoassay based on metal ion functionalized titanium phosphate nanospheres. Anal Chem 2012;84:7810-5. [PMID: 22913388 DOI: 10.1021/ac301438v] [Cited by in Crossref: 102] [Cited by in F6Publishing: 94] [Article Influence: 11.3] [Reference Citation Analysis]
78 Nassar AF, Williams BJ, Yaworksy DC, Patel V, Rusling JF. Rapid label-free profiling of oral cancer biomarker proteins using nano-UPLC-Q-TOF ion mobility mass spectrometry. Prot Clin Appl 2016;10:280-9. [DOI: 10.1002/prca.201500025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
79 Ostadhossein F, Sar D, Tripathi I, Soares J, Remsen EE, Pan D. Oligodots: Structurally Defined Fluorescent Nanoprobes for Multiscale Dual-Color Imaging in Vitro and in Vivo. ACS Appl Mater Interfaces 2020;12:10183-92. [DOI: 10.1021/acsami.0c00705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
80 Schaaij-visser TB, Brakenhoff RH, Leemans CR, Heck AJ, Slijper M. Protein biomarker discovery for head and neck cancer. Journal of Proteomics 2010;73:1790-803. [DOI: 10.1016/j.jprot.2010.01.013] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 3.7] [Reference Citation Analysis]
81 López Vélez M, Martínez Martínez F. Study of serum antioxidant capacity and relation with CA 19-9 and PSA in patients with gastrointestinal tract and prostate tumors. Clin Biochem 2011;44:1121-7. [PMID: 21723270 DOI: 10.1016/j.clinbiochem.2011.06.082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
82 Deb B, George IA, Sharma J, Kumar P. Phosphoproteomics Profiling to Identify Altered Signaling Pathways and Kinase-Targeted Cancer Therapies. Methods Mol Biol 2020;2051:241-64. [PMID: 31552632 DOI: 10.1007/978-1-4939-9744-2_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
83 Yu L, Issaq HJ, Veenstra TD. Phosphoproteomics for the discovery of kinases as cancer biomarkers and drug targets. Prot Clin Appl 2007;1:1042-57. [DOI: 10.1002/prca.200700102] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
84 Tang LQ, Chen QY, Guo SS, Chen WH, Li CF, Zhang L, Lai XP, He Y, Xu YX, Hu DP, Wen SH, Peng YT, Liu H, Liu LT, Yan SM, Guo L, Zhao C, Cao KJ, Liu Q, Qian CN, Ma J, Guo X, Zeng MS, Mai HQ. The impact of plasma Epstein-Barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational study. Br J Cancer 2014;111:1102-11. [PMID: 25051405 DOI: 10.1038/bjc.2014.393] [Cited by in Crossref: 32] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
85 Walter MA, Meier C, Radimerski T, Iten F, Kränzlin M, Müller-Brand J, de Groot JW, Kema IP, Links TP, Müller B. Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer. Cancer 2010;116:31-40. [PMID: 19890958 DOI: 10.1002/cncr.24738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
86 Tan DS, Gerlinger M, Teh B, Swanton C. Anti-cancer drug resistance: Understanding the mechanisms through the use of integrative genomics and functional RNA interference. European Journal of Cancer 2010;46:2166-77. [DOI: 10.1016/j.ejca.2010.03.019] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
87 Powell AGMT, Eley C, Chin C, Coxon AH, Christian A, Lewis WG; South East Wales Oesophagogastric Cancer Collaborative. Prognostic significance of serum inflammatory markers in esophageal cancer. Esophagus 2021;18:267-77. [PMID: 32865623 DOI: 10.1007/s10388-020-00772-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
88 Hüttenhain R, Soste M, Selevsek N, Röst H, Sethi A, Carapito C, Farrah T, Deutsch EW, Kusebauch U, Moritz RL, Niméus-Malmström E, Rinner O, Aebersold R. Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics. Sci Transl Med. 2012;4:142ra94. [PMID: 22786679 DOI: 10.1126/scitranslmed.3003989] [Cited by in Crossref: 187] [Cited by in F6Publishing: 180] [Article Influence: 23.4] [Reference Citation Analysis]
89 Nishizuka SS, Mills GB. New era of integrated cancer biomarker discovery using reverse-phase protein arrays. Drug Metabolism and Pharmacokinetics 2016;31:35-45. [DOI: 10.1016/j.dmpk.2015.11.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
90 Kurdistani SK. Histone modifications in cancer biology and prognosis. Prog Drug Res 2011;67:91-106. [PMID: 21141726 DOI: 10.1007/978-3-7643-8989-5_5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 29] [Article Influence: 0.6] [Reference Citation Analysis]
91 Zhou J, Lv R, Song X, Li D, Hu X, Ying B, Wei Y, Wang L. Association between two genetic variants in miRNA and primary liver cancer risk in the Chinese population. DNA Cell Biol. 2012;31:524-530. [PMID: 21861697 DOI: 10.1089/dna.2011.1340] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
92 Mak JS, Rutledge SA, Abu-ghazalah RM, Eftekhari F, Irizar J, Tam NC, Zheng G, Helmy AS. Recent developments in optofluidic-assisted Raman spectroscopy. Progress in Quantum Electronics 2013;37:1-50. [DOI: 10.1016/j.pquantelec.2012.11.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
93 Qiu FM, Yu JK, Chen YD, Jin QF, Sui MH, Huang J. Mining novel biomarkers for prognosis of gastric cancer with serum proteomics. J Exp Clin Cancer Res 2009;28:126. [PMID: 19740432 DOI: 10.1186/1756-9966-28-126] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
94 Chong SJF, Iskandar K, Lai JXH, Qu J, Raman D, Valentin R, Herbaux C, Collins M, Low ICC, Loh T, Davids M, Pervaiz S. Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism. Nucleic Acids Res 2020;48:12727-45. [PMID: 33245769 DOI: 10.1093/nar/gkaa1110] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
95 Irigaray P, Belpomme D. Circulating free methylglyoxal as a metabolic tumor biomarker in a rat colon adenocarcinoma model. Mol Clin Oncol 2020;12:311-6. [PMID: 32190311 DOI: 10.3892/mco.2020.2000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Abbas M, Kassim SA, Habib M, Li X, Shi M, Wang ZC, Hu Y, Zhu HL. Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China. Front Oncol 2020;10:800. [PMID: 32582542 DOI: 10.3389/fonc.2020.00800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
97 Proctor I, Stoeber K, Williams GH. Biomarkers in bladder cancer. Histopathology. 2010;57:1-13. [PMID: 20579130 DOI: 10.1111/j.1365-2559.2010.03592.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
98 Sun WY, Hu SS, Wu JJ, Huang Q, Ma Y, Wang QT, Chen JY, Wei W. Down-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinoma. Sci Rep 2016;6:35609. [PMID: 27759077 DOI: 10.1038/srep35609] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
99 Alvarez-Manilla G, Warren NL, Atwood J 3rd, Orlando R, Dalton S, Pierce M. Glycoproteomic analysis of embryonic stem cells: identification of potential glycobiomarkers using lectin affinity chromatography of glycopeptides. J Proteome Res 2010;9:2062-75. [PMID: 19545112 DOI: 10.1021/pr8007489] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
100 Islam MN, Masud MK, Haque MH, Hossain MSA, Yamauchi Y, Nguyen N, Shiddiky MJA. RNA Biomarkers: Diagnostic and Prognostic Potentials and Recent Developments of Electrochemical Biosensors. Small Methods 2017;1:1700131. [DOI: 10.1002/smtd.201700131] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
101 El-Boubbou K, Zhu DC, Vasileiou C, Borhan B, Prosperi D, Li W, Huang X. Magnetic glyco-nanoparticles: a tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging. J Am Chem Soc 2010;132:4490-9. [PMID: 20201530 DOI: 10.1021/ja100455c] [Cited by in Crossref: 205] [Cited by in F6Publishing: 166] [Article Influence: 18.6] [Reference Citation Analysis]
102 Abramczyk H, Imiela A, Brozek-Pluska B, Kopec M. Advances in Raman imaging combined with AFM and fluorescence microscopy are beneficial for oncology and cancer research. Nanomedicine (Lond) 2019;14:1873-88. [PMID: 31305216 DOI: 10.2217/nnm-2018-0335] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]
103 Paik YK, Kim H, Lee EY, Kwon MS, Cho SY. Overview and introduction to clinical proteomics. Methods Mol Biol 2008;428:1-31. [PMID: 18287765 DOI: 10.1007/978-1-59745-117-8_1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
104 Yoshimura Y, Matsushita T, Fujitani N, Takegawa Y, Fujihira H, Naruchi K, Gao XD, Manri N, Sakamoto T, Kato K, Hinou H, Nishimura S. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups. Biochemistry 2010;49:5929-41. [PMID: 20540529 DOI: 10.1021/bi100623g] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
105 Xie W, Liu L, He H, Yang K. Prognostic value of hypoxia-inducible factor-1 alpha in nasopharyngeal carcinoma: a meta-analysis. Int J Biol Markers 2018;33:447-54. [DOI: 10.1177/1724600818778756] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
106 Liu R, Ye X, Cui T. Recent Progress of Biomarker Detection Sensors. Research (Wash D C) 2020;2020:7949037. [PMID: 33123683 DOI: 10.34133/2020/7949037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
107 Kuzmanov U, Kosanam H, Diamandis EP. The sweet and sour of serological glycoprotein tumor biomarker quantification. BMC Med. 2013;11:31. [PMID: 23390961 DOI: 10.1186/1741-7015-11-31] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
108 Tabish TA, Scotton CJ, J Ferguson DC, Lin L, der Veen AV, Lowry S, Ali M, Jabeen F, Ali M, Winyard PG, Zhang S. Biocompatibility and toxicity of graphene quantum dots for potential application in photodynamic therapy. Nanomedicine 2018;13:1923-37. [DOI: 10.2217/nnm-2018-0018] [Cited by in Crossref: 67] [Cited by in F6Publishing: 51] [Article Influence: 22.3] [Reference Citation Analysis]
109 Xiang Y, Qian X, Chen Y, Zhang Y, Chai Y, Yuan R. A reagentless and disposable electronic genosensor: from multiplexed analysis to molecular logic gates. Chem Commun 2011;47:2080. [DOI: 10.1039/c0cc04350h] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
110 Takes RP, Rinaldo A, Silver CE, Piccirillo JF, Haigentz M, Suárez C, Van der Poorten V, Hermans R, Rodrigo JP, Devaney KO. Future of the TNM classification and staging system in head and neck cancer. Head Neck. 2010;32:1693-1711. [PMID: 20191627 DOI: 10.1002/hed.21361] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 7.5] [Reference Citation Analysis]
111 Zhou W, Su J, Chai Y, Yuan R, Xiang Y. Naked eye detection of trace cancer biomarkers based on biobarcode and enzyme-assisted DNA recycling hybrid amplifications. Biosensors and Bioelectronics 2014;53:494-8. [DOI: 10.1016/j.bios.2013.10.020] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
112 Ji ES, Hwang H, Park GW, Lee JY, Lee HK, Choi NY, Jeong HK, Kim KH, Kim JY, Lee S, Ahn YH, Yoo JS. Analysis of fucosylation in liver-secreted N-glycoproteins from human hepatocellular carcinoma plasma using liquid chromatography with tandem mass spectrometry. Anal Bioanal Chem 2016;408:7761-74. [PMID: 27565792 DOI: 10.1007/s00216-016-9878-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
113 Sinclair J, Timms JF. Quantitative profiling of serum samples using TMT protein labelling, fractionation and LC-MS/MS. Methods 2011;54:361-9. [PMID: 21397697 DOI: 10.1016/j.ymeth.2011.03.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
114 Lawrence YR, Werner-Wasik M, Dicker AP. Biologically conformal treatment: biomarkers and functional imaging in radiation oncology. Future Oncol 2008;4:689-704. [PMID: 18922126 DOI: 10.2217/14796694.4.5.689] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
115 Warton K, Mahon KL, Samimi G. Methylated circulating tumor DNA in blood: power in cancer prognosis and response. Endocr Relat Cancer 2016;23:R157-71. [PMID: 26764421 DOI: 10.1530/ERC-15-0369] [Cited by in Crossref: 104] [Cited by in F6Publishing: 56] [Article Influence: 20.8] [Reference Citation Analysis]
116 Mashreghi M, Faal Maleki M, Karimi M, Kalalinia F, Badiee A, Jaafari MR. Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide. J Drug Target 2021;29:617-30. [PMID: 33393376 DOI: 10.1080/1061186X.2020.1870230] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
117 Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol. 2010;28:1721-1726. [PMID: 20194856 DOI: 10.1200/jco.2009.24.9342] [Cited by in Crossref: 557] [Cited by in F6Publishing: 355] [Article Influence: 50.6] [Reference Citation Analysis]
118 Li B, Chang J, Chu Y, Kang H, Yang J, Jiang J, Ma H. Membrane proteomic analysis comparing squamous cell lung cancer tissue and tumour-adjacent normal tissue. Cancer Lett 2012;319:118-24. [PMID: 22252117 DOI: 10.1016/j.canlet.2011.12.037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
119 Kailemia MJ, Park D, Lebrilla CB. Glycans and glycoproteins as specific biomarkers for cancer. Anal Bioanal Chem. 2017;409:395-410. [PMID: 27590322 DOI: 10.1007/s00216-016-9880-6] [Cited by in Crossref: 174] [Cited by in F6Publishing: 154] [Article Influence: 34.8] [Reference Citation Analysis]
120 McDonnell LA, Corthals GL, Willems SM, van Remoortere A, van Zeijl RJ, Deelder AM. Peptide and protein imaging mass spectrometry in cancer research. J Proteomics. 2010;73:1921-1944. [PMID: 20510389 DOI: 10.1016/j.jprot.2010.05.007] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 10.6] [Reference Citation Analysis]
121 Saha S, Majumdar R, Hussain A, Dighe RR, Chakravarty AR. Biotin-conjugated tumour-targeting photocytotoxic iron(III) complexes. Phil Trans R Soc A 2013;371:20120190. [DOI: 10.1098/rsta.2012.0190] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
122 Hassanein M, Rahman JS, Chaurand P, Massion PP. Advances in proteomic strategies toward the early detection of lung cancer. Proc Am Thorac Soc 2011;8:183-8. [PMID: 21543799 DOI: 10.1513/pats.201012-069MS] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
123 Su L, Zhang M, Zhang W, Cai C, Hong J. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e6364. [PMID: 28296774 DOI: 10.1097/MD.0000000000006364] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
124 Toon CW, Chou A, DeSilva K, Chan J, Patterson J, Clarkson A, Sioson L, Jankova L, Gill AJ. BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer. Mod Pathol. 2014;27:644-650. [PMID: 24157612 DOI: 10.1038/modpathol.2013.200] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
125 Ericsson C, Franzén B, Nistér M. Frozen tissue biobanks. Tissue handling, cryopreservation, extraction, and use for proteomic analysis. Acta Oncol 2006;45:643-61. [PMID: 16938807 DOI: 10.1080/02841860600818047] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
126 Schaaij-Visser TB, de Wit M, Lam SW, Jiménez CR. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context. Biochim Biophys Acta. 2013;1834:2242-2258. [PMID: 23376433 DOI: 10.1016/j.bbapap.2013.01.029] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 8.1] [Reference Citation Analysis]
127 Bisoffi M, Heaphy CM, Griffith JK. Telomeres: prognostic markers for solid tumors. Int J Cancer. 2006;119:2255-2260. [PMID: 16858685 DOI: 10.1002/ijc.22120] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 5.6] [Reference Citation Analysis]
128 Gosho M, Nagashima K, Sato Y. Study designs and statistical analyses for biomarker research. Sensors (Basel) 2012;12:8966-86. [PMID: 23012528 DOI: 10.3390/s120708966] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
129 Shang Y, Zhang F, Li D, Li C, Li H, Jiang Y, Zhang D. Overexpression of UQCRC2 is correlated with tumor progression and poor prognosis in colorectal cancer. Pathology - Research and Practice 2018;214:1613-20. [DOI: 10.1016/j.prp.2018.08.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
130 Yin H, Zhang L, Xie L, Huang L, Xu Y, Cai S, Yang P, Lu H. Hyperplex-MRM: A Hybrid Multiple Reaction Monitoring Method Using mTRAQ/iTRAQ Labeling for Multiplex Absolute Quantification of Human Colorectal Cancer Biomarker. J Proteome Res 2013;12:3912-9. [DOI: 10.1021/pr4005025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
131 Budnik BA, Lee RS, Steen JA. Global methods for protein glycosylation analysis by mass spectrometry. Biochim Biophys Acta. 2006;1764:1870-1880. [PMID: 17118724 DOI: 10.1016/j.bbapap.2006.10.005] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 4.5] [Reference Citation Analysis]
132 Laversin SA, Phatak VM, Powe DG, Li G, Miles AK, Hughes DC, Ball GR, Ellis IO, Gritzapis AD, Missitzis I, McArdle SE, Rees RC. Identification of novel breast cancer-associated transcripts by UniGene database mining and gene expression analysis in normal and malignant cells. Genes Chromosomes Cancer 2013;52:316-29. [PMID: 23225347 DOI: 10.1002/gcc.22031] [Reference Citation Analysis]
133 Taguchi A, Rho JH, Yan Q, Zhang Y, Zhao Y, Xu H, Tripathi SC, Wang H, Brenner DE, Kucherlapati M, Kucherlapati R, Boutin AT, Wang YA, DePinho RA, Feng Z, Lampe PD, Hanash SM. MAPRE1 as a plasma biomarker for early-stage colorectal cancer and adenomas. Cancer Prev Res (Phila) 2015;8:1112-9. [PMID: 26342024 DOI: 10.1158/1940-6207.CAPR-15-0077] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
134 Yu SL, Chen HY, Yang PC, Chen JJ. Unique MicroRNA signature and clinical outcome of cancers. DNA Cell Biol 2007;26:283-92. [PMID: 17504024 DOI: 10.1089/dna.2006.0555] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
135 Chen Y, Ding X, Zhang Y, Natalia A, Sun X, Wang Z, Shao H. Design and synthesis of magnetic nanoparticles for biomedical diagnostics. Quant Imaging Med Surg 2018;8:957-70. [PMID: 30505724 DOI: 10.21037/qims.2018.10.07] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
136 Premaratne G, Farias S, Krishnan S. Pyrenyl carbon nanostructures for ultrasensitive measurements of formaldehyde in urine. Anal Chim Acta 2017;970:23-9. [PMID: 28433055 DOI: 10.1016/j.aca.2017.03.032] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
137 Kayes OJ, Loddo M, Patel N, Patel P, Minhas S, Ambler G, Freeman A, Wollenschlaeger A, Ralph DJ, Stoeber K, Williams GH. DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma. Clin Cancer Res 2009;15:7335-44. [PMID: 19920109 DOI: 10.1158/1078-0432.CCR-09-0882] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
138 Yuan Y, Adriani G, Xu Y, Chan Y. Highly fluorescent, monolithic semiconductor nanorod clusters for ultrasensitive biodetection. Chem Commun 2018;54:11352-5. [DOI: 10.1039/c8cc04524k] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
139 Großerueschkamp F, Bracht T, Diehl HC, Kuepper C, Ahrens M, Kallenbach-Thieltges A, Mosig A, Eisenacher M, Marcus K, Behrens T, Brüning T, Theegarten D, Sitek B, Gerwert K. Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomics. Sci Rep 2017;7:44829. [PMID: 28358042 DOI: 10.1038/srep44829] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 9.5] [Reference Citation Analysis]
140 Chen Y, Xu L, Meng J, Deng S, Ma L, Zhang S, Zhang X, Wang S. Superwettable microchips with improved spot homogeneity toward sensitive biosensing. Biosensors and Bioelectronics 2018;102:418-24. [DOI: 10.1016/j.bios.2017.11.036] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
141 Kurdistani SK. Histone modifications as markers of cancer prognosis: a cellular view. Br J Cancer 2007;97:1-5. [PMID: 17592497 DOI: 10.1038/sj.bjc.6603844] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 6.1] [Reference Citation Analysis]
142 Nice E, Rothacker J, Weinstock J, Lim L, Catimel B. Use of multidimensional separation protocols for the purification of trace components in complex biological samples for proteomics analysis. Journal of Chromatography A 2007;1168:190-210. [DOI: 10.1016/j.chroma.2007.06.015] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
143 Rahi A, Sattarahmady N, Heli H. Label-free electrochemical aptasensing of the human prostate-specific antigen using gold nanospears. Talanta 2016;156-157:218-24. [PMID: 27260456 DOI: 10.1016/j.talanta.2016.05.029] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 13.0] [Reference Citation Analysis]
144 Markin PA, Brito A, Moskaleva N, Fodor M, Lartsova EV, Shpot YV, Lerner YV, Mikhajlov VY, Potoldykova NV, Enikeev DV, Lyundup AV, Appolonova SA. Plasma Sarcosine Measured by Gas Chromatography-Mass Spectrometry Distinguishes Prostatic Intraepithelial Neoplasia and Prostate Cancer from Benign Prostate Hyperplasia. Lab Med 2020;51:566-73. [PMID: 32161964 DOI: 10.1093/labmed/lmaa008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
145 Dong M, Liu J, Song Z, Li X, Shi T, Wang D, Ren D, Chen J. Primary Multiple Pulmonary Primitive Neuroectodermal Tumor: Case Report and Literature Review. Medicine (Baltimore) 2015;94:e1136. [PMID: 26166119 DOI: 10.1097/MD.0000000000001136] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
146 Shi Y, Gong HL, Zhou L, Tian J, Wang Y. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2012;74:78-85. [PMID: 22354323 DOI: 10.1159/000335584] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
147 Sakaeda T, Yamamori M, Kuwahara A, Nishiguchi K. Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy. Adv Drug Deliv Rev 2009;61:388-401. [PMID: 19135108 DOI: 10.1016/j.addr.2008.10.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
148 Martínez-Rodríguez F, Limones-González JE, Mendoza-Almanza B, Esparza-Ibarra EL, Gallegos-Flores PI, Ayala-Luján JL, Godina-González S, Salinas E, Mendoza-Almanza G. Understanding Cervical Cancer through Proteomics. Cells 2021;10:1854. [PMID: 34440623 DOI: 10.3390/cells10081854] [Reference Citation Analysis]
149 Na SS, Aldonza MB, Sung HJ, Kim YI, Son YS, Cho S, Cho JY. Stanniocalcin-2 (STC2): A potential lung cancer biomarker promotes lung cancer metastasis and progression. Biochim Biophys Acta. 2015;1854:668-676. [PMID: 25463045 DOI: 10.1016/j.bbapap.2014.11.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
150 Siravegna G, Bardelli A. Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients. Mol Oncol. 2016;10:475-480. [PMID: 26774880 DOI: 10.1016/j.molonc.2015.12.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
151 Li MH, Fu SB, Xiao HS. Genome-wide analysis of microRNA and mRNA expression signatures in cancer. Acta Pharmacol Sin 2015;36:1200-11. [PMID: 26299954 DOI: 10.1038/aps.2015.67] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 7.2] [Reference Citation Analysis]
152 Li D, Dong S. 6-Aminopyridine-3-boronic acid functionalized magnetic nanoparticles for highly efficient enrichment of cis-diol-containing biomolecules. Anal Methods 2021;13:2331-7. [PMID: 33969834 DOI: 10.1039/d1ay00414j] [Reference Citation Analysis]
153 Pezzolo E, Modena Y, Corso B, Giusti P, Gusella M. Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year literature update and critical review. Eur J Clin Pharmacol 2015;71:529-39. [PMID: 25740678 DOI: 10.1007/s00228-015-1824-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
154 Mashreghi M, Azarpara H, Bazaz MR, Jafari A, Masoudifar A, Mirzaei H, Jaafari MR. Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis. J Cell Physiol 2018;233:2949-65. [DOI: 10.1002/jcp.26049] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 16.0] [Reference Citation Analysis]
155 Rosenblum LT, Choyke PL, Kobayashi H. Quantitative and specific molecular imaging of cancer with labeled engineered monoclonal antibody fragments. Therapeutic Delivery 2011;2:345-58. [DOI: 10.4155/tde.10.79] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
156 Tien WS, Chen PM, Chuang CY, Lui SM, Kuo HC, Chen YJ, Wu KP. Combining membrane proteomics and computational three-way pathway analysis revealed signalling pathways preferentially regulated in human iPSCs and human ESCs. Sci Rep 2017;7:15055. [PMID: 29118436 DOI: 10.1038/s41598-017-15347-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Omenn GS. Strategies for plasma proteomic profiling of cancers. Proteomics. 2006;6:5662-5673. [PMID: 16991194 DOI: 10.1002/pmic.200600331] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 4.4] [Reference Citation Analysis]
158 Huang SP, Li CH, Chang WM, Lin YF. BICD Cargo Adaptor 1 (BICD1) Downregulation Correlates with a Decreased Level of PD-L1 and Predicts a Favorable Prognosis in Patients with IDH1-Mutant Lower-Grade Gliomas. Biology (Basel) 2021;10:701. [PMID: 34439934 DOI: 10.3390/biology10080701] [Reference Citation Analysis]
159 Fan B, Zhang LH, Jia YN, Zhong XY, Liu YQ, Cheng XJ, Wang XH, Xing XF, Hu Y, Li YA. Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer. BMC Cancer. 2012;12:316. [PMID: 22838504 DOI: 10.1186/1471-2407-12-316] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
160 Leung KS, Fong BM. LC–MS/MS in the routine clinical laboratory: has its time come? Anal Bioanal Chem 2014;406:2289-301. [DOI: 10.1007/s00216-013-7542-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
161 Bayram S, Ülger Y, Sümbül AT, Kaya BY, Rencüzoğulları A, Genç A, Sevgiler Y, Bozkurt O, Rencüzoğulları E. A functional HOTAIR rs920778 polymorphism does not contributes to gastric cancer in a Turkish population: a case–control study. Familial Cancer 2015;14:561-7. [DOI: 10.1007/s10689-015-9813-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
162 Makawita S, Diamandis EP. The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification. Clin Chem. 2010;56:212-222. [PMID: 20007861 DOI: 10.1373/clinchem.2009.127019] [Cited by in Crossref: 130] [Cited by in F6Publishing: 117] [Article Influence: 10.8] [Reference Citation Analysis]
163 Wang M, Hu M, Hu B, Guo C, Song Y, Jia Q, He L, Zhang Z, Fang S. Bimetallic cerium and ferric oxides nanoparticles embedded within mesoporous carbon matrix: Electrochemical immunosensor for sensitive detection of carbohydrate antigen 19-9. Biosens Bioelectron 2019;135:22-9. [PMID: 30991268 DOI: 10.1016/j.bios.2019.04.018] [Cited by in Crossref: 99] [Cited by in F6Publishing: 27] [Article Influence: 49.5] [Reference Citation Analysis]
164 Mani V, Chikkaveeraiah BV, Rusling JF. Magnetic particles in ultrasensitive biomarker protein measurements for cancer detection and monitoring. Expert Opin Med Diagn 2011;5:381-91. [PMID: 22102846 DOI: 10.1517/17530059.2011.607161] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
165 Ahn SB, Mohamedali A, Chan C, Fletcher J, Kwun SY, Clarke C, Dent OF, Chapuis PH, Nice E, Baker MS. Correlations between integrin ανβ6 expression and clinico-pathological features in stage B and stage C rectal cancer. PLoS One 2014;9:e97248. [PMID: 24821188 DOI: 10.1371/journal.pone.0097248] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
166 Egalite N, Groisman IJ, Godard B. Personalized medicine in oncology: ethical implications for the delivery of healthcare. Per Med 2014;11:659-68. [PMID: 29764052 DOI: 10.2217/pme.14.53] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
167 Zhao B, Serrano MAC, Gao J, Zhuang J, Vachet RW, Thayumanavan S. Self-assembly of random co-polymers for selective binding and detection of peptides. Polym Chem 2018;9:1066-71. [PMID: 29725358 DOI: 10.1039/C7PY01947E] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 3.3] [Reference Citation Analysis]
168 Xue H, Lu B, Lai M. The cancer secretome: a reservoir of biomarkers. J Transl Med 2008;6:52. [PMID: 18796163 DOI: 10.1186/1479-5876-6-52] [Cited by in Crossref: 103] [Cited by in F6Publishing: 105] [Article Influence: 7.9] [Reference Citation Analysis]
169 Miura Y, Kato K, Takegawa Y, Kurogochi M, Furukawa J, Shinohara Y, Nagahori N, Amano M, Hinou H, Nishimura S. Glycoblotting-Assisted O -Glycomics: Ammonium Carbamate Allows for Highly Efficient O -Glycan Release from Glycoproteins. Anal Chem 2010;82:10021-9. [DOI: 10.1021/ac101599p] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 6.0] [Reference Citation Analysis]
170 Roberts JN, Karvonen C, Graham K, Weinfeld M, Joy AA, Koebel M, Morris D, Robson PJ, Johnston RN, Brockton NT. Biobanking in the Twenty-First Century: Driving Population Metrics into Biobanking Quality. In: Karimi-busheri F, editor. Biobanking in the 21st Century. Cham: Springer International Publishing; 2015. pp. 95-114. [DOI: 10.1007/978-3-319-20579-3_8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
171 Liu R, Zhang Y, Zhang S, Qiu W, Gao Y. Silver Enhancement of Gold Nanoparticles for Biosensing: From Qualitative to Quantitative. Applied Spectroscopy Reviews 2013;49:121-38. [DOI: 10.1080/05704928.2013.807817] [Cited by in Crossref: 50] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]
172 Rossi F, Noren H, Jove R, Beljanski V, Grinnemo KH. Differences and similarities between cancer and somatic stem cells: therapeutic implications. Stem Cell Res Ther 2020;11:489. [PMID: 33208173 DOI: 10.1186/s13287-020-02018-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
173 Garrido-medina R, Farina-gomez N, Diez-masa JC, de Frutos M. Immunoaffinity chromatographic isolation of prostate-specific antigen from seminal plasma for capillary electrophoresis analysis of its isoforms. Analytica Chimica Acta 2014;820:47-55. [DOI: 10.1016/j.aca.2014.02.031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
174 Sharma B, Kanwar SS. Phosphatidylserine: A cancer cell targeting biomarker. Seminars in Cancer Biology 2018;52:17-25. [DOI: 10.1016/j.semcancer.2017.08.012] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 21.0] [Reference Citation Analysis]
175 Hahn YK, Park J. Versatile immunoassays based on isomagnetophoresis. Lab Chip 2011;11:2045. [DOI: 10.1039/c0lc00569j] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
176 Liu LT, Liang YJ, Guo SS, Xie Y, Jia GD, Wen DX, Tang LQ, Chen QY, Mai HQ. Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: A study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein-Barr virus DNA. Head Neck 2021. [PMID: 34636116 DOI: 10.1002/hed.26897] [Reference Citation Analysis]
177 Lakpour N, Saliminejad K, Ghods R, Reza Sadeghi M, Pilatz A, Khosravi F, Madjd Z. Potential biomarkers for testicular germ cell tumour: Risk assessment, diagnostic, prognostic and monitoring of recurrence. Andrologia 2021;53:e13998. [PMID: 33534171 DOI: 10.1111/and.13998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Cao Y, Huang P, Li X, Ge W, Hou D, Zhang G. Terahertz spectral unmixing based method for identifying gastric cancer. Phys Med Biol 2018;63:035016. [DOI: 10.1088/1361-6560/aa9e1a] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 5.7] [Reference Citation Analysis]
179 Aoto Y, Okumura K, Hachiya T, Hase S, Wakabayashi Y, Ishikawa F, Sakakibara Y. Time-Series Analysis of Tumorigenesis in a Murine Skin Carcinogenesis Model. Sci Rep 2018;8:12994. [PMID: 30158594 DOI: 10.1038/s41598-018-31349-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
180 Ma X, Chen Z, Kannan P, Lin Z, Qiu B, Guo L. Gold Nanorods as Colorful Chromogenic Substrates for Semiquantitative Detection of Nucleic Acids, Proteins, and Small Molecules with the Naked Eye. Anal Chem 2016;88:3227-34. [DOI: 10.1021/acs.analchem.5b04621] [Cited by in Crossref: 84] [Cited by in F6Publishing: 64] [Article Influence: 16.8] [Reference Citation Analysis]
181 Zhao W, Hu L, Xu J, Shen H, Hu Z, Ma H, Shu Y, Shao Y, Yin Y. Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer. Cancer Chemother Pharmacol 2013;71:1287-95. [PMID: 23479135 DOI: 10.1007/s00280-013-2127-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
182 Tao Y, Auguste DT. Array-based identification of triple-negative breast cancer cells using fluorescent nanodot-graphene oxide complexes. Biosensors and Bioelectronics 2016;81:431-7. [DOI: 10.1016/j.bios.2016.03.033] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
183 Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Rev Clin Oncol 2008;5:588-99. [DOI: 10.1038/ncponc1187] [Cited by in Crossref: 442] [Cited by in F6Publishing: 436] [Article Influence: 34.0] [Reference Citation Analysis]
184 Brunetto AT, Kristeleit RS, de Bono JS. Early oncology clinical trial design in the era of molecular-targeted agents. Future Oncology 2010;6:1339-52. [DOI: 10.2217/fon.10.92] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
185 Chang NW, Dai HJ, Shih YY, Wu CY, Dela Rosa MAC, Obena RP, Chen YJ, Hsu WL, Oyang YJ. Biomarker identification of hepatocellular carcinoma using a methodical literature mining strategy. Database (Oxford) 2017;2017:bax082. [PMID: 31725857 DOI: 10.1093/database/bax082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
186 Grassberger C, Ellsworth SG, Wilks MQ, Keane FK, Loeffler JS. Assessing the interactions between radiotherapy and antitumour immunity. Nat Rev Clin Oncol 2019;16:729-45. [PMID: 31243334 DOI: 10.1038/s41571-019-0238-9] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 31.0] [Reference Citation Analysis]
187 Ferhan AR, Jackman JA, Park JH, Cho N, Kim D. Nanoplasmonic sensors for detecting circulating cancer biomarkers. Advanced Drug Delivery Reviews 2018;125:48-77. [DOI: 10.1016/j.addr.2017.12.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 17.3] [Reference Citation Analysis]
188 Marchet A, Mocellin S, Belluco C, Ambrosi A, DeMarchi F, Mammano E, Digito M, Leon A, D'Arrigo A, Lise M, Nitti D. Gene expression profile of primary gastric cancer: towards the prediction of lymph node status. Ann Surg Oncol. 2007;14:1058-1064. [PMID: 17106627 DOI: 10.1245/s10434-006-9090-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
189 Krohn KA, O'Sullivan F, Crowley J, Eary JF, Linden HM, Link JM, Mankoff DA, Muzi M, Rajendran JG, Spence AM, Swanson KR. Challenges in clinical studies with multiple imaging probes. Nucl Med Biol 2007;34:879-85. [PMID: 17921038 DOI: 10.1016/j.nucmedbio.2007.07.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
190 Powell AGMT, Parkinson D, Patel N, Chan D, Christian A, Lewis WG. Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer. J Gastrointest Surg 2018;22:595-605. [PMID: 29234999 DOI: 10.1007/s11605-017-3597-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
191 Xing S, Zeng T, Xue N, He Y, Lai YZ, Li HL, Huang Q, Chen SL, Liu WL. Development and Validation of Tumor-educated Blood Platelets Integrin Alpha 2b (ITGA2B) RNA for Diagnosis and Prognosis of Non-small-cell Lung Cancer through RNA-seq. Int J Biol Sci 2019;15:1977-92. [PMID: 31523198 DOI: 10.7150/ijbs.36284] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
192 Surinova S, Radová L, Choi M, Srovnal J, Brenner H, Vitek O, Hajdúch M, Aebersold R. Non-invasive prognostic protein biomarker signatures associated with colorectal cancer. EMBO Mol Med. 2015;7:1153-1165. [PMID: 26253080 DOI: 10.15252/emmm.201404874] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
193 Liu LT, Chen QY, Tang LQ, Guo SS, Guo L, Mo HY, Chen MY, Zhao C, Guo X, Qian CN, Zeng MS, Bei JX, Tan J, Chen S, Hong MH, Shao JY, Sun Y, Ma J, Mai HQ. The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients. Cancer Res Treat 2018;50:19-29. [PMID: 28392551 DOI: 10.4143/crt.2016.595] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
194 Masica DL, Li S, Douville C, Manola J, Ferris RL, Burtness B, Forastiere AA, Koch WM, Chung CH, Karchin R. Predicting survival in head and neck squamous cell carcinoma from TP53 mutation. Hum Genet 2015;134:497-507. [PMID: 25108461 DOI: 10.1007/s00439-014-1470-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
195 Chen QY, Tang QN, Tang LQ, Chen WH, Guo SS, Liu LT, Li CF, Li Y, Liang YJ, Sun XS, Guo L, Mo HY, Sun R, Luo DH, Fan YY, He Y, Chen MY, Cao KJ, Qian CN, Guo X, Mai HQ. Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective Study. Cancer Res Treat 2018;50:701-11. [PMID: 28707462 DOI: 10.4143/crt.2017.180] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
196 Martin NE, Mucci LA, Loda M, Depinho RA. Prognostic determinants in prostate cancer. Cancer J 2011;17:429-37. [PMID: 22157287 DOI: 10.1097/PPO.0b013e31823b042c] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
197 Guinn B, Mohamedali A, Mills KI, Czepulkowski B, Schmitt M, Greiner J. Leukemia Associated Antigens: Their Dual Role as Biomarkers and Immunotherapeutic Targets for Acute Myeloid Leukemia. Biomark�Insights 2007;2:117727190700200. [DOI: 10.1177/117727190700200015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
198 Teichert F, Winkler S, Keun HC, Steward WP, Gescher AJ, Farmer PB, Singh R. Evaluation of urinary ribonucleoside profiling for clinical biomarker discovery using constant neutral loss scanning liquid chromatography/tandem mass spectrometry: Urinary ribonucleoside profiling by tandem mass spectrometry. Rapid Commun Mass Spectrom 2011;25:2071-82. [DOI: 10.1002/rcm.5086] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
199 He ZH, Lv W, Wang LM, Wang YQ, Hu J. Identification of Genes Associated with Lung Adenocarcinoma Prognosis. Comb Chem High Throughput Screen 2019;22:220-4. [PMID: 30947660 DOI: 10.2174/1386207322666190404152140] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
200 Xu L, Fengji L, Changning L, Liangcai Z, Yinghui L, Yu L, Shanguang C, Jianghui X. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers. PLoS One 2015;10:e0142433. [PMID: 26606135 DOI: 10.1371/journal.pone.0142433] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
201 Islam MN, Gopalan V, Haque MH, Masud MK, Hossain MSA, Yamauchi Y, Nguyen NT, Lam AK, Shiddiky MJA. A PCR-free electrochemical method for messenger RNA detection in cancer tissue samples. Biosens Bioelectron 2017;98:227-33. [PMID: 28688308 DOI: 10.1016/j.bios.2017.06.051] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
202 Hu Z, Shu Y, Chen Y, Chen J, Dong J, Liu Y, Pan S, Xu L, Xu J, Wang Y, Dai J, Ma H, Jin G, Shen H. Genetic Polymorphisms in the Precursor MicroRNA Flanking Region and Non–Small Cell Lung Cancer Survival. Am J Respir Crit Care Med 2011;183:641-8. [DOI: 10.1164/rccm.201005-0717oc] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
203 Li D, Li Y, Li X, Bie Z, Pan X, Zhang Q, Liu Z. A high boronate avidity monolithic capillary for the selective enrichment of trace glycoproteins. Journal of Chromatography A 2015;1384:88-96. [DOI: 10.1016/j.chroma.2015.01.050] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 9.7] [Reference Citation Analysis]
204 Ren L, Chen L, Wu W, Garribba L, Tian H, Liu Z, Vogel I, Li C, Hickson ID, Liu Y. Potential biomarkers of DNA replication stress in cancer. Oncotarget 2017;8:36996-7008. [PMID: 28445142 DOI: 10.18632/oncotarget.16940] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
205 Fang Z, Soleymani L, Pampalakis G, Yoshimoto M, Squire JA, Sargent EH, Kelley SO. Direct profiling of cancer biomarkers in tumor tissue using a multiplexed nanostructured microelectrode integrated circuit. ACS Nano 2009;3:3207-13. [PMID: 19736919 DOI: 10.1021/nn900733d] [Cited by in Crossref: 70] [Cited by in F6Publishing: 66] [Article Influence: 6.4] [Reference Citation Analysis]
206 Zhang S, Chen Y, Zhu Z, Ding Y, Ren S, Zuo Y. Differential expression of carbohydrate antigen 19-9 in human colorectal cancer: A comparison with colon and rectal cancers. Mol Clin Oncol 2013;1:1072-8. [PMID: 24649295 DOI: 10.3892/mco.2013.173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
207 Wang C, Wang J, Chen Z, Gao Y, He J. Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review. Chin J Cancer. 2017;36:65. [PMID: 28818096 DOI: 10.1186/s40880-017-0232-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
208 Hong CS, Cui J, Ni Z, Su Y, Puett D, Li F, Xu Y. A computational method for prediction of excretory proteins and application to identification of gastric cancer markers in urine. PLoS One 2011;6:e16875. [PMID: 21365014 DOI: 10.1371/journal.pone.0016875] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
209 Rothacker J, Ramsay RG, Ciznadija D, Gras E, Neylon CB, Elwood NJ, Bouchier-Hayes D, Gibbs P, Rosenthal MA, Nice EC. A novel magnetic bead-based assay with high sensitivity and selectivity for analysis of telomerase in exfoliated cells from patients with bladder and colon cancer. Electrophoresis 2007;28:4435-46. [PMID: 17987629 DOI: 10.1002/elps.200600829] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
210 Xu H, Wang D, He S, Li J, Feng B, Ma P, Xu P, Gao S, Zhang S, Liu Q, Lu J, Song S, Fan C. Graphene-based nanoprobes and a prototype optical biosensing platform. Biosensors and Bioelectronics 2013;50:251-5. [DOI: 10.1016/j.bios.2013.06.039] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
211 Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother. 2010;64:399-408. [PMID: 20363096 DOI: 10.1016/j.biopha.2010.01.018] [Cited by in Crossref: 181] [Cited by in F6Publishing: 172] [Article Influence: 16.5] [Reference Citation Analysis]
212 Alizadeh N, Salimi A. Ultrasensitive Bioaffinity Electrochemical Sensors: Advances and New Perspectives. Electroanalysis 2018;30:2803-40. [DOI: 10.1002/elan.201800598] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
213 Jones PS, Jones D. New regulatory framework for cancer drug development. Drug Discov Today 2012;17:227-31. [PMID: 22207222 DOI: 10.1016/j.drudis.2011.12.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
214 Sun D, Zhang Z, Chen M, Zhang Y, Amagat J, Kang S, Zheng Y, Hu B, Chen M. Co-Immobilization of Ce6 Sono/Photosensitizer and Protonated Graphitic Carbon Nitride on PCL/Gelation Fibrous Scaffolds for Combined Sono-Photodynamic Cancer Therapy. ACS Appl Mater Interfaces 2020;12:40728-39. [PMID: 32794726 DOI: 10.1021/acsami.0c08446] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
215 Wang L, Hu X, Wang P, Shao ZM. The 3'UTR signature defines a highly metastatic subgroup of triple-negative breast cancer. Oncotarget 2016;7:59834-44. [PMID: 27494850 DOI: 10.18632/oncotarget.10975] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
216 Huang W, Chang CL, Brault ND, Gur O, Wang Z, Jalal SI, Low PS, Ratliff TL, Pili R, Savran CA. Separation and dual detection of prostate cancer cells and protein biomarkers using a microchip device. Lab Chip 2017;17:415-28. [PMID: 28054089 DOI: 10.1039/c6lc01279e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
217 Michaud SA, Sinclair NJ, Pětrošová H, Palmer AL, Pistawka AJ, Zhang S, Hardie DB, Mohammed Y, Eshghi A, Richard VR, Sickmann A, Borchers CH. Molecular phenotyping of laboratory mouse strains using 500 multiple reaction monitoring mass spectrometry plasma assays. Commun Biol 2018;1:78. [PMID: 30271959 DOI: 10.1038/s42003-018-0087-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
218 Ali Akbar-Esfahani S, Karimipoor M, Bahreini F, Soltania AR, Aletaha N, Mahdavinezhad A. Diagnostic Value of Plasma Long Non-coding RNA HOTTIP as a Non-invasive Biomarker for Colorectal Cancer (A Case- Control Study). Int J Mol Cell Med 2019;8:240-7. [PMID: 32587834 DOI: 10.22088/IJMCM.BUMS.8.4.240] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
219 He Z, Huffman J, Curtin K, Garner KL, Bowdridge EC, Li X, Nurkiewicz TR, Li P. Composable Microfluidic Plates (cPlate): A Simple and Scalable Fluid Manipulation System for Multiplexed Enzyme-Linked Immunosorbent Assay (ELISA). Anal Chem 2021;93:1489-97. [PMID: 33326204 DOI: 10.1021/acs.analchem.0c03651] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
220 Chen HY, Yu SL, Li KC, Yang PC. Biomarkers and transcriptome profiling of lung cancer. Respirology 2012;17:620-6. [PMID: 22372638 DOI: 10.1111/j.1440-1843.2012.02154.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
221 Panteli JT, Van Dessel N, Forbes NS. Detection of tumors with fluoromarker-releasing bacteria. Int J Cancer 2020;146:137-49. [PMID: 31093970 DOI: 10.1002/ijc.32414] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
222 Hao Y, Gao Y, Song H, Niu Y, Chen X, Liu X, Gao R, Wang S. Fabrication of metal coordination-synergistic magnetic imprinted microspheres based on ligand-free Fe3O4-Cu for specific recognition of bovine hemoglobin. Talanta 2021;233:122496. [PMID: 34215114 DOI: 10.1016/j.talanta.2021.122496] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 Rodenburg W, Pennings JL, van Oostrom CT, Roodbergen M, Kuiper RV, Luijten M, de Vries A. Identification of breast cancer biomarkers in transgenic mouse models: A proteomics approach. Proteomics Clin Appl 2010;4:603-12. [PMID: 21137078 DOI: 10.1002/prca.200900175] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
224 Fries GR, Pfaffenseller B, Stertz L, Paz AV, Dargél AA, Kunz M, Kapczinski F. Staging and neuroprogression in bipolar disorder. Curr Psychiatry Rep. 2012;14:667-675. [PMID: 23090632 DOI: 10.1007/s11920-012-0319-2] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 9.5] [Reference Citation Analysis]
225 Hao L, Leng J, Xiao R, Kingsley T, Li X, Tu Z, Yang X, Deng X, Xiong M, Xiong J, Zhang Q. Bioinformatics analysis of the prognostic value of Tripartite Motif 28 in breast cancer. Oncol Lett 2017;13:2670-8. [PMID: 28454449 DOI: 10.3892/ol.2017.5764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
226 Bayram S, Akkız H, Ülger Y, Bekar A, Akgöllü E, Yıldırım S. Lack of an association of programmed cell death-1 PD1.3 polymorphism with risk of hepatocellular carcinoma susceptibility in Turkish population: a case-control study. Gene 2012;511:308-13. [PMID: 23041554 DOI: 10.1016/j.gene.2012.09.119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
227 Nam J, Yoo M, Yeo W. Measurement of prostate-specific antigen level as a biomarker for breast cancer by using mass signal amplification. BioChip J 2015;9:124-9. [DOI: 10.1007/s13206-015-9205-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
228 Li W, Fan G, Gao F, Cui Y, Wang W, Luo X. High-activity Fe3O4 nanozyme as signal amplifier: A simple, low-cost but efficient strategy for ultrasensitive photoelectrochemical immunoassay. Biosensors and Bioelectronics 2019;127:64-71. [DOI: 10.1016/j.bios.2018.11.043] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 20.5] [Reference Citation Analysis]
229 Huang P, Cheng CL, Chang YH, Liu CH, Hsu YC, Chen JS, Chang GC, Ho BC, Su KY, Chen HY, Yu SL. Molecular gene signature and prognosis of non-small cell lung cancer. Oncotarget 2016;7:51898-907. [PMID: 27437769 DOI: 10.18632/oncotarget.10622] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
230 Li Y, Liu Z, Liu H, Wang LE, Onodera H, Suzuki A, Suzuki K, Wadhwa R, Elimova E, Sudo K, Shiozaki H, Estrella J, Lee JS, Song S, Tan D, Ajani JA, Wei Q. Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients. Carcinogenesis 2014;35:2031-8. [PMID: 24990617 DOI: 10.1093/carcin/bgu142] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
231 Zhang Y, Li Z, Zhang J, Li H, Qiao Y, Huang C, Li B. Genetic Variants in MTHFR Gene Predict ≥ 2 Radiation Pneumonitis in Esophageal Squamous Cell Carcinoma Patients Treated with Thoracic Radiotherapy. PLoS One 2017;12:e0169147. [PMID: 28046029 DOI: 10.1371/journal.pone.0169147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
232 Thaysen-andersen M, Larsen MR, Packer NH, Palmisano G. Structural analysis of glycoprotein sialylation – Part I: pre-LC-MS analytical strategies. RSC Adv 2013;3:22683. [DOI: 10.1039/c3ra42960a] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
233 Ma RT, Zhao XB, Sun XY, Liu J, Ha W, Shi YP. A fluorescent molecularly imprinted device for the on-line analysis of AFP in human serum. J Mater Chem B 2019;7:6187-94. [PMID: 31565721 DOI: 10.1039/c9tb01331h] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
234 Zhang M, Liu X, Liu X, Li H, Sun W, Zhang Y. A pilot investigation of a urinary metabolic biomarker discovery in renal cell carcinoma. Int Urol Nephrol 2020;52:437-46. [DOI: 10.1007/s11255-019-02332-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
235 Roudnicky F, Poyet C, Buser L, Saba K, Wild P, Otto VI, Detmar M. Characterization of Tumor Blood Vasculature Expression of Human Invasive Bladder Cancer by Laser Capture Microdissection and Transcriptional Profiling. Am J Pathol 2020;190:1960-70. [PMID: 32585158 DOI: 10.1016/j.ajpath.2020.05.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
236 Gerger A, LaBonte M, Lenz HJ. Molecular predictors of response to antiangiogenesis therapies. Cancer J. 2011;17:134-141. [PMID: 21427557 DOI: 10.1097/ppo.0b013e318212db3c] [Cited by in Crossref: 43] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
237 Rajc J, Gugić D, Fröhlich I, Marjanović K, Dumenčić B. Prognostic role of Nectin-4 expression in luminal B (HER2 negative) breast cancer. Pathol Res Pract 2017;213:1102-8. [PMID: 28778498 DOI: 10.1016/j.prp.2017.07.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
238 Ülger Y, Dadaş E, Yalinbaş Kaya B, Sümbül AT, Genç A, Bayram S. The analysis of lncRNA HOTAIR rs12826786 C>T polymorphism and gastric cancer susceptibility in a Turkish population: lack of any association in a hospital-based case-control study. Ir J Med Sci 2017;186:859-65. [PMID: 28342055 DOI: 10.1007/s11845-017-1596-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
239 Panteli JT, Forkus BA, Van Dessel N, Forbes NS. Genetically modified bacteria as a tool to detect microscopic solid tumor masses with triggered release of a recombinant biomarker. Integr Biol (Camb) 2015;7:423-34. [PMID: 25737274 DOI: 10.1039/c5ib00047e] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
240 Flepisi BT, Bouic P, Sissolak G, Rosenkranz B. Biomarkers of HIV-associated Cancer. Biomark Cancer 2014;6:11-20. [PMID: 25057241 DOI: 10.4137/BIC.S15056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
241 Formicola D, Petrosino G, Lasorsa VA, Pignataro P, Cimmino F, Vetrella S, Longo L, Tonini GP, Oberthuer A, Iolascon A, Fischer M, Capasso M. An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma. J Transl Med 2016;14:142. [PMID: 27188717 DOI: 10.1186/s12967-016-0896-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
242 Yin JJ, Zhou ZW, Zhou SF. Cyclodextrin-based targeting strategies for tumor treatment. Drug Deliv Transl Res 2013;3:364-74. [PMID: 25788282 DOI: 10.1007/s13346-013-0140-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
243 Wei LQ, Li L, Lu C, Liu J, Chen Y, Wu H. Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1. J Cell Physiol 2019;234:5153-62. [PMID: 30362512 DOI: 10.1002/jcp.27319] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
244 Rana S, Singla AK, Bajaj A, Elci SG, Miranda OR, Mout R, Yan B, Jirik FR, Rotello VM. Array-based sensing of metastatic cells and tissues using nanoparticle-fluorescent protein conjugates. ACS Nano 2012;6:8233-40. [PMID: 22920837 DOI: 10.1021/nn302917e] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 8.7] [Reference Citation Analysis]
245 Mundi N, Prokopec SD, Ghasemi F, Warner A, Patel K, MacNeil D, Howlett C, Stecho W, Plantinga P, Pinto N, Ruicci KM, Khan MI, Han MW, Yoo J, Fung K, Sahovaler A, Palma DA, Winquist E, Mymryk JS, Barrett JW, Boutros PC, Nichols AC. Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival. Cancers Head Neck 2019;4:5. [PMID: 31844556 DOI: 10.1186/s41199-019-0045-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
246 Liu R, Liu X, Tang Y, Wu L, Hou X, Lv Y. Highly Sensitive Immunoassay Based on Immunogold−Silver Amplification and Inductively Coupled Plasma Mass Spectrometric Detection. Anal Chem 2011;83:2330-6. [DOI: 10.1021/ac103265z] [Cited by in Crossref: 133] [Cited by in F6Publishing: 121] [Article Influence: 13.3] [Reference Citation Analysis]
247 Chandler K, Goldman R. Glycoprotein disease markers and single protein-omics. Mol Cell Proteomics. 2013;12:836-845. [PMID: 23399550 DOI: 10.1074/mcp.R112.026930] [Cited by in Crossref: 44] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
248 Tang Q, Holland-Letz T, Slynko A, Cuk K, Marme F, Schott S, Heil J, Qu B, Golatta M, Bewerunge-Hudler M, Sutter C, Surowy H, Wappenschmidt B, Schmutzler R, Hoth M, Bugert P, Bartram CR, Sohn C, Schneeweiss A, Yang R, Burwinkel B. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA. Oncotarget 2016;7:64191-202. [PMID: 27577081 DOI: 10.18632/oncotarget.11640] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
249 Monteiro-Amado F, Castro-Silva II, Lima CJ, Soares FA, Kowalski LP, Granjeiro JM. Immunohistochemical evaluation of MMP-2, MMP-9 and CD31/microvascular density in squamous cell carcinomas of the floor of the mouth. Braz Dent J 2013;24:3-9. [PMID: 23657405 DOI: 10.1590/0103-6440201301941] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
250 Yang R, Pfütze K, Zucknick M, Sutter C, Wappenschmidt B, Marme F, Qu B, Cuk K, Engel C, Schott S, Schneeweiss A, Brenner H, Claus R, Plass C, Bugert P, Hoth M, Sohn C, Schmutzler R, Bartram CR, Burwinkel B. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood. Int J Cancer 2015;136:1845-55. [PMID: 25213452 DOI: 10.1002/ijc.29205] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
251 Garrido-medina R, Diez-masa JC, de Frutos M. On-capillary fluorescent labeling and capillary electrophoresis laser-induced fluorescence analysis of glycoforms of intact prostate-specific antigen: CE and CEC. ELECTROPHORESIS 2013;34:2295-302. [DOI: 10.1002/elps.201200651] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
252 Rigau M, Olivan M, Garcia M, Sequeiros T, Montes M, Colás E, Llauradó M, Planas J, Torres Id, Morote J, Cooper C, Reventós J, Clark J, Doll A. The present and future of prostate cancer urine biomarkers. Int J Mol Sci 2013;14:12620-49. [PMID: 23774836 DOI: 10.3390/ijms140612620] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
253 Perfézou M, Turner A, Merkoçi A. Cancer detection using nanoparticle-based sensors. Chem Soc Rev 2012;41:2606-22. [PMID: 21796315 DOI: 10.1039/c1cs15134g] [Cited by in Crossref: 256] [Cited by in F6Publishing: 30] [Article Influence: 25.6] [Reference Citation Analysis]
254 Zhao J, Mai C, Weng D, Chen C, Zhou Z, Liu Y, Zhou Z, Wang P. Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients. Cancer Biomark 2018;22:375-84. [PMID: 29758923 DOI: 10.3233/CBM-170832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
255 Varghese S, Lao-Sirieix P, Fitzgerald RC. Identification and clinical implementation of biomarkers for Barrett’s esophagus. Gastroenterology. 2012;142:435-441.e2. [PMID: 22266150 DOI: 10.1053/j.gastro.2012.01.013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
256 Végvári A, Marko-Varga G. Clinical protein science and bioanalytical mass spectrometry with an emphasis on lung cancer. Chem Rev 2010;110:3278-98. [PMID: 20415473 DOI: 10.1021/cr100011x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
257 Saeed A, Najam-ul-haq M, Jabeen F, Svec F. High Affinity Phosphopeptides Enrichment and Desalting of Biological Materials on Newly Engineered Poly(Glycidyl Propargyl Ether/Divinyl Benzene). Anal Chem 2013;85:8979-86. [DOI: 10.1021/ac4015484] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
258 Triozzi PL, Singh AD. Blood biomarkers for uveal melanoma. Future Oncol 2012;8:205-15. [PMID: 22335584 DOI: 10.2217/fon.11.150] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
259 Bleker de Oliveira M, Koshkin V, Liu G, Krylov SN. Analytical Challenges in Development of Chemoresistance Predictors for Precision Oncology. Anal Chem 2020;92:12101-10. [PMID: 32790291 DOI: 10.1021/acs.analchem.0c02644] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
260 Koren A, Motaln H, Cufer T. Lung cancer stem cells: a biological and clinical perspective. Cell Oncol 2013;36:265-75. [DOI: 10.1007/s13402-013-0141-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
261 Li D, Tu T, Wu X. Efficient preparation of template immobilization-based boronate affinity surface-imprinted silica nanoparticles using poly(4-aminobenzyl alcohol) as an imprinting coating for glycoprotein recognition. Anal Methods 2018;10:4419-29. [DOI: 10.1039/c8ay00632f] [Cited by in Crossref: 27] [Article Influence: 9.0] [Reference Citation Analysis]
262 Proença CA, Baldo TA, Freitas TA, Materón EM, Wong A, Durán AA, Melendez ME, Zambrano G, Faria RC. Novel enzyme-free immunomagnetic microfluidic device based on Co0.25Zn0.75Fe2O4 for cancer biomarker detection. Analytica Chimica Acta 2019;1071:59-69. [DOI: 10.1016/j.aca.2019.04.047] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
263 Song R, Liu Q, Hutvagner G, Nguyen H, Ramamohanarao K, Wong L, Li J. Rule discovery and distance separation to detect reliable miRNA biomarkers for the diagnosis of lung squamous cell carcinoma. BMC Genomics 2014;15 Suppl 9:S16. [PMID: 25521201 DOI: 10.1186/1471-2164-15-S9-S16] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
264 Yaoxing H, Danchun Y, Xiaojuan S, Shuman J, Qingqing Y, Lin J. Identification of Novel Susceptible Genes of Gastric Cancer Based on Integrated Omics Data. Front Cell Dev Biol 2021;9:712020. [PMID: 34354996 DOI: 10.3389/fcell.2021.712020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
265 Bol D, Ebner R. Gene expression profiling in the discovery, optimization and development of novel drugs: one universal screening platform. Pharmacogenomics 2006;7:227-35. [DOI: 10.2217/14622416.7.2.227] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
266 Ahmed SA, Hamed MA, Omar OS. Clinical utility of certain biomarkers as predictors of breast cancer with or without metastasis among Egyptian females. Tumour Biol 2015;36:815-22. [PMID: 25296733 DOI: 10.1007/s13277-014-2689-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
267 Sang Y, Bi X, Liu Y, Zhang W, Wang D. Adverse prognostic impact of TGFB1 T869C polymorphism in non-small-cell lung cancer. Onco Targets Ther 2017;10:1513-8. [PMID: 28331344 DOI: 10.2147/OTT.S123685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
268 Dey S, Vaidyanathan R, Carrascosa LG, Shiddiky MJA, Trau M. Electric Field Induced Isolation, Release, and Recapture of Tumor Cells. ACS Sens 2016;1:399-405. [DOI: 10.1021/acssensors.5b00157] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
269 Polanco C, Vazquez II, Martinez-Rivas A, Arias-Estrada M, Buhse T, Calva JJ, Aguilar Salinas C, Pimentel Hernández C, Uversky VN. Real Time Monitoring of Children, and Adults with Mental Disabilities Using a Low-Cost Non-Invasive Electronic Device. Micromachines (Basel) 2017;8:E292. [PMID: 30400482 DOI: 10.3390/mi8100292] [Reference Citation Analysis]
270 de Valpine P, Bitter HM, Brown MP, Heller J. A simulation-approximation approach to sample size planning for high-dimensional classification studies. Biostatistics 2009;10:424-35. [PMID: 19234308 DOI: 10.1093/biostatistics/kxp001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
271 Yang H, Zhuang Y, Sun Y, Dai A, Shi X, Wu D, Li F, Hu H, Yang S. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Biomaterials 2011;32:4584-93. [DOI: 10.1016/j.biomaterials.2011.03.018] [Cited by in Crossref: 203] [Cited by in F6Publishing: 186] [Article Influence: 20.3] [Reference Citation Analysis]
272 Stenemo M, Teleman J, Sjöström M, Grubb G, Malmström E, Malmström J, Niméus E. Cancer associated proteins in blood plasma: Determining normal variation. Proteomics 2016;16:1928-37. [PMID: 27121749 DOI: 10.1002/pmic.201500204] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
273 Virtanen C, Woodgett J. Clinical Uses of Microarrays in Cancer Research. In: Trent RJ, editor. Clinical Bioinformatics. Totowa: Humana Press; 2008. pp. 87-113. [DOI: 10.1007/978-1-60327-148-6_6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
274 Putila J, Remick SC, Guo NL. Combining clinical, pathological, and demographic factors refines prognosis of lung cancer: a population-based study. PLoS One 2011;6:e17493. [PMID: 21364765 DOI: 10.1371/journal.pone.0017493] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
275 Gori A, Longhi R, Peri C, Colombo G. Peptides for immunological purposes: design, strategies and applications. Amino Acids 2013;45:257-68. [DOI: 10.1007/s00726-013-1526-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
276 Pesch B, Brüning T, Johnen G, Casjens S, Bonberg N, Taeger D, Müller A, Weber DG, Behrens T. Biomarker research with prospective study designs for the early detection of cancer. Biochim Biophys Acta 2014;1844:874-83. [PMID: 24361552 DOI: 10.1016/j.bbapap.2013.12.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
277 Safavi M, Sabourian R, Abdollahi M. The development of biomarkers to reduce attrition rate in drug discovery focused on oncology and central nervous system. Expert Opinion on Drug Discovery 2016;11:939-56. [DOI: 10.1080/17460441.2016.1217196] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
278 Reynoso D, Subbiah V, Trent JC, Guadagnolo BA, Lazar AJ, Benjamin R, Pollock RE, Ludwig JA. Neoadjuvant treatment of soft-tissue sarcoma: A multimodality approach. J Surg Oncol 2010;101:327-33. [DOI: 10.1002/jso.21481] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
279 Zhao Q, Piao J, Peng W, Wang J, Gao W, Wu X, Wang H, Gong X, Chang J, Zhang B. A Metal Chelator as a Plasmonic Signal-Generation Superregulator for Ultrasensitive Colorimetric Bioassays of Disease Biomarkers. Adv Sci (Weinh) 2018;5:1800295. [PMID: 30027059 DOI: 10.1002/advs.201800295] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
280 Silva MLS. Lectin biosensors in cancer glycan biomarker detection. Adv Clin Chem 2019;93:1-61. [PMID: 31655728 DOI: 10.1016/bs.acc.2019.07.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
281 Kolk A, Jubitz N, Mengele K, Mantwill K, Bissinger O, Schmitt M, Kremer M, Holm PS. Expression of Y-box-binding protein YB-1 allows stratification into long- and short-term survivors of head and neck cancer patients. Br J Cancer 2011;105:1864-73. [PMID: 22095225 DOI: 10.1038/bjc.2011.491] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
282 Zhu Y, Peng J, Jiang L, Zhu J. Fluorescent immunosensor based on CuS nanoparticles for sensitive detection of cancer biomarker. Analyst 2014;139:649-55. [DOI: 10.1039/c3an01987j] [Cited by in Crossref: 63] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
283 Padler-Karavani V, Yu H, Cao H, Chokhawala H, Karp F, Varki N, Chen X, Varki A. Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology 2008;18:818-30. [PMID: 18669916 DOI: 10.1093/glycob/cwn072] [Cited by in Crossref: 230] [Cited by in F6Publishing: 207] [Article Influence: 17.7] [Reference Citation Analysis]
284 Trost B, Kindrachuk J, Scruten E, Griebel P, Kusalik A, Napper S. Kinotypes: stable species- and individual-specific profiles of cellular kinase activity. BMC Genomics 2013;14:854. [PMID: 24314169 DOI: 10.1186/1471-2164-14-854] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
285 Iliescu FS, Poenar DP, Yu F, Ni M, Chan KH, Cima I, Taylor HK, Cima I, Iliescu C. Recent advances in microfluidic methods in cancer liquid biopsy. Biomicrofluidics 2019;13:041503. [PMID: 31431816 DOI: 10.1063/1.5087690] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
286 Nettikadan S, Radke K, Johnson J, Xu J, Lynch M, Mosher C, Henderson E. Detection and quantification of protein biomarkers from fewer than 10 cells. Mol Cell Proteomics 2006;5:895-901. [PMID: 16489239 DOI: 10.1074/mcp.M500350-MCP200] [Cited by in Crossref: 45] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
287 Munoz DF, Plevritis SK. Estimating Breast Cancer Survival by Molecular Subtype in the Absence of Screening and Adjuvant Treatment. Med Decis Making 2018;38:32S-43S. [PMID: 29554464 DOI: 10.1177/0272989X17743236] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
288 Dudas SP, Tainsky MA. Detecting tumor-specific autoantibodies for cancer diagnosis: a technology overview. Expert Opin Med Diagn 2009;3:251-61. [PMID: 23488461 DOI: 10.1517/17530050902832848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
289 Ali Danovi S. Finding the needle in the haystack. Nat Rev Cancer 2008;8:659-659. [DOI: 10.1038/nrc2474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
290 Gramolini A, Peterman S, Kislinger T. Mass Spectrometry–Based Proteomics: A Useful Tool for Biomarker Discovery? Clin Pharmacol Ther 2008;83:758-60. [DOI: 10.1038/clpt.2008.18] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
291 Rusling JF. Multiplexed electrochemical protein detection and translation to personalized cancer diagnostics. Anal Chem 2013;85:5304-10. [PMID: 23635325 DOI: 10.1021/ac401058v] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 12.4] [Reference Citation Analysis]
292 Kwon HN, Lee H, Park JW, Kim YH, Park S, Kim JJ. Screening for Early Gastric Cancer Using a Noninvasive Urine Metabolomics Approach. Cancers (Basel) 2020;12:E2904. [PMID: 33050308 DOI: 10.3390/cancers12102904] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
293 Vivek R, Rejeeth C, Thangam R. Targeted Nanotherapeutics Based on Cancer Biomarkers. Multifunctional Systems for Combined Delivery, Biosensing and Diagnostics. Elsevier; 2017. pp. 229-44. [DOI: 10.1016/b978-0-323-52725-5.00012-5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
294 Phang CW, Abd Malek SN, Karsani SA. Flavokawain C exhibits anti-tumor effects on in vivo HCT 116 xenograft and identification of its apoptosis-linked serum biomarkers via proteomic analysis. Biomed Pharmacother 2021;137:110846. [PMID: 33761587 DOI: 10.1016/j.biopha.2020.110846] [Reference Citation Analysis]
295 Castellano JJ, Navarro A, Viñolas N, Marrades RM, Moises J, Cordeiro A, Saco A, Muñoz C, Fuster D, Molins L, Ramirez J, Monzo M. LincRNA-p21 Impacts Prognosis in Resected Non–Small Cell Lung Cancer Patients through Angiogenesis Regulation. Journal of Thoracic Oncology 2016;11:2173-82. [DOI: 10.1016/j.jtho.2016.07.015] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 9.6] [Reference Citation Analysis]
296 Eng KH. Randomized reverse marker strategy design for prospective biomarker validation. Stat Med 2014;33:3089-99. [PMID: 24639051 DOI: 10.1002/sim.6146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
297 Jeevanandam J, Sabbih G, Tan KX, Danquah MK. Oncological Ligand-Target Binding Systems and Developmental Approaches for Cancer Theranostics. Mol Biotechnol 2021;63:167-83. [PMID: 33423212 DOI: 10.1007/s12033-020-00296-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
298 Cho JY. Molecular diagnosis for personalized target therapy in gastric cancer. J Gastric Cancer. 2013;13:129-135. [PMID: 24156032 DOI: 10.5230/jgc.2013.13.3.129] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.8] [Reference Citation Analysis]
299 Nahavandi S, Baratchi S, Soffe R, Tang S, Nahavandi S, Mitchell A, Khoshmanesh K. Microfluidic platforms for biomarker analysis. Lab Chip 2014;14:1496-514. [DOI: 10.1039/c3lc51124c] [Cited by in Crossref: 83] [Cited by in F6Publishing: 31] [Article Influence: 11.9] [Reference Citation Analysis]
300 Timpe LC, Yen R, Haste NV, Litsakos-Cheung C, Yen TY, Macher BA. Systemic alteration of cell-surface and secreted glycoprotein expression in malignant breast cancer cell lines. Glycobiology 2013;23:1240-9. [PMID: 23918816 DOI: 10.1093/glycob/cwt060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
301 Madu CO, Lu Y. Novel diagnostic biomarkers for prostate cancer. J Cancer 2010;1:150-77. [PMID: 20975847 DOI: 10.7150/jca.1.150] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 11.4] [Reference Citation Analysis]
302 Yip S, Iafrate AJ, Louis DN. Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers. J Neuropathol Exp Neurol 2008;67:1-15. [PMID: 18091559 DOI: 10.1097/nen.0b013e31815f65fb] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 4.9] [Reference Citation Analysis]
303 Song Z, Li M, Li B, Yan Y, Song Y. Automatic detecting and counting magnetic beads-labeled target cells from a suspension in a microfluidic chip. ELECTROPHORESIS 2019;40:897-905. [DOI: 10.1002/elps.201800345] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
304 Zhang Q, Liu H, Zhu Q, Zhan P, Zhu S, Zhang J, Lv T, Song Y. Patterns and functional implications of platelets upon tumor "education". Int J Biochem Cell Biol 2017;90:68-80. [PMID: 28754316 DOI: 10.1016/j.biocel.2017.07.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
305 Li C, Ma X, Guan Y, Tang J, Zhang B. Microcantilever Array Biosensor for Simultaneous Detection of Carcinoembryonic Antigens and α-Fetoprotein Based on Real-Time Monitoring of the Profile of Cantilever. ACS Sens 2019;4:3034-41. [DOI: 10.1021/acssensors.9b01604] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
306 Tang CK, Vaze A, Rusling JF. Paper-based electrochemical immunoassay for rapid, inexpensive cancer biomarker protein detection. Anal Methods 2014;6:8878-81. [PMID: 25431626 DOI: 10.1039/C4AY01962H] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 3.4] [Reference Citation Analysis]
307 Too IH, Ling MH. Signal Peptidase Complex Subunit 1 and Hydroxyacyl-CoA Dehydrogenase Beta Subunit Are Suitable Reference Genes in Human Lungs. ISRN Bioinform 2012;2012:790452. [PMID: 25969744 DOI: 10.5402/2012/790452] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
308 Sugawara K, Kadoya T, Kuramitz H, Mihara Y. Design of carbohydrate/electron-transfer peptides for human histocytic lymphoma cell sensing. Anal Chim Acta 2017;983:198-205. [PMID: 28811027 DOI: 10.1016/j.aca.2017.06.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
309 Jiang R, Zou X, Hu W, Fan Y, Yan Y, Zhang M, You R, Sun R, Luo D, Chen Q, Huang P, Hua Y, Guo L, Chen M. The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients. Tumor Biol 2015;36:7775-87. [DOI: 10.1007/s13277-015-3505-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
310 Ahn SM, Simpson RJ. Body fluid proteomics: Prospects for biomarker discovery. Proteomics Clin Appl 2007;1:1004-15. [PMID: 21136753 DOI: 10.1002/prca.200700217] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 5.1] [Reference Citation Analysis]
311 Qiu Z, Du X, Chen K, Dai Y, Wang S, Xiao J, Li G. Gene signatures with predictive and prognostic survival values in human osteosarcoma. PeerJ 2021;9:e10633. [PMID: 33520450 DOI: 10.7717/peerj.10633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
312 Tsau H, Yen AM, Fann JC, Wu WY, Yu C, Chen SL, Chiu SY, Tabár L, Kuo W, Chen H, Chang K. Mammographic tumour appearance and triple-negative breast cancer associated with long-term prognosis of breast cancer death: A Swedish Cohort Study. Cancer Epidemiology 2015;39:200-8. [DOI: 10.1016/j.canep.2015.01.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
313 Ludwig JA, Lamhamedi-Cherradi SE, Lee HY, Naing A, Benjamin R. Dual targeting of the insulin-like growth factor and collateral pathways in cancer: combating drug resistance. Cancers (Basel) 2011;3:3029-54. [PMID: 24212944 DOI: 10.3390/cancers3033029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
314 Reza KK, Dey S, Wuethrich A, Sina AAI, Korbie D, Wang Y, Trau M. Parallel profiling of cancer cells and proteins using a graphene oxide functionalized ac-EHD SERS immunoassay. Nanoscale 2018;10:18482-91. [DOI: 10.1039/c8nr02886a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 4.7] [Reference Citation Analysis]
315 Tan DSW, Thomas GV, Garrett MD, Banerji U, de Bono JS, Kaye SB, Workman P. Biomarker-Driven Early Clinical Trials in Oncology: A Paradigm Shift in Drug Development. The Cancer Journal 2009;15:406-20. [DOI: 10.1097/ppo.0b013e3181bd0445] [Cited by in Crossref: 130] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
316 Ma Y, Chi J, Zheng Z, Attygalle A, Kim IY, Du H. Therapeutic prognosis of prostate cancer using surface-enhanced Raman scattering of patient urine and multivariate statistical analysis. J Biophotonics 2021;14:e202000275. [PMID: 32909380 DOI: 10.1002/jbio.202000275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
317 Zhu YM, Zhong ZX, Liu ZM. Relationship between let-7a and gastric mucosa cancerization and its significance. World J Gastroenterol 2010; 16(26): 3325-3329 [PMID: 20614490 DOI: 10.3748/wjg.v16.i26.3325] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
318 Kim S, Loevner L, Quon H, Sherman E, Weinstein G, Kilger A, Poptani H. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res. 2009;15:986-994. [PMID: 19188170 DOI: 10.1158/1078-0432.ccr-08-1287] [Cited by in Crossref: 278] [Cited by in F6Publishing: 134] [Article Influence: 23.2] [Reference Citation Analysis]
319 Samarendra H, Jones K, Petrinic T, Silva MA, Reddy S, Soonawalla Z, Gordon-Weeks A. A meta-analysis of CXCL12 expression for cancer prognosis. Br J Cancer. 2017;117:124-135. [PMID: 28535157 DOI: 10.1038/bjc.2017.134] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
320 Qian X, Xiang Y, Zhang H, Chen Y, Chai Y, Yuan R. Aptamer/nanoparticle-based sensitive, multiplexed electronic coding of proteins and small biomolecules through a backfilling strategy. Chemistry 2010;16:14261-5. [PMID: 21108261 DOI: 10.1002/chem.201002585] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
321 Tolmachev V, Stone-elander S, Orlova A. Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls. The Lancet Oncology 2010;11:992-1000. [DOI: 10.1016/s1470-2045(10)70088-7] [Cited by in Crossref: 81] [Cited by in F6Publishing: 27] [Article Influence: 7.4] [Reference Citation Analysis]
322 Bock C. Epigenetic biomarker development. Epigenomics 2009;1:99-110. [PMID: 22122639 DOI: 10.2217/epi.09.6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 8.3] [Reference Citation Analysis]
323 Wang Z, Han B, Zhang Z, Pan J, Xia H. Expression of angiopoietin-like 4 and tenascin C but not cathepsin C mRNA predicts prognosis of oral tongue squamous cell carcinoma. Biomarkers 2010;15:39-46. [PMID: 19775228 DOI: 10.3109/13547500903261362] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
324 Hu L, Yang GZ, Zhang Y, Feng D, Zhai YX, Gong H, Qi CY, Fu H, Ye MM, Cai QP, Gao CF. Overexpression of SULT2B1b is an independent prognostic indicator and promotes cell growth and invasion in colorectal carcinoma. Lab Invest 2015;95:1005-18. [PMID: 26121319 DOI: 10.1038/labinvest.2015.84] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
325 Sarker D, Pacey S, Workman P. Use of pharmacokinetic/pharmacodynamic biomarkers to support rational cancer drug development. Biomark Med 2007;1:399-417. [PMID: 20477383 DOI: 10.2217/17520363.1.3.399] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
326 Ma Y, Li X, Li W, Liu Z. Glycan-Imprinted Magnetic Nanoparticle-Based SELEX for Efficient Screening of Glycoprotein-Binding Aptamers. ACS Appl Mater Interfaces 2018;10:40918-26. [PMID: 30379519 DOI: 10.1021/acsami.8b14441] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
327 Pan S, Chen R, Aebersold R, Brentnall TA. Mass spectrometry based glycoproteomics--from a proteomics perspective. Mol Cell Proteomics. 2011;10:R110.003251. [PMID: 20736408 DOI: 10.1074/mcp.r110.003251] [Cited by in Crossref: 164] [Cited by in F6Publishing: 78] [Article Influence: 14.9] [Reference Citation Analysis]
328 Dzik-jurasz A. Are targeted contrast agents realistically going to reach the clinic? Recent regulatory experience with targeted MRI contrast agents. BJR 2006;79:870-2. [DOI: 10.1259/bjr/68807002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
329 Solivio MJ, Less R, Rynes ML, Kramer M, Aksan A. Adsorbing/dissolving Lyoprotectant Matrix Technology for Non-cryogenic Storage of Archival Human Sera. Sci Rep 2016;6:24186. [PMID: 27068126 DOI: 10.1038/srep24186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
330 Chua MMJ, Lee M, Dominguez I. Cancer-type dependent expression of CK2 transcripts. PLoS One 2017;12:e0188854. [PMID: 29206231 DOI: 10.1371/journal.pone.0188854] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
331 Hiura H, Okae H, Kobayash H, Miyauchi N, Sato F, Sato A, Suzuki F, Nagase S, Sugawara J, Nakai K, Yaegashi N, Arima T. High-throughput detection of aberrant imprint methylation in the ovarian cancer by the bisulphite PCR-Luminex method. BMC Med Genomics 2012;5:8. [PMID: 22443985 DOI: 10.1186/1755-8794-5-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
332 Hoffmann AC, Brabender J, Metzger R, Ling F, Warnecke-Eberz U, Lurje G, Hoelscher AH, Schneider PM, Vallböhmer D. Dihydropyrimidine dehydrogenase mRNA expression in peripheral blood of rectal cancer patients is significantly associated with residual tumor and distant metastases following resection. J Surg Oncol 2009;99:296-301. [PMID: 19180589 DOI: 10.1002/jso.21233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
333 Ong CA, Shannon NB, Ross-Innes CS, O'Donovan M, Rueda OM, Hu DE, Kettunen MI, Walker CE, Noorani A, Hardwick RH, Caldas C, Brindle K, Fitzgerald RC. Amplification of TRIM44: pairing a prognostic target with potential therapeutic strategy. J Natl Cancer Inst 2014;106:dju050. [PMID: 24777112 DOI: 10.1093/jnci/dju050] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
334 Shoushtari AN, Szmulewitz RZ, Rinker-Schaeffer CW. Metastasis-suppressor genes in clinical practice: lost in translation? Nat Rev Clin Oncol 2011;8:333-42. [PMID: 21522123 DOI: 10.1038/nrclinonc.2011.65] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
335 Liu T, Hossain M, Schepmoes AA, Fillmore TL, Sokoll LJ, Kronewitter SR, Izmirlian G, Shi T, Qian WJ, Leach RJ, Thompson IM, Chan DW, Smith RD, Kagan J, Srivastava S, Rodland KD, Camp DG 2nd. Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests. J Proteomics 2012;75:4747-57. [PMID: 22846433 DOI: 10.1016/j.jprot.2012.01.035] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
336 Geng J, Sun J, Lin Q, Gu J, Zhao Y, Zhang H, Feng X, He Y, Wang W, Zhou X, Yu J. Methylation status of NEUROG2 and NID2 improves the diagnosis of stage I NSCLC. Oncol Lett 2012;3:901-6. [PMID: 22741015 DOI: 10.3892/ol.2012.587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 0.2] [Reference Citation Analysis]
337 Mavrič T, Benčina M, Imani R, Junkar I, Valant M, Kralj-iglič V, Iglič A. Electrochemical Biosensor Based on TiO 2 Nanomaterials for Cancer Diagnostics. Elsevier; 2018. pp. 63-105. [DOI: 10.1016/bs.abl.2017.12.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
338 Lee CE, Vincent-Chong VK, Ramanathan A, Kallarakkal TG, Karen-Ng LP, Ghani WM, Rahman ZA, Ismail SM, Abraham MT, Tay KK, Mustafa WM, Cheong SC, Zain RB. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications. Int J Med Sci 2015;12:937-45. [PMID: 26664254 DOI: 10.7150/ijms.11605] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
339 Matsumura K, Opiekun M, Oka H, Vachani A, Albelda SM, Yamazaki K, Beauchamp GK. Urinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancer. PLoS One 2010;5:e8819. [PMID: 20111698 DOI: 10.1371/journal.pone.0008819] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 7.6] [Reference Citation Analysis]
340 Ke R, Nong RY, Fredriksson S, Landegren U, Nilsson M. Improving precision of proximity ligation assay by amplified single molecule detection. PLoS One 2013;8:e69813. [PMID: 23874999 DOI: 10.1371/journal.pone.0069813] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
341 Sun X, Dong J, Li J, Ye M, Zhang W, Ou J. Facile preparation of polysaccharide functionalized macroporous adsorption resin for highly selective enrichment of glycopeptides. Journal of Chromatography A 2017;1498:72-9. [DOI: 10.1016/j.chroma.2016.12.045] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
342 Zhang L, Wang F, Li Q, Wang L, Fan C, Li J, Zhu Y. Classifying Cell Types with DNA-Encoded Ligand-Receptor Interactions on the Cell Membrane. Nano Lett 2020;20:3521-7. [PMID: 32223268 DOI: 10.1021/acs.nanolett.0c00445] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
343 Shimada K, Fujii T, Anai S, Fujimoto K, Konishi N. ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder. BMC Urol 2011;11:22. [PMID: 22032647 DOI: 10.1186/1471-2490-11-22] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
344 Yan B, Dai X, Ma Q, Wu X. Stromal Neutrophil Extracellular Trap Density Is an Independent Prognostic Factor for Cervical Cancer Recurrence. Front Oncol 2021;11:659445. [PMID: 34458135 DOI: 10.3389/fonc.2021.659445] [Reference Citation Analysis]
345 Wong KM, Capasso A, Eckhardt SG. The changing landscape of phase I trials in oncology. Nat Rev Clin Oncol 2016;13:106-17. [DOI: 10.1038/nrclinonc.2015.194] [Cited by in Crossref: 55] [Cited by in F6Publishing: 34] [Article Influence: 9.2] [Reference Citation Analysis]
346 Falcón-Pérez JM, Lu SC, Mato JM. Sub-proteome approach to the knowledge of liver. Proteomics Clin Appl 2010;4:407-15. [PMID: 21137060 DOI: 10.1002/prca.200900123] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
347 Song J, Liu J, Lv D, Meng X, Li X. Analysis of Genome-Wide Alternative Splicing Profiling and Development of Potential Drugs in Lung Adenocarcinoma. Front Genet 2021;12:767259. [PMID: 34737768 DOI: 10.3389/fgene.2021.767259] [Reference Citation Analysis]
348 Honda K, Ono M, Shitashige M, Masuda M, Kamita M, Miura N, Yamada T. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine. Jpn J Clin Oncol 2013;43:103-9. [PMID: 23248327 DOI: 10.1093/jjco/hys200] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
349 Rusling JF, Kumar CV, Gutkind JS, Patel V. Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. Analyst. 2010;135:2496-2511. [PMID: 20614087 DOI: 10.1039/c0an00204f] [Cited by in Crossref: 368] [Cited by in F6Publishing: 308] [Article Influence: 33.5] [Reference Citation Analysis]
350 Wang B, Zhao M, Mehdi M, Wang G, Gao P, Zhang K. Biomolecule-assisted synthesis and functionality of metal nanoclusters for biological sensing: a review. Mater Chem Front 2019;3:1722-35. [DOI: 10.1039/c9qm00165d] [Cited by in Crossref: 22] [Article Influence: 11.0] [Reference Citation Analysis]
351 Jia Y, Gao C, He J, Feng D, Xing K, Wu M, Liu Y, Cai W, Feng X. Unlabeled multi tumor marker detection system based on bioinitiated light addressable potentiometric sensor. Analyst 2012;137:3806. [DOI: 10.1039/c2an35188a] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
352 Wang L, Zhang H, Wang C, Xu Y, Su J, Wang X, Liu X, Feng D, Wang L, Zuo X, Shi J, Ge Z, Fan C, Mi X. Poly-adenine-mediated spherical nucleic acids for strand displacement-based DNA/RNA detection. Biosens Bioelectron 2019;127:85-91. [PMID: 30594078 DOI: 10.1016/j.bios.2018.12.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
353 Malhotra R, Patel V, Chikkaveeraiah BV, Munge BS, Cheong SC, Zain RB, Abraham MT, Dey DK, Gutkind JS, Rusling JF. Ultrasensitive detection of cancer biomarkers in the clinic by use of a nanostructured microfluidic array. Anal Chem 2012;84:6249-55. [PMID: 22697359 DOI: 10.1021/ac301392g] [Cited by in Crossref: 131] [Cited by in F6Publishing: 117] [Article Influence: 14.6] [Reference Citation Analysis]
354 Pradhan M, Pathak S, Mathur D, Ladiwala U. Optically trapping tumor cells to assess differentiation and prognosis of cancers. Biomed Opt Express 2016;7:943-8. [PMID: 27231599 DOI: 10.1364/BOE.7.000943] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
355 Riedmaier I, Becker C, Pfaffl MW, Meyer HH. The use of omic technologies for biomarker development to trace functions of anabolic agents. Journal of Chromatography A 2009;1216:8192-9. [DOI: 10.1016/j.chroma.2009.01.094] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.0] [Reference Citation Analysis]
356 Tinelli A, Vergara D, Martignago R, Leo G, Malvasi A, Tinelli R, Marsigliante S, Maffia M, Lorusso V. Ovarian cancer biomarkers: a focus on genomic and proteomic findings. Curr Genomics 2007;8:335-42. [PMID: 19384429 DOI: 10.2174/138920207782446142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
357 Wei Y, Ma H, Ren X, Ding C, Wang H, Sun X, Du B, Zhang Y, Wei Q. A dual-signaling electrochemical ratiometric method for sensitive detection of carcinoembryonic antigen based on Au-Cu2S-CuS/graphene and Au-CeO2 supported toluidine blue complex. Sensors and Actuators B: Chemical 2018;256:504-11. [DOI: 10.1016/j.snb.2017.10.136] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 7.7] [Reference Citation Analysis]
358 Bii VM, Rae DT, Trobridge GD. A novel gammaretroviral shuttle vector insertional mutagenesis screen identifies SHARPIN as a breast cancer metastasis gene and prognostic biomarker. Oncotarget 2015;6:39507-20. [PMID: 26506596 DOI: 10.18632/oncotarget.6232] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
359 Chatterjee M, Levin NK, Shah JP, Ionan A, Grates HE, Tainsky MA. Pathways to implementation of serum proteomics for cancer. Expert Opin Med Diagn 2007;1:3-15. [PMID: 23489265 DOI: 10.1517/17530059.1.1.3] [Reference Citation Analysis]
360 Randall SA, Mckay MJ, Molloy MP. Evaluation of blood collection tubes using selected reaction monitoring MS: Implications for proteomic biomarker studies: SRM-MS of plasma proteins from various blood collection tubes. Proteomics 2010;10:2050-6. [DOI: 10.1002/pmic.200900517] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
361 Suzuki S, Tanigawara Y. Forced expression of S100A10 reduces sensitivity to oxaliplatin in colorectal cancer cells. Proteome Sci 2014;12:26. [PMID: 24851084 DOI: 10.1186/1477-5956-12-26] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
362 Stoch SA, Wagner JA. Biomarker Analysis as a Decision-Making Tool in Drug Discovery and Development: Implications for Peroxisome Proliferator-Activator Receptors. International Journal of Pharmaceutical Medicine 2007;21:271-7. [DOI: 10.2165/00124363-200721040-00003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
363 Zhang Y, Jing H, Wen T, Wang Y, Zhao Y, Wang X, Qian X, Ying W. Phenylboronic acid functionalized C3N4 facultative hydrophilic materials for enhanced enrichment of glycopeptides. Talanta 2019;191:509-18. [PMID: 30262092 DOI: 10.1016/j.talanta.2018.09.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
364 Lim SM, Lim JY, Cho JY. Targeted therapy in gastric cancer: Personalizing cancer treatment based on patient genome. World J Gastroenterol 2014; 20(8): 2042-2050 [PMID: 24587678 DOI: 10.3748/wjg.v20.i8.2042] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
365 Badr HA, AlSadek DM, El-Houseini ME, Saeui CT, Mathew MP, Yarema KJ, Ahmed H. Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example. Biomaterials 2017;116:158-73. [PMID: 27926828 DOI: 10.1016/j.biomaterials.2016.11.044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
366 Zhang S, Zhao Z, Duan W, Li Z, Nan Z, Du H, Wang M, Yang J, Huang C. The Influence of Blood Collection Tubes in Biomarkers' Screening by Mass Spectrometry. Proteomics Clin Appl 2020;14:e1900113. [PMID: 32365266 DOI: 10.1002/prca.201900113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
367 Zhang Y, Wang X, Cui D, Zhu J. Proteomic and N-glycoproteomic quantification reveal aberrant changes in the human saliva of oral ulcer patients. Proteomics 2016;16:3173-82. [PMID: 27763718 DOI: 10.1002/pmic.201600127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
368 Tien W, Chen Y, Wu K. SecretePipe: A Screening Pipeline for Secreted Proteins with Competence to Identify Potential Membrane-Bound Shed Markers. J Proteome Res 2013;12:1235-44. [DOI: 10.1021/pr3009012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
369 Chen YC, Tan X, Sun Q, Chen Q, Wang W, Fan X. Laser-emission imaging of nuclear biomarkers for high-contrast cancer screening and immunodiagnosis. Nat Biomed Eng 2017;1:724-35. [PMID: 29204310 DOI: 10.1038/s41551-017-0128-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 25] [Article Influence: 13.8] [Reference Citation Analysis]
370 Sheng KL, Kang L, Pridham KJ, Dunkenberger LE, Sheng Z, Varghese RT. An integrated approach to biomarker discovery reveals gene signatures highly predictive of cancer progression. Sci Rep 2020;10:21246. [PMID: 33277589 DOI: 10.1038/s41598-020-78126-3] [Reference Citation Analysis]
371 Sundaresan N, Rosen G, Boriani S. Primary Malignant Tumors of the Spine. Orthopedic Clinics of North America 2009;40:21-36. [DOI: 10.1016/j.ocl.2008.10.004] [Cited by in Crossref: 83] [Cited by in F6Publishing: 62] [Article Influence: 6.9] [Reference Citation Analysis]
372 Gruhl FJ, Rapp BE, Länge K. Biosensors for diagnostic applications. Adv Biochem Eng Biotechnol 2013;133:115-48. [PMID: 22223139 DOI: 10.1007/10_2011_130] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
373 Bessa C, Matos P, Jordan P, Gonçalves V. Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics. Int J Mol Sci 2020;21:E9032. [PMID: 33261131 DOI: 10.3390/ijms21239032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
374 Soliman SE, Abdelaleem AH, Alhanafy AM, Ibrahem RAL, Elhaded ASA, Assar MFA. Circulating miR-21-5p and miR-126-3p: diagnostic, prognostic value, and multivariate analysis in non-small-cell lung cancer. Mol Biol Rep 2021;48:2543-52. [PMID: 33837901 DOI: 10.1007/s11033-021-06302-3] [Reference Citation Analysis]
375 Stella R, Biancotto G, Arrigoni G, Barrucci F, Angeletti R, James P. Proteomics for the detection of indirect markers of steroids treatment in bovine muscle. Proteomics 2015;15:2332-41. [DOI: 10.1002/pmic.201400468] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
376 Xiong Q, Lim CY, Ren J, Zhou J, Pu K, Chan-Park MB, Mao H, Lam YC, Duan H. Magnetic nanochain integrated microfluidic biochips. Nat Commun 2018;9:1743. [PMID: 29717124 DOI: 10.1038/s41467-018-04172-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 17.0] [Reference Citation Analysis]
377 Taniguchi K, Kuyama H, Kajihara S, Tanaka K. MALDI mass spectrometry-based sequence analysis of arginine-containing glycopeptides: improved fragmentation of glycan and peptide chains by modifying arginine residue: Sequencing of glycopeptide. J Mass Spectrom 2013;48:951-60. [DOI: 10.1002/jms.3241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
378 Pospisil P, Iyer LK, Adelstein SJ, Kassis AI. A combined approach to data mining of textual and structured data to identify cancer-related targets. BMC Bioinformatics 2006;7:354. [PMID: 16857057 DOI: 10.1186/1471-2105-7-354] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
379 Lari SA, Kuerer HM. Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review. J Cancer 2011;2:232-61. [PMID: 21552384 DOI: 10.7150/jca.2.232] [Cited by in Crossref: 111] [Cited by in F6Publishing: 96] [Article Influence: 11.1] [Reference Citation Analysis]
380 Ascierto PA, Agarwala S, Botti G, Cesano A, Ciliberto G, Davies MA, Demaria S, Dummer R, Eggermont AM, Ferrone S, Fu YX, Gajewski TF, Garbe C, Huber V, Khleif S, Krauthammer M, Lo RS, Masucci G, Palmieri G, Postow M, Puzanov I, Silk A, Spranger S, Stroncek DF, Tarhini A, Taube JM, Testori A, Wang E, Wargo JA, Yee C, Zarour H, Zitvogel L, Fox BA, Mozzillo N, Marincola FM, Thurin M. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015. J Transl Med 2016;14:313. [PMID: 27846884 DOI: 10.1186/s12967-016-1070-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
381 Skeie JM, Brown EN, Martinez HD, Russell SR, Birkholz ES, Folk JC, Boldt HC, Gehrs KM, Stone EM, Wright ME, Mahajan VB. Proteomic analysis of vitreous biopsy techniques. Retina 2012;32:2141-9. [PMID: 23095728 DOI: 10.1097/IAE.0b013e3182562017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
382 Joshi R, Fuller B, Li J, Tavana H. Statistical analysis of multi-dimensional, temporal gene expression of stem cells to elucidate colony size-dependent neural differentiation. Mol Omics 2018;14:109-20. [PMID: 29659650 DOI: 10.1039/c8mo00011e] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
383 Shirasu M, Touhara K. The scent of disease: volatile organic compounds of the human body related to disease and disorder. Journal of Biochemistry 2011;150:257-66. [DOI: 10.1093/jb/mvr090] [Cited by in Crossref: 279] [Cited by in F6Publishing: 228] [Article Influence: 27.9] [Reference Citation Analysis]
384 Sümbül AT, Akkız H, Bayram S, Bekar A, Akgöllü E, Sandıkçı M. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study. Mol Biol Rep. 2012;39:1639-1647. [PMID: 21607615 DOI: 10.1007/s11033-011-0903-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
385 Scherzer CR. Chipping away at diagnostics for neurodegenerative diseases. Neurobiol Dis 2009;35:148-56. [PMID: 19285134 DOI: 10.1016/j.nbd.2009.02.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
386 Velstra B, van der Burgt YE, Mertens BJ, Mesker WE, Deelder AM, Tollenaar RA. Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures. J Cancer Res Clin Oncol 2012;138:1983-92. [PMID: 22763645 DOI: 10.1007/s00432-012-1273-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
387 Huang Z, Lin L, Gao Y, Chen Y, Yan X, Xing J, Hang W. Bladder cancer determination via two urinary metabolites: a biomarker pattern approach. Mol Cell Proteomics. 2011;10:M111.007922. [PMID: 21799048 DOI: 10.1074/mcp.m111.007922] [Cited by in Crossref: 67] [Cited by in F6Publishing: 35] [Article Influence: 6.7] [Reference Citation Analysis]
388 McKee CM, Ding Y, Zhou J, Li C, Huang L, Xin X, He J, Allen JE, El-Deiry WS, Cao Y, Muschel RJ, Xu D. Protease nexin 1 induces apoptosis of prostate tumor cells through inhibition of X-chromosome-linked inhibitor of apoptosis protein. Oncotarget 2015;6:3784-96. [PMID: 25686839 DOI: 10.18632/oncotarget.2921] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
389 Hausner SH. Basic Principles of Molecular Imaging. In: Chen X, editor. Nanoplatform-Based Molecular Imaging. Hoboken: John Wiley & Sons, Inc.; 2011. pp. 1-24. [DOI: 10.1002/9780470767047.ch1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
390 Munge BS, Stracensky T, Gamez K, DiBiase D, Rusling JF. Multiplex Immunosensor Arrays for Electrochemical Detection of Cancer Biomarker Proteins. Electroanalysis 2016;28:2644-58. [PMID: 28592919 DOI: 10.1002/elan.201600183] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 11.8] [Reference Citation Analysis]
391 Si H, Wang L, Li Q, Li X, Li L, Tang B. In situ fluorescence monitoring of diagnosis and treatment: a versatile nanoprobe combining tumor targeting based on MUC1 and controllable DOX release by telomerase. Chem Commun (Camb) 2018;54:8277-80. [PMID: 29989641 DOI: 10.1039/c8cc05052j] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 6.3] [Reference Citation Analysis]
392 Chikkaveeraiah BV, Mani V, Patel V, Gutkind JS, Rusling JF. Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum. Biosens Bioelectron 2011;26:4477-83. [PMID: 21632234 DOI: 10.1016/j.bios.2011.05.005] [Cited by in Crossref: 165] [Cited by in F6Publishing: 136] [Article Influence: 16.5] [Reference Citation Analysis]
393 Subbiah V, Anderson P, Lazar AJ, Burdett E, Raymond K, Ludwig JA. Ewing’s Sarcoma: Standard and Experimental Treatment Options. Curr Treat Options in Oncol 2009;10:126-40. [DOI: 10.1007/s11864-009-0104-6] [Cited by in Crossref: 90] [Cited by in F6Publishing: 79] [Article Influence: 7.5] [Reference Citation Analysis]
394 Xiong Z, Qin H, Wan H, Huang G, Zhang Z, Dong J, Zhang L, Zhang W, Zou H. Layer-by-layer assembly of multilayer polysaccharide coated magnetic nanoparticles for the selective enrichment of glycopeptides. Chem Commun 2013;49:9284. [DOI: 10.1039/c3cc45008b] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 11.1] [Reference Citation Analysis]
395 Kumar V, Kukkar D, Hashemi B, Kim K, Deep A. Advanced Functional Structure-Based Sensing and Imaging Strategies for Cancer Detection: Possibilities, Opportunities, Challenges, and Prospects. Adv Funct Mater 2019;29:1807859. [DOI: 10.1002/adfm.201807859] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
396 Guan T, Wang X, Li D, Zhang Y, He Y, Shi L, Liu Y, Yang Y, Xu Y, Cui R. Determination of Tumor Marker Carcinoembryonic Antigen with Biosensor Based on Optical Quantum Weak Measurements. Sensors (Basel) 2018;18:E1550. [PMID: 29757961 DOI: 10.3390/s18051550] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
397 Noo M, Tollenaar R, Deelder A, Bouwman L. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: Hopes and fears. World J Gastroenterol 2006; 12(41): 6594-6601 [PMID: 17075970 DOI: 10.3748/wjg.v12.i41.6594] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
398 Zhang Z, Sun Z, Zhu J, Liu J, Huang G, Ye M, Zou H. High-Throughput Determination of the Site-Specific N-Sialoglycan Occupancy Rates by Differential Oxidation of Glycoproteins Followed with Quantitative Glycoproteomics Analysis. Anal Chem 2014;86:9830-7. [DOI: 10.1021/ac5024638] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
399 Hwang HS, An J, Kang HJ, Oh B, Oh YJ, Oh JH, Kim W, Sung CO, Shim JH, Yu E. Prognostic Molecular Indices of Resectable Hepatocellular Carcinoma: Implications of S100P for Early Recurrence. Ann Surg Oncol 2021. [PMID: 33786678 DOI: 10.1245/s10434-021-09825-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
400 Xu J, Tian S, Yin Z, Wu S, Liu L, Qian Y, Pei D, Gao W, Xu J, Yin Y, Liu P, Shu Y. MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer. Lung Cancer 2014;85:442-8. [DOI: 10.1016/j.lungcan.2014.06.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
401 Nie H, Chen Y, Lü C, Liu Z. Efficient selection of glycoprotein-binding DNA aptamers via boronate affinity monolithic capillary. Anal Chem 2013;85:8277-83. [PMID: 23895515 DOI: 10.1021/ac4015353] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
402 Soda N, Rehm BHA, Sonar P, Nguyen NT, Shiddiky MJA. Advanced liquid biopsy technologies for circulating biomarker detection. J Mater Chem B 2019;7:6670-704. [PMID: 31646316 DOI: 10.1039/c9tb01490j] [Cited by in Crossref: 41] [Cited by in F6Publishing: 19] [Article Influence: 20.5] [Reference Citation Analysis]
403 Wu Y, Guo W, Peng W, Zhao Q, Piao J, Zhang B, Wu X, Wang H, Gong X, Chang J. Enhanced Fluorescence ELISA Based on HAT Triggering Fluorescence “Turn-on” with Enzyme–Antibody Dual Labeled AuNP Probes for Ultrasensitive Detection of AFP and HBsAg. ACS Appl Mater Interfaces 2017;9:9369-77. [DOI: 10.1021/acsami.6b16236] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 13.8] [Reference Citation Analysis]
404 Zhang J, Zhao H, Gao Y, Zhang W. Secretory miRNAs as novel cancer biomarkers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012;1826:32-43. [DOI: 10.1016/j.bbcan.2012.03.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
405 Saha K, Agasti SS, Kim C, Li X, Rotello VM. Gold nanoparticles in chemical and biological sensing. Chem Rev 2012;112:2739-79. [PMID: 22295941 DOI: 10.1021/cr2001178] [Cited by in Crossref: 3192] [Cited by in F6Publishing: 2474] [Article Influence: 354.7] [Reference Citation Analysis]
406 Taly V, Pekin D, Benhaim L, Kotsopoulos SK, Le Corre D, Li X, Atochin I, Link DR, Griffiths AD, Pallier K, Blons H, Bouché O, Landi B, Hutchison JB, Laurent-Puig P. Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients. Clin Chem 2013;59:1722-31. [PMID: 23938455 DOI: 10.1373/clinchem.2013.206359] [Cited by in Crossref: 350] [Cited by in F6Publishing: 306] [Article Influence: 43.8] [Reference Citation Analysis]
407 Wallace TJ, Torre T, Grob M, Yu J, Avital I, Brücher B, Stojadinovic A, Man YG. Current approaches, challenges and future directions for monitoring treatment response in prostate cancer. J Cancer 2014;5:3-24. [PMID: 24396494 DOI: 10.7150/jca.7709] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
408 Munoz-Bendix C, Slotty PJ, Ahmadi SA, Bostelmann R, Steiger HJ, Cornelius JF. Primary bone tumors of the spine revisited: A 10-year single-center experience of the management and outcome in a neurosurgical department. J Craniovertebr Junction Spine 2015;6:21-9. [PMID: 25788817 DOI: 10.4103/0974-8237.151587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
409 Zou X, Jie J, Yang B. A facile and cheap synthesis of zwitterion coatings of the CS@PGMA@IDA nanomaterial for highly specific enrichment of glycopeptides. Chem Commun 2016;52:3251-3. [DOI: 10.1039/c5cc10416e] [Cited by in Crossref: 36] [Cited by in F6Publishing: 1] [Article Influence: 7.2] [Reference Citation Analysis]
410 Chen J, Wang X. MicroRNA-21 in breast cancer: diagnostic and prognostic potential. Clin Transl Oncol 2014;16:225-33. [DOI: 10.1007/s12094-013-1132-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
411 Hao Y, Gao R, Liu D, He G, Tang Y, Guo Z. A facile and general approach for preparation of glycoprotein-imprinted magnetic nanoparticles with synergistic selectivity. Talanta 2016;153:211-20. [DOI: 10.1016/j.talanta.2016.03.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
412 Huhn C, Ruhaak LR, Wuhrer M, Deelder AM. Hexapeptide library as a universal tool for sample preparation in protein glycosylation analysis. J Proteomics 2012;75:1515-28. [PMID: 22154983 DOI: 10.1016/j.jprot.2011.11.028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
413 Li Y, Sun N, Lu Z, Sun S, Huang J, Chen Z, He J. Prognostic alternative mRNA splicing signature in non-small cell lung cancer. Cancer Lett 2017;393:40-51. [PMID: 28223168 DOI: 10.1016/j.canlet.2017.02.016] [Cited by in Crossref: 93] [Cited by in F6Publishing: 105] [Article Influence: 23.3] [Reference Citation Analysis]
414 Buchan BW, Ledeboer NA. Emerging technologies for the clinical microbiology laboratory. Clin Microbiol Rev 2014;27:783-822. [PMID: 25278575 DOI: 10.1128/CMR.00003-14] [Cited by in Crossref: 145] [Cited by in F6Publishing: 60] [Article Influence: 24.2] [Reference Citation Analysis]
415 Luey N, Toon CW, Sioson L, Clarkson A, Watson N, Cussigh C, Kedziora A, Pincott S, Pillinger S, Evans J, Percy J, Engel A, Schnitzler M, Gill AJ. A further investigation of combined mismatch repair and BRAFV600E mutation specific immunohistochemistry as a predictor of overall survival in colorectal carcinoma. PLoS One 2014;9:e106105. [PMID: 25153715 DOI: 10.1371/journal.pone.0106105] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
416 Li J, Peng Y, Liu Y, Li W, Jin Y, Tang Z, Duan Y. Investigation of potential breath biomarkers for the early diagnosis of breast cancer using gas chromatography–mass spectrometry. Clinica Chimica Acta 2014;436:59-67. [DOI: 10.1016/j.cca.2014.04.030] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 7.6] [Reference Citation Analysis]
417 Hennecke G, Scherzer CR. RNA biomarkers of Parkinson's disease: developing tools for novel therapies. Biomark Med 2008;2:41-53. [PMID: 20477362 DOI: 10.2217/17520363.2.1.41] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
418 Ali ES, Sharker SM, Islam MT, Khan IN, Shaw S, Rahman MA, Uddin SJ, Shill MC, Rehman S, Das N, Ahmad S, Shilpi JA, Tripathi S, Mishra SK, Mubarak MS. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives. Semin Cancer Biol 2021;69:52-68. [PMID: 32014609 DOI: 10.1016/j.semcancer.2020.01.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 22.0] [Reference Citation Analysis]
419 Zhang X, Li Y, Lv H, Gao Z, Zhang C, Zhang S, Wang Y, Xu Z, Zhao Z. Electrochemical Immunosensor with Enhanced Stability for Sensitive Detection of α-fetoprotein Based on Pd@Ag@CeO 2 as Signal Amplification Label. J Electrochem Soc 2018;165:B931-8. [DOI: 10.1149/2.1181816jes] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
420 Jubb AM, Oates AJ, Holden S, Koeppen H. Predicting benefit from anti-angiogenic agents in malignancy. Nat Rev Cancer 2006;6:626-35. [DOI: 10.1038/nrc1946] [Cited by in Crossref: 170] [Cited by in F6Publishing: 156] [Article Influence: 11.3] [Reference Citation Analysis]
421 Xie W, Yan O, Liu F, Han Y, Wang H. Prognostic Value of Survivin in Nasopharyngeal Carcinoma: A Systematic Review and Meta-analysis. J Cancer 2021;12:4399-407. [PMID: 34093840 DOI: 10.7150/jca.46282] [Reference Citation Analysis]
422 Driscoll AJ, Harpster MH, Johnson PA. The development of surface-enhanced Raman scattering as a detection modality for portable in vitro diagnostics: progress and challenges. Phys Chem Chem Phys 2013;15:20415-33. [PMID: 24177331 DOI: 10.1039/c3cp52334a] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
423 Bayram S, Ülger Y, Sümbül AT, Kaya BY, Genç A, Rencüzoğullari E, Dadaş E. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study. Gene 2016;585:84-92. [PMID: 27016301 DOI: 10.1016/j.gene.2016.03.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
424 Gu W, Choi H, Ghosh D. Global associations between copy number and transcript mRNA microarray data: an empirical study. Cancer Inform 2008;6:17-23. [PMID: 19259399 DOI: 10.4137/cin.s342] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
425 Jin G, Miao R, Hu Z, Xu L, Huang X, Chen Y, Tian T, Wei Q, Boffetta P, Shen H. Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population. Int J Cancer 2009;124:2172-8. [PMID: 19132754 DOI: 10.1002/ijc.24190] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
426 Peters CJ, Rees JR, Hardwick RH, Hardwick JS, Vowler SL, Ong CA, Zhang C, Save V, O'Donovan M, Rassl D, Alderson D, Caldas C, Fitzgerald RC; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Study Group. A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. Gastroenterology 2010;139:1995-2004.e15. [PMID: 20621683 DOI: 10.1053/j.gastro.2010.05.080] [Cited by in Crossref: 104] [Cited by in F6Publishing: 102] [Article Influence: 9.5] [Reference Citation Analysis]
427 Tang Q, Cheng J, Cao X, Surowy H, Burwinkel B. Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clin Epigenetics 2016;8:115. [PMID: 27895805 DOI: 10.1186/s13148-016-0282-6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 15.0] [Reference Citation Analysis]
428 Ioannidis JP. Molecular evidence-based medicine: evolution and integration of information in the genomic era. Eur J Clin Invest 2007;37:340-9. [PMID: 17461979 DOI: 10.1111/j.1365-2362.2007.01794.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
429 Pan S, Tamura Y, Chen R, May D, McIntosh MW, Brentnall TA. Large-scale quantitative glycoproteomics analysis of site-specific glycosylation occupancy. Mol Biosyst 2012;8:2850-6. [PMID: 22892896 DOI: 10.1039/c2mb25268f] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
430 Niveditha D, Jasoria M, Narayan J, Majumder S, Mukherjee S, Chowdhury R, Chowdhury S. Common and Unique microRNAs in Multiple Carcinomas Regulate Similar Network of Pathways to Mediate Cancer Progression. Sci Rep 2020;10:2331. [PMID: 32047181 DOI: 10.1038/s41598-020-59142-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
431 Chen C, Su W, Huang B, Chen Y, Tai H, Obena RP. Interaction modes and approaches to glycopeptide and glycoprotein enrichment. Analyst 2014;139:688-704. [DOI: 10.1039/c3an01813j] [Cited by in Crossref: 88] [Cited by in F6Publishing: 22] [Article Influence: 12.6] [Reference Citation Analysis]
432 Fan G, Ren X, Zhu C, Zhang J, Zhu J. A new signal amplification strategy of photoelectrochemical immunoassay for highly sensitive interleukin-6 detection based on TiO2/CdS/CdSe dual co-sensitized structure. Biosensors and Bioelectronics 2014;59:45-53. [DOI: 10.1016/j.bios.2014.03.011] [Cited by in Crossref: 101] [Cited by in F6Publishing: 85] [Article Influence: 14.4] [Reference Citation Analysis]
433 Schwamborn K, Gaisa NT, Henkel C. Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers. Expert Rev Proteomics 2010;7:897-906. [PMID: 21142890 DOI: 10.1586/epr.10.82] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
434 Chikkaveeraiah BV, Bhirde AA, Morgan NY, Eden HS, Chen X. Electrochemical immunosensors for detection of cancer protein biomarkers. ACS Nano 2012;6:6546-61. [PMID: 22835068 DOI: 10.1021/nn3023969] [Cited by in Crossref: 473] [Cited by in F6Publishing: 413] [Article Influence: 52.6] [Reference Citation Analysis]
435 Cho WC. Proteomics in translational cancer research: biomarker discovery for clinical applications. Expert Rev Proteomics 2014;11:131-3. [PMID: 24646121 DOI: 10.1586/14789450.2014.899908] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
436 Kon OL, Yip TT, Ho MF, Chan WH, Wong WK, Tan SY, Ng WH, Kam SY, Eng AKh, Ho P, Viner R, Ong HS, Kumarasinghe MP. The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile. BMC Med Genomics. 2008;1:54. [PMID: 18950519 DOI: 10.1186/1755-8794-1-54] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
437 Furukawa J, Fujitani N, Shinohara Y. Recent advances in cellular glycomic analyses. Biomolecules 2013;3:198-225. [PMID: 24970165 DOI: 10.3390/biom3010198] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
438 Mulrane L, Rexhepaj E, Penney S, Callanan JJ, Gallagher WM. Automated image analysis in histopathology: a valuable tool in medical diagnostics. Expert Rev Mol Diagn 2008;8:707-25. [PMID: 18999923 DOI: 10.1586/14737159.8.6.707] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 6.1] [Reference Citation Analysis]
439 Schatzkin A. Can Biomarkers Help Us Understand the Nutritional and Lifestyle Factors Important in Cancer Prognosis? The Journal of Nutrition 2007;137:249S-52S. [DOI: 10.1093/jn/137.1.249s] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
440 Vickers AJ, Jang K, Sargent D, Lilja H, Kattan MW. Systematic review of statistical methods used in molecular marker studies in cancer. Cancer 2008;112:1862-8. [PMID: 18320601 DOI: 10.1002/cncr.23365] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
441 Wu Q, Wang X, Nepovimova E, Wang Y, Yang H, Kuca K. Mechanism of cyclosporine A nephrotoxicity: Oxidative stress, autophagy, and signalings. Food and Chemical Toxicology 2018;118:889-907. [DOI: 10.1016/j.fct.2018.06.054] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 13.0] [Reference Citation Analysis]
442 Farokhizadeh Z, Dehbidi S, Geramizadeh B, Yaghobi R, Malekhosseini SA, Behmanesh M, Sanati MH, Afshari A, Moravej A, Karimi MH. Association of MicroRNA Polymorphisms With Hepatocellular Carcinoma in an Iranian Population. Ann Lab Med 2019;39:58-66. [PMID: 30215231 DOI: 10.3343/alm.2019.39.1.58] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
443 Zhang Y, Wang M, Gu D, Wu D, Zhang X, Gong W, Tan Y, Zhou J, Wu X, Tang C, Zhang Z, Chen J. Association of XRCC1 gene polymorphisms with the survival and clinicopathological characteristics of gastric cancer. DNA Cell Biol 2013;32:111-8. [PMID: 23425027 DOI: 10.1089/dna.2012.1840] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
444 Long Y, Zhang Z, Yan X, Xing J, Zhang K, Huang J, Zheng J, Li W. Multiplex immunodetection of tumor markers with a suspension array built upon core–shell structured functional fluorescence-encoded microspheres. Analytica Chimica Acta 2010;665:63-8. [DOI: 10.1016/j.aca.2010.03.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
445 Choi YY, Lee SY, Lee WK, Jeon HS, Lee EB, Lee HC, Choi JE, Kang HG, Lee EJ, Bae EY, Yoo SS, Lee J, Cha SI, Kim CH, Kim IS, Lee MH, Kim YT, Jheon S, Park JY. RACK1 is a candidate gene associated with the prognosis of patients with early stage non-small cell lung cancer. Oncotarget 2015;6:4451-66. [PMID: 25686824 DOI: 10.18632/oncotarget.2865] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
446 Schwenk JM, Igel U, Neiman M, Langen H, Becker C, Bjartell A, Ponten F, Wiklund F, Grönberg H, Nilsson P, Uhlen M. Toward next generation plasma profiling via heat-induced epitope retrieval and array-based assays. Mol Cell Proteomics 2010;9:2497-507. [PMID: 20682762 DOI: 10.1074/mcp.M110.001560] [Cited by in Crossref: 47] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
447 Li S, Thomas SN, Yang S. Glycoprotein Biomarkers. In: Weng N, Jian W, editors. Targeted Biomarker Quantitation by LC-MS. Hoboken: John Wiley & Sons, Inc.; 2017. pp. 245-72. [DOI: 10.1002/9781119413073.ch16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
448 Zhang Y, Zhu H, Zhang X, Gu D, Zhou X, Wang M, Cao C, Zhang X, Wu X, Gong W. Clinical significance of MYT1L gene polymorphisms in Chinese patients with gastric cancer. PLoS One. 2013;8:e71979. [PMID: 24015200 DOI: 10.1371/journal.pone.0071979] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
449 Powers TW, Jones EE, Betesh LR, Romano PR, Gao P, Copland JA, Mehta AS, Drake RR. Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues. Anal Chem 2013;85:9799-806. [PMID: 24050758 DOI: 10.1021/ac402108x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 99] [Article Influence: 12.9] [Reference Citation Analysis]
450 Do TTN, Van Phi T, Nguy TP, Wagner P, Eersels K, Vestergaard MC, Truong LTN. Anisotropic In Situ-Coated AuNPs on Screen-Printed Carbon Surface for Enhanced Prostate-Specific Antigen Impedimetric Aptasensor. Journal of Elec Materi 2017;46:3542-52. [DOI: 10.1007/s11664-016-5187-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
451 Zheng Z, Hong D, Zhang X, Chang Y, Sun N, Lin Z, Li H, Huang S, Zhang R, Xie Q, Huang H, Jin H. uc.77- Downregulation Promotes Colorectal Cancer Cell Proliferation by Inhibiting FBXW8-Mediated CDK4 Protein Degradation. Front Oncol 2021;11:673223. [PMID: 34094975 DOI: 10.3389/fonc.2021.673223] [Reference Citation Analysis]
452 Hüttenhain R, Malmström J, Picotti P, Aebersold R. Perspectives of targeted mass spectrometry for protein biomarker verification. Curr Opin Chem Biol 2009;13:518-25. [PMID: 19818677 DOI: 10.1016/j.cbpa.2009.09.014] [Cited by in Crossref: 140] [Cited by in F6Publishing: 122] [Article Influence: 11.7] [Reference Citation Analysis]
453 Akkız H, Bayram S, Bekar A, Akgöllü E, Usküdar O, Sandıkçı M. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study. Gene. 2011;486:104-109. [PMID: 21807077 DOI: 10.1016/j.gene.2011.07.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
454 Hoffmann AC, Vallböhmer D, Prenzel K, Metzger R, Heitmann M, Neiss S, Ling F, Hölscher AH, Schneider PM, Brabender J. Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. J Cancer Res Clin Oncol. 2009;135:1231-1237. [PMID: 19259700 DOI: 10.1007/s00432-009-0564-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
455 Fallon BP, Curnutte B, Maupin KA, Partyka K, Choi S, Brand RE, Langmead CJ, Tembe W, Haab BB. The Marker State Space (MSS) method for classifying clinical samples. PLoS One 2013;8:e65905. [PMID: 23750276 DOI: 10.1371/journal.pone.0065905] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
456 Ressom HW, Varghese RS, Goldman L, An Y, Loffredo CA, Abdel-Hamid M, Kyselova Z, Mechref Y, Novotny M, Drake SK, Goldman R. Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma. J Proteome Res 2008;7:603-10. [PMID: 18189345 DOI: 10.1021/pr0705237] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
457 Golberg A, Sheviryov J, Solomon O, Anavy L, Yakhini Z. Molecular harvesting with electroporation for tissue profiling. Sci Rep 2019;9:15750. [PMID: 31673038 DOI: 10.1038/s41598-019-51634-7] [Reference Citation Analysis]
458 Parisi A, Porzio G, Pulcini F, Cannita K, Ficorella C, Mattei V, Delle Monache S. What Is Known about Theragnostic Strategies in Colorectal Cancer. Biomedicines 2021;9:140. [PMID: 33535557 DOI: 10.3390/biomedicines9020140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
459 Hu L, Ye M, Zou H. Peptidome Analysis of Mouse Liver Tissue by Size Exclusion Chromatography Prefractionation. In: Soloviev M, editor. Peptidomics. Totowa: Humana Press; 2010. pp. 207-16. [DOI: 10.1007/978-1-60761-535-4_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
460 Li D, Xia H, Wang L. Branched polyethyleneimine-assisted boronic acid-functionalized silica nanoparticles for the selective enrichment of trace glycoproteins. Talanta 2018;184:235-43. [PMID: 29674038 DOI: 10.1016/j.talanta.2018.02.021] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 12.3] [Reference Citation Analysis]
461 Nyren-Erickson EK, Bouton M, Raval M, Totzauer J, Mallik S, Alberto N. Urinary concentrations of ADAM 12 from breast cancer patients pre- and post-surgery vs. cancer-free controls: a clinical study for biomarker validation. J Negat Results Biomed 2014;13:5. [PMID: 24690292 DOI: 10.1186/1477-5751-13-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
462 Pan S, Chen R, Crispin DA, May D, Stevens T, McIntosh MW, Bronner MP, Ziogas A, Anton-Culver H, Brentnall TA. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J Proteome Res. 2011;10:2359-2376. [PMID: 21443201 DOI: 10.1021/pr101148r] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 7.1] [Reference Citation Analysis]
463 Kanwar JR, Singh N, Kanwar RK. Role of nanomedicine in reversing drug resistance mediated by ATP binding cassette transporters and P-glycoprotein in melanoma. Nanomedicine 2011;6:701-14. [DOI: 10.2217/nnm.11.48] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
464 Liu L, Liu N, Xu M, Liu Y, Min J, Pang H, Zhang N, Zhang H, Zhang H. Lentivirus-delivered Krüppel-like factor 8 small interfering RNA inhibits gastric cancer cell growth in vitro and in vivo. Tumour Biol. 2012;33:53-61. [PMID: 22081373 DOI: 10.1007/s13277-011-0245-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
465 Balasubramanian V, Liu Z, Hirvonen J, Santos HA. Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines. Adv Healthcare Mater 2018;7:1700432. [DOI: 10.1002/adhm.201700432] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
466 Xie L, Wang Q, Nan F, Ge L, Dang Y, Sun X, Li N, Dong H, Han Y, Zhang G, Zhu W, Guo X. OSacc: Gene Expression-Based Survival Analysis Web Tool For Adrenocortical Carcinoma. Cancer Manag Res 2019;11:9145-52. [PMID: 31749633 DOI: 10.2147/CMAR.S215586] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
467 Yu YH, Morales J, Feng L, Lee JJ, El-Naggar AK, Vigneswaran N. CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray study. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;119:553-65. [PMID: 25747176 DOI: 10.1016/j.oooo.2014.12.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
468 Phan JH, Moffitt RA, Stokes TH, Liu J, Young AN, Nie S, Wang MD. Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment. Trends Biotechnol 2009;27:350-8. [PMID: 19409634 DOI: 10.1016/j.tibtech.2009.02.010] [Cited by in Crossref: 60] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
469 Klewes L, Höbsch C, Katzir N, Rourke D, Garini Y, Mai S. Novel automated three-dimensional genome scanning based on the nuclear architecture of telomeres. Cytometry A 2011;79:159-66. [PMID: 21265009 DOI: 10.1002/cyto.a.21012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
470 Min J, Im H, Allen M, McFarland PJ, Degani I, Yu H, Normandin E, Pathania D, Patel JM, Castro CM, Weissleder R, Lee H. Computational Optics Enables Breast Cancer Profiling in Point-of-Care Settings. ACS Nano 2018;12:9081-90. [PMID: 30113824 DOI: 10.1021/acsnano.8b03029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
471 Padler-karavani V. Aiming at the sweet side of cancer: Aberrant glycosylation as possible target for personalized-medicine. Cancer Letters 2014;352:102-12. [DOI: 10.1016/j.canlet.2013.10.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 6.9] [Reference Citation Analysis]
472 Alymani NA, Smith MD, Williams DJ, Petty RD. Predictive biomarkers for personalised anti-cancer drug use: discovery to clinical implementation. Eur J Cancer 2010;46:869-79. [PMID: 20138504 DOI: 10.1016/j.ejca.2010.01.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
473 Taylor BS, Varambally S, Chinnaiyan AM. Differential proteomic alterations between localised and metastatic prostate cancer. Br J Cancer 2006;95:425-30. [PMID: 16880794 DOI: 10.1038/sj.bjc.6603274] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
474 Dong H, Bao D, Guo X, Hu J, Li X, Wan S, Xing J. Effect of thymidylate synthase gene polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer patients. Tumor Biol 2015;36:7151-7. [DOI: 10.1007/s13277-015-3447-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
475 Lim SY, Lee JH, Diefenbach RJ, Kefford RF, Rizos H. Liquid biomarkers in melanoma: detection and discovery. Mol Cancer 2018;17:8. [PMID: 29343260 DOI: 10.1186/s12943-018-0757-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
476 González-Arriaga P, Pascual T, García-Alvarez A, Fernández-Somoano A, López-Cima MF, Tardón A. Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival. BMC Cancer 2012;12:121. [PMID: 22455335 DOI: 10.1186/1471-2407-12-121] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
477 Zhou M, Scott J, Chaudhury B, Hall L, Goldgof D, Yeom KW, Iv M, Ou Y, Kalpathy-Cramer J, Napel S, Gillies R, Gevaert O, Gatenby R. Radiomics in Brain Tumor: Image Assessment, Quantitative Feature Descriptors, and Machine-Learning Approaches. AJNR Am J Neuroradiol 2018;39:208-16. [PMID: 28982791 DOI: 10.3174/ajnr.A5391] [Cited by in Crossref: 138] [Cited by in F6Publishing: 70] [Article Influence: 34.5] [Reference Citation Analysis]
478 Yamada K, Shibata H, Suzuki K, Citterio D. Toward practical application of paper-based microfluidics for medical diagnostics: state-of-the-art and challenges. Lab Chip 2017;17:1206-49. [DOI: 10.1039/c6lc01577h] [Cited by in Crossref: 229] [Cited by in F6Publishing: 52] [Article Influence: 57.3] [Reference Citation Analysis]
479 Goldman R, Ressom HW, Varghese RS, Goldman L, Bascug G, Loffredo CA, Abdel-Hamid M, Gouda I, Ezzat S, Kyselova Z. Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res. 2009;15:1808-1813. [PMID: 19223512 DOI: 10.1158/1078-0432.ccr-07-5261] [Cited by in Crossref: 108] [Cited by in F6Publishing: 66] [Article Influence: 9.0] [Reference Citation Analysis]
480 Su J, He X, Chen L, Zhang Y. A combination of “thiol−ene” click chemistry and surface initiated atom transfer radical polymerization: Fabrication of boronic acid functionalized magnetic graphene oxide composite for enrichment of glycoproteins. Talanta 2018;180:54-60. [DOI: 10.1016/j.talanta.2017.12.037] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 12.7] [Reference Citation Analysis]
481 Li Y, Yan L, Liu Y, Qian K, Liu B, Yang P, Liu B. High-efficiency nano/micro-reactors for protein analysis. RSC Adv 2015;5:1331-42. [DOI: 10.1039/c4ra12333f] [Cited by in Crossref: 32] [Article Influence: 5.3] [Reference Citation Analysis]
482 Ioannidis JPA. Is Molecular Profiling Ready for Use in Clinical Decision Making? The Oncol 2007;12:301-11. [DOI: 10.1634/theoncologist.12-3-301] [Cited by in Crossref: 96] [Cited by in F6Publishing: 71] [Article Influence: 6.9] [Reference Citation Analysis]
483 Huang YP, Chang NW. Proteomic analysis of oral cancer reveals new potential therapeutic targets involved in the Warburg effect. Clin Exp Pharmacol Physiol 2017;44:880-7. [PMID: 28453233 DOI: 10.1111/1440-1681.12774] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
484 Zhang T, Qin Y, Tan T, Lv Y. Targeted Live Cell Raman Imaging and Visualization of Cancer Biomarkers with Thermal‐Stimuli Responsive Imprinted Nanoprobes. Part Part Syst Charact 2018;35:1800390. [DOI: 10.1002/ppsc.201800390] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
485 S Tandel G, Biswas M, G Kakde O, Tiwari A, S Suri H, Turk M, Laird JR, Asare CK, A Ankrah A, N Khanna N, K Madhusudhan B, Saba L, Suri JS. A Review on a Deep Learning Perspective in Brain Cancer Classification. Cancers (Basel) 2019;11:E111. [PMID: 30669406 DOI: 10.3390/cancers11010111] [Cited by in Crossref: 72] [Cited by in F6Publishing: 42] [Article Influence: 36.0] [Reference Citation Analysis]
486 Mocellin S, Zavagno G, Nitti D. The prognostic value of serum S100B in patients with cutaneous melanoma: A meta-analysis. Int J Cancer 2008;123:2370-6. [DOI: 10.1002/ijc.23794] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 5.1] [Reference Citation Analysis]
487 Chamseddine IM, Frieboes HB, Kokkolaras M. Multi-objective optimization of tumor response to drug release from vasculature-bound nanoparticles. Sci Rep 2020;10:8294. [PMID: 32427977 DOI: 10.1038/s41598-020-65162-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
488 Peng J, Zhu Y, Li X, Jiang L, Abdel-halim ES, Zhu J. Electrochemical immunoassay for the prostate specific antigen using ceria mesoporous nanospheres. Microchim Acta 2014;181:1505-12. [DOI: 10.1007/s00604-014-1193-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
489 Sugano K, Kakizoe T. Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging. Nat Clin Pract Urol 2006;3:642-52. [PMID: 17149381 DOI: 10.1038/ncpuro0649] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
490 Yang CH, Moi SH, Chuang LY, Yuan SF, Hou MF, Lee YC, Chang HW. Interaction of MRE11 and Clinicopathologic Characteristics in Recurrence of Breast Cancer: Individual and Cumulated Receiver Operating Characteristic Analyses. Biomed Res Int 2017;2017:2563910. [PMID: 28133604 DOI: 10.1155/2017/2563910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
491 Dhar C, Sasmal A, Varki A. From "Serum Sickness" to "Xenosialitis": Past, Present, and Future Significance of the Non-human Sialic Acid Neu5Gc. Front Immunol 2019;10:807. [PMID: 31057542 DOI: 10.3389/fimmu.2019.00807] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]
492 Yang Z, Chevolot Y, Géhin T, Solassol J, Mange A, Souteyrand E, Laurenceau E. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera. Biosens Bioelectron 2013;40:385-92. [PMID: 23017679 DOI: 10.1016/j.bios.2012.08.019] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
493 Nadal E, Chen G, Gallegos M, Lin L, Ferrer-Torres D, Truini A, Wang Z, Lin J, Reddy RM, Llatjos R, Escobar I, Moya J, Chang AC, Cardenal F, Capellà G, Beer DG. Epigenetic inactivation of microRNA-34b/c predicts poor disease-free survival in early-stage lung adenocarcinoma. Clin Cancer Res 2013;19:6842-52. [PMID: 24130071 DOI: 10.1158/1078-0432.CCR-13-0736] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
494 Lynn K, Chen C, Lih TM, Cheng C, Su W, Chang C, Cheng C, Hsu W, Chen Y, Sung T. MAGIC: An Automated N-Linked Glycoprotein Identification Tool Using a Y1-Ion Pattern Matching Algorithm and in Silico MS 2 Approach. Anal Chem 2015;87:2466-73. [DOI: 10.1021/ac5044829] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 8.5] [Reference Citation Analysis]
495 Zhang SG, Li YF, Zhao NN, Lai CC, Cheng SJ, Yan J, Zhang P, Wang Z, Wang XL, Yang PH. Decreased expression of long non-coding RNA LOC728290 in human hepatocellular carcinoma. Oncol Lett 2017;14:4551-6. [PMID: 29085452 DOI: 10.3892/ol.2017.6776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
496 Chen J, Hagiwara M, Givi B, Schmidt B, Liu C, Chen Q, Logan J, Mikheev A, Rusinek H, Kim SG. Assessment of metastatic lymph nodes in head and neck squamous cell carcinomas using simultaneous 18F-FDG-PET and MRI. Sci Rep 2020;10:20764. [PMID: 33247166 DOI: 10.1038/s41598-020-77740-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
497 Hossain M, Kaleta DT, Robinson EW, Liu T, Zhao R, Page JS, Kelly RT, Moore RJ, Tang K, Camp DG 2nd, Qian WJ, Smith RD. Enhanced sensitivity for selected reaction monitoring mass spectrometry-based targeted proteomics using a dual stage electrodynamic ion funnel interface. Mol Cell Proteomics 2011;10:M000062-MCP201. [PMID: 20410378 DOI: 10.1074/mcp.M000062-MCP201] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
498 Chen Y, Jiang W, Xi D, Chen J, Xu G, Yin W, Chen J, Gu W. Development and validation of nomogram based on SIRI for predicting the clinical outcome in patients with nasopharyngeal carcinomas. J Investig Med 2019;67:691-8. [PMID: 30127099 DOI: 10.1136/jim-2018-000801] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
499 Wang P, Whiteaker JR, Paulovich AG. The evolving role of mass spectrometry in cancer biomarker discovery. Cancer Biol Ther 2009;8:1083-94. [PMID: 19502776 DOI: 10.4161/cbt.8.12.8634] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
500 Cai J, Lin K, Cai W, Lin Y, Liu X, Guo L, Zhang J, Xu W, Lin Z, Wong CW, Sander M, Hu J, Yan G, Zhu W, Liang J. Tumors driven by RAS signaling harbor a natural vulnerability to oncolytic virus M1. Mol Oncol 2020;14:3153-68. [PMID: 33037696 DOI: 10.1002/1878-0261.12820] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
501 Ladd JJ, Busald T, Johnson MM, Zhang Q, Pitteri SJ, Wang H, Brenner DE, Lampe PD, Kucherlapati R, Feng Z, Prentice RL, Hanash SM. Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women. Cancer Prev Res (Phila) 2012;5:655-64. [PMID: 22277732 DOI: 10.1158/1940-6207.CAPR-11-0412] [Cited by in Crossref: 59] [Cited by in F6Publishing: 40] [Article Influence: 6.6] [Reference Citation Analysis]
502 Liu J, Xu F, Cheng W, Gao L. Identification and verification of a ten-gene signature predicting overall survival for ovarian cancer. Experimental Cell Research 2020;395:112235. [DOI: 10.1016/j.yexcr.2020.112235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
503 West CA, Black AP, Mehta AS. Analysis of Hepatocellular Carcinoma Tissue for Biomarker Discovery. In: Hoshida Y, editor. Hepatocellular Carcinoma. Cham: Springer International Publishing; 2019. pp. 93-107. [DOI: 10.1007/978-3-030-21540-8_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
504 Jones AL, Dhanapala L, Baldo TA, Sharafeldin M, Krause CE, Shen M, Moghaddam S, Faria RC, Dey DK, Watson RW, Andrawis R, Lee NH, Rusling JF. Prostate Cancer Diagnosis in the Clinic Using an 8-Protein Biomarker Panel. Anal Chem 2021;93:1059-67. [PMID: 33289381 DOI: 10.1021/acs.analchem.0c04034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
505 Strebhardt K, Ullrich A. Paul Ehrlich’s magic bullet concept: 100 years of progress. Nat Rev Cancer. 2008;8:473-480. [PMID: 18469827 DOI: 10.1038/nrc2394] [Cited by in Crossref: 684] [Cited by in F6Publishing: 559] [Article Influence: 52.6] [Reference Citation Analysis]
506 Zhang H, Lv H, Weng M, Wang H, Cata JP, Chen W, Miao C. Preoperative leukocytosis is associated with increased tumour-infiltrating neutrophil extracellular traps and worse outcomes in esophageal cancer.Ann Transl Med. 2020;8:441. [PMID: 32395485 DOI: 10.21037/atm.2020.03.190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
507 Song J, Kim S, Kim HY, Hur KH, Kim Y, Park HG. A novel method to detect mutation in DNA by utilizing exponential amplification reaction triggered by the CRISPR-Cas9 system. Nanoscale 2021;13:7193-201. [PMID: 33720266 DOI: 10.1039/d1nr00438g] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
508 Khare T, Khare S, Ibdah JA. Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma. World J Gastrointest Oncol 2017; 9(1): 1-3 [PMID: 28144394 DOI: 10.4251/wjgo.v9.i1.1] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
509 Merlo LM, Maley CC. The role of genetic diversity in cancer. J Clin Invest 2010;120:401-3. [PMID: 20101092 DOI: 10.1172/JCI42088] [Cited by in Crossref: 45] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
510 Nordeman P, Estrada S, Odell LR, Larhed M, Antoni G. (11)C-Labeling of a potent hydroxyethylamine BACE-1 inhibitor and evaluation in vitro and in vivo. Nucl Med Biol 2014;41:536-43. [PMID: 24857866 DOI: 10.1016/j.nucmedbio.2014.03.024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
511 Mano R, Baniel J, Shoshany O, Margel D, Bar-On T, Nativ O, Rubinstein J, Halachmi S. Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer. Urol Oncol 2015;33:67.e1-7. [PMID: 25060672 DOI: 10.1016/j.urolonc.2014.06.010] [Cited by in Crossref: 42] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
512 Xu X, Huang L, Chan CH, Yu T, Miao R, Liu C. Assessing the clinical utility of genomic expression data across human cancers. Oncotarget 2016;7:45926-36. [PMID: 27322207 DOI: 10.18632/oncotarget.10002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
513 Montagnana M, Danese E, Giudici S, Franchi M, Guidi G, Plebani M, Lippi G. HE4 in ovarian cancer. Elsevier; 2011. pp. 1-20. [DOI: 10.1016/b978-0-12-387042-1.00001-0] [Cited by in Crossref: 56] [Article Influence: 5.6] [Reference Citation Analysis]
514 Schwamborn K. Imaging mass spectrometry in biomarker discovery and validation. J Proteomics 2012;75:4990-8. [PMID: 22749859 DOI: 10.1016/j.jprot.2012.06.015] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
515 Hudler P, Gorsic M, Komel R. Proteomic strategies and challenges in tumor metastasis research. Clin Exp Metastasis. 2010;27:441-451. [PMID: 20607365 DOI: 10.1007/s10585-010-9339-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
516 Zeineldin R. Nanotechnology for cancer screening and diagnosis. Biomaterials for Cancer Therapeutics. Elsevier; 2013. pp. 137-64. [DOI: 10.1533/9780857096760.3.137] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
517 Rousseau M, Ferraiuolo MA, Crutchley JL, Wang XQ, Miura H, Blanchette M, Dostie J. Classifying leukemia types with chromatin conformation data. Genome Biol 2014;15:R60. [PMID: 24995990 DOI: 10.1186/gb-2014-15-4-r60] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
518 Zhang X, Wei D, Yap Y, Li L, Guo S, Chen F. Mass spectrometry‐based “omics” technologies in cancer diagnostics. Mass Spectrom Rev 2007;26:403-31. [DOI: 10.1002/mas.20132] [Cited by in Crossref: 68] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
519 Shinohara Y, Furukawa J, Miura Y. Glycome as Biomarkers. In: Preedy VR, Patel VB, editors. General Methods in Biomarker Research and their Applications. Dordrecht: Springer Netherlands; 2015. pp. 111-40. [DOI: 10.1007/978-94-007-7696-8_23] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
520 Chiang AWT, Baghdassarian HM, Kellman BP, Bao B, Sorrentino JT, Liang C, Kuo CC, Masson HO, Lewis NE. Systems glycobiology for discovering drug targets, biomarkers, and rational designs for glyco-immunotherapy. J Biomed Sci 2021;28:50. [PMID: 34158025 DOI: 10.1186/s12929-021-00746-2] [Reference Citation Analysis]
521 Cai H, Stott MA, Ozcelik D, Parks JW, Hawkins AR, Schmidt H. On-chip wavelength multiplexed detection of cancer DNA biomarkers in blood. Biomicrofluidics 2016;10:064116. [PMID: 28058082 DOI: 10.1063/1.4968033] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
522 Czibere A, Grall F, Aivado M. Perspectives of proteomics in acute myeloid leukemia. Expert Rev Anticancer Ther 2006;6:1663-75. [PMID: 17134369 DOI: 10.1586/14737140.6.11.1663] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
523 Furukawa J, Tsuda M, Okada K, Kimura T, Piao J, Tanaka S, Shinohara Y. Comprehensive Glycomics of a Multistep Human Brain Tumor Model Reveals Specific Glycosylation Patterns Related to Malignancy. PLoS One 2015;10:e0128300. [PMID: 26132161 DOI: 10.1371/journal.pone.0128300] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
524 Zhang F, Wang ZM, Liu HY, Bai Y, Wei S, Li Y, Wang M, Chen J, Zhou QH. Application of RT-PCR in formalin-fixed and paraffin-embedded lung cancer tissues. Acta Pharmacol Sin 2010;31:111-7. [PMID: 20037605 DOI: 10.1038/aps.2009.178] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
525 Kim YI, Ahn JM, Sung HJ, Na SS, Hwang J, Kim Y, Cho JY. Meta-markers for the differential diagnosis of lung cancer and lung disease. J Proteomics 2016;148:36-43. [PMID: 27168012 DOI: 10.1016/j.jprot.2016.04.052] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
526 Naesens M, Sarwal MM. Molecular diagnostics in transplantation. Nat Rev Nephrol. 2010;6:614-628. [PMID: 20736923 DOI: 10.1038/nrneph.2010.113] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 6.1] [Reference Citation Analysis]
527 Robinson WH, Lindstrom TM, Cheung RK, Sokolove J. Mechanistic biomarkers for clinical decision making in rheumatic diseases. Nat Rev Rheumatol 2013;9:267-76. [PMID: 23419428 DOI: 10.1038/nrrheum.2013.14] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 7.6] [Reference Citation Analysis]
528 Zou X, Jie J, Yang B. Single-Step Enrichment of N -Glycopeptides and Phosphopeptides with Novel Multifunctional Ti 4+ -Immobilized Dendritic Polyglycerol Coated Chitosan Nanomaterials. Anal Chem 2017;89:7520-6. [DOI: 10.1021/acs.analchem.7b01209] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 11.3] [Reference Citation Analysis]
529 Hong Y, Zhao H, Pu C, Zhan Q, Sheng Q, Lan M. Hydrophilic Phytic Acid-Coated Magnetic Graphene for Titanium(IV) Immobilization as a Novel Hydrophilic Interaction Liquid Chromatography-Immobilized Metal Affinity Chromatography Platform for Glyco- and Phosphopeptide Enrichment with Controllable Selectivity. Anal Chem 2018;90:11008-15. [PMID: 30136585 DOI: 10.1021/acs.analchem.8b02614] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 15.0] [Reference Citation Analysis]
530 Flaig TW, Nordeen SK, Lucia MS, Harrison GS, Glodé LM. Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes. J Urol 2007;177:1229-37. [PMID: 17382696 DOI: 10.1016/j.juro.2006.11.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
531 Ren Y, Lv Y, Li T, Jiang Q. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data. Gene 2020;763:145072. [PMID: 32827679 DOI: 10.1016/j.gene.2020.145072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
532 Hao D, He S, Harada K, Pizzi MP, Lu Y, Guan P, Chen L, Wang R, Zhang S, Sewastjanow-Silva M, Abdelhakeem A, Shanbhag N, Bhutani M, Han G, Lee JH, Zhao S, Weston B, Blum Murphy M, Waters R, Estrella JS, Roy-Chowdhuri S, Gan Q, Lee JS, Peng G, Hanash SM, Calin GA, Song X, Zhang J, Song S, Wang L, Ajani JA. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma. Gut 2020:gutjnl-2020-322707. [PMID: 33334899 DOI: 10.1136/gutjnl-2020-322707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
533 Zhang L, Yang M, Bi N, Fang M, Sun T, Ji W, Tan W, Zhao L, Yu D, Lin D, Wang L. ATM polymorphisms are associated with risk of radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys 2010;77:1360-8. [PMID: 20171797 DOI: 10.1016/j.ijrobp.2009.07.1675] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
534 Fang C, Xiong Z, Qin H, Huang G, Liu J, Ye M, Feng S, Zou H. One-pot synthesis of magnetic colloidal nanocrystal clusters coated with chitosan for selective enrichment of glycopeptides. Anal Chim Acta 2014;841:99-105. [PMID: 25109867 DOI: 10.1016/j.aca.2014.05.037] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 7.9] [Reference Citation Analysis]
535 Liu J, Qian J, Mo Q, Tang L, Xu Q. LncRNA NR2F2-AS1 Silencing Induces Cell Cycle Arrest in G0/G1 Phase via Downregulating Cyclin D1 in Colorectal Cancer. Cancer Manag Res 2020;12:1835-43. [PMID: 32210626 DOI: 10.2147/CMAR.S221996] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
536 Castro MA, Dal-Pizzol F, Zdanov S, Soares M, Müller CB, Lopes FM, Zanotto-Filho A, da Cruz Fernandes M, Moreira JC, Shacter E, Klamt F. CFL1 expression levels as a prognostic and drug resistance marker in nonsmall cell lung cancer. Cancer 2010;116:3645-55. [PMID: 20564088 DOI: 10.1002/cncr.25125] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
537 Hanai Y, Shimono K, Oka H, Baba Y, Yamazaki K, Beauchamp GK. Analysis of volatile organic compounds released from human lung cancer cells and from the urine of tumor-bearing mice. Cancer Cell Int 2012;12:7. [PMID: 22364569 DOI: 10.1186/1475-2867-12-7] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 7.2] [Reference Citation Analysis]
538 Baek DH, Kim GH, Song GA, Han IS, Park EY, Kim HS, Jo HJ, Ko SH, Park DY, Cho YK. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study. Clin Transl Gastroenterol 2019;10:e00055. [PMID: 31246593 DOI: 10.14309/ctg.0000000000000055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
539 Jollans L, Whelan R. Neuromarkers for Mental Disorders: Harnessing Population Neuroscience. Front Psychiatry 2018;9:242. [PMID: 29928237 DOI: 10.3389/fpsyt.2018.00242] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 8.7] [Reference Citation Analysis]
540 Separovic D, Shields AF, Philip PA, Bielawski J, Bielawska A, Pierce JS, Tarca AL. Altered Levels of Serum Ceramide, Sphingosine and Sphingomyelin Are Associated with Colorectal Cancer: A Retrospective Pilot Study. Anticancer Res 2017;37:1213-8. [PMID: 28314284 DOI: 10.21873/anticanres.11436] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
541 Kim M, Kim HJ, Choi BY, Kim J, Song K, Noh S, Kim JC, Han DS, Kim S, Kim YS. Identification of potential serum biomarkers for gastric cancer by a novel computational method, multiple normal tissues corrected differential analysis. Clinica Chimica Acta 2012;413:428-33. [DOI: 10.1016/j.cca.2011.10.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
542 Kumar HR, Zhong X, Rescorla FJ, Hickey RJ, Malkas LH, Sandoval JA. Proteomic approaches in neuroblastoma: a complementary clinical platform for the future. Expert Rev Proteomics 2009;6:387-94. [PMID: 19681674 DOI: 10.1586/epr.09.58] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
543 Belinsky SA, Leng S, Wu G, Thomas CL, Picchi MA, Lee SJ, Aisner S, Ramalingam S, Khuri FR, Karp DD. Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence. Cancer Prev Res (Phila) 2017;10:635-40. [PMID: 28904059 DOI: 10.1158/1940-6207.CAPR-17-0177] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
544 Laber EB, Zhao YQ. Tree-based methods for individualized treatment regimes. Biometrika 2015;102:501-14. [PMID: 26893526 DOI: 10.1093/biomet/asv028] [Cited by in Crossref: 76] [Cited by in F6Publishing: 48] [Article Influence: 12.7] [Reference Citation Analysis]
545 Lai G, Wang L, Wu J, Ju H, Yan F. Electrochemical stripping analysis of nanogold label-induced silver deposition for ultrasensitive multiplexed detection of tumor markers. Analytica Chimica Acta 2012;721:1-6. [DOI: 10.1016/j.aca.2012.01.048] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 7.8] [Reference Citation Analysis]
546 Jin Y, Da W. Screening of key genes in gastric cancer with DNA microarray analysis. Eur J Med Res. 2013;18:37. [PMID: 24093889 DOI: 10.1186/2047-783x-18-37] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
547 Timms JF, Arslan-Low E, Gentry-Maharaj A, Luo Z, T'Jampens D, Podust VN, Ford J, Fung ET, Gammerman A, Jacobs I. Preanalytic influence of sample handling on SELDI-TOF serum protein profiles. Clin Chem. 2007;53:645-656. [PMID: 17303688 DOI: 10.1373/clinchem.2006.080101] [Cited by in Crossref: 109] [Cited by in F6Publishing: 102] [Article Influence: 7.8] [Reference Citation Analysis]
548 Robertson R, Germanos MS, Manfredi MG, Smith PG, Silva MD. Multimodal imaging with (18)F-FDG PET and Cerenkov luminescence imaging after MLN4924 treatment in a human lymphoma xenograft model. J Nucl Med 2011;52:1764-9. [PMID: 21994410 DOI: 10.2967/jnumed.111.091710] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
549 Koulman A, Lane GA, Harrison SJ, Volmer DA. From differentiating metabolites to biomarkers. Anal Bioanal Chem 2009;394:663-70. [PMID: 19277615 DOI: 10.1007/s00216-009-2690-3] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 6.4] [Reference Citation Analysis]
550 D'Souza AL, Chevillet JR, Ghanouni P, Yan X, Tewari M, Gambhir SS. Tumor characterization by ultrasound-release of multiple protein and microRNA biomarkers, preclinical and clinical evidence. PLoS One 2018;13:e0194268. [PMID: 29547636 DOI: 10.1371/journal.pone.0194268] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
551 Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau CK, Li MLY, Tam KH, Lam CT, Poon RTP, Fan ST. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008;47:919-28. [DOI: 10.1002/hep.22082] [Cited by in Crossref: 251] [Cited by in F6Publishing: 243] [Article Influence: 19.3] [Reference Citation Analysis]
552 Bayani J, Diamandis EP. The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6). Clin Chem Lab Med 2011;50:211-33. [PMID: 22047144 DOI: 10.1515/CCLM.2011.750] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
553 Liu YL, Wu HP, Zhou Q, Song QX, Rui JZ, Guan XX, Zhou GH, Zou BJ. Controllable extension of hairpin-structured flaps to allow low-background cascade invasive reaction for a sensitive DNA logic sensor for mutation detection. Chem Sci 2018;9:1666-73. [PMID: 29675214 DOI: 10.1039/c7sc04210h] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
554 Zhao Y, Cao M, Mcclelland JF, Shao Z, Lu M. A photoacoustic immunoassay for biomarker detection. Biosensors and Bioelectronics 2016;85:261-6. [DOI: 10.1016/j.bios.2016.05.028] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
555 Kuzmanov U, Smith CR, Batruch I, Soosaipillai A, Diamandis A, Diamandis EP. Separation of kallikrein 6 glycoprotein subpopulations in biological fluids by anion-exchange chromatography coupled to ELISA and identification by mass spectrometry. Proteomics 2012;12:799-809. [PMID: 22539431 DOI: 10.1002/pmic.201100371] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
556 Tang L, Li C, Chen Q, Zhang L, Lai X, He Y, Xu Y, Hu D, Wen S, Peng Y, Chen W, Liu H, Guo S, Liu L, Li J, Zhang J, Guo L, Zhao C, Cao K, Qian C, Zeng Y, Guo X, Mai H, Zeng M. High-Sensitivity C-Reactive Protein Complements Plasma Epstein-Barr Virus Deoxyribonucleic Acid Prognostication in Nasopharyngeal Carcinoma: A Large-Scale Retrospective and Prospective Cohort Study. International Journal of Radiation Oncology*Biology*Physics 2015;91:325-36. [DOI: 10.1016/j.ijrobp.2014.10.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
557 Wang FY, Wang-Gou SY, Cao H, Jiang N, Yang Q, Huang Q, Huang CH, Li XJ. Proteomics identifies EGF-like domain multiple 7 as a potential therapeutic target for epidermal growth factor receptor-positive glioma. Cancer Commun (Lond) 2020;40:518-30. [PMID: 32888253 DOI: 10.1002/cac2.12092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
558 Riedmaier I, Pfaffl MW, Meyer HHD. The analysis of the transcriptome as a new approach for biomarker development to trace the abuse of anabolic steroid hormones. Drug Test Analysis 2011;3:676-81. [DOI: 10.1002/dta.304] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
559 Vincent-Chong VK, Salahshourifar I, Woo KM, Anwar A, Razali R, Gudimella R, Rahman ZA, Ismail SM, Kallarakkal TG, Ramanathan A, Wan Mustafa WM, Abraham MT, Tay KK, Zain RB. Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance. PLoS One 2017;12:e0174865. [PMID: 28384287 DOI: 10.1371/journal.pone.0174865] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
560 Khondakar KR, Dey S, Wuethrich A, Sina AAI, Trau M. Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems. Acc Chem Res 2019;52:2113-23. [DOI: 10.1021/acs.accounts.9b00192] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
561 Javidi MA, Ahmadi AH, Bakhshinejad B, Nouraee N, Babashah S, Sadeghizadeh M. Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids. Med Oncol. 2014;31:295. [PMID: 25362261 DOI: 10.1007/s12032-014-0295-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
562 Shin SJ, Hwang JW, Ahn JB, Rha SY, Roh JK, Chung HC. Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent. Invest New Drugs. 2013;31:1-13. [PMID: 22539090 DOI: 10.1007/s10637-012-9817-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
563 Yuan T, Sun S, Cao Z, Feng X, Gao Y. Prognostic immunohistochemical markers for small cell lung cancer: A review. Pathol Res Pract 2021;217:153311. [PMID: 33310282 DOI: 10.1016/j.prp.2020.153311] [Reference Citation Analysis]
564 Colvin EK, Chang DK, Merrett ND, Kench JG, Biankin AV. Individualizing therapy for pancreatic cancer. Journal of Gastroenterology and Hepatology 2008;23:1779-82. [DOI: 10.1111/j.1440-1746.2008.05683.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
565 Song YX, Zhou X, Wang ZN, Gao P, Li AL, Liang JW, Zhu JL, Xu YY, Xu HM. The association between individual SNPs or haplotypes of matrix metalloproteinase 1 and gastric cancer susceptibility, progression and prognosis. PLoS One 2012;7:e38002. [PMID: 22655095 DOI: 10.1371/journal.pone.0038002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
566 Mishra A, Verma M. Cancer biomarkers: are we ready for the prime time? Cancers (Basel) 2010;2:190-208. [PMID: 24281040 DOI: 10.3390/cancers2010190] [Cited by in Crossref: 97] [Cited by in F6Publishing: 73] [Article Influence: 8.8] [Reference Citation Analysis]
567 Liu H, Ma L, Lin J, Cao B, Qu D, Luo C, Huang W, Han L, Xu H, Wu Z, Xu R, Zhang D. Advances in molecular mechanisms of drugs affecting abnormal glycosylation and metastasis of breast cancer. Pharmacol Res 2020;155:104738. [PMID: 32151681 DOI: 10.1016/j.phrs.2020.104738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
568 Lu YW, Chien CW, Lin PC, Huang LD, Chen CY, Wu SW, Han CL, Khoo KH, Lin CC, Chen YJ. BAD-lectins: boronic acid-decorated lectins with enhanced binding affinity for the selective enrichment of glycoproteins. Anal Chem 2013;85:8268-76. [PMID: 23895469 DOI: 10.1021/ac401581u] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
569 Nawaz M, Camussi G, Valadi H, Nazarenko I, Ekström K, Wang X, Principe S, Shah N, Ashraf NM, Fatima F, Neder L, Kislinger T. The emerging role of extracellular vesicles as biomarkers for urogenital cancers. Nat Rev Urol 2014;11:688-701. [PMID: 25403245 DOI: 10.1038/nrurol.2014.301] [Cited by in Crossref: 180] [Cited by in F6Publishing: 180] [Article Influence: 25.7] [Reference Citation Analysis]
570 Jarrett AM, Hormuth DA 2nd, Wu C, Kazerouni AS, Ekrut DA, Virostko J, Sorace AG, DiCarlo JC, Kowalski J, Patt D, Goodgame B, Avery S, Yankeelov TE. Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging data. Neoplasia 2020;22:820-30. [PMID: 33197744 DOI: 10.1016/j.neo.2020.10.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
571 Kim W, Kim SJ. Heat Shock Factor 1 as a Prognostic and Diagnostic Biomarker of Gastric Cancer. Biomedicines 2021;9:586. [PMID: 34064083 DOI: 10.3390/biomedicines9060586] [Reference Citation Analysis]
572 Brierley J, O'Sullivan B, Asamura H, Byrd D, Huang SH, Lee A, Piñeros M, Mason M, Moraes FY, Rösler W, Rous B, Torode J, van Krieken JH, Gospodarowicz M. Global Consultation on Cancer Staging: promoting consistent understanding and use. Nat Rev Clin Oncol 2019;16:763-71. [PMID: 31388125 DOI: 10.1038/s41571-019-0253-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
573 Wang Y, Shan Q, Hou G, Zhang J, Bai J, Lv X, Xie Y, Zhu H, Su S, Li Y, Zi J, Lin L, Han W, Zhao X, Wang H, Xu N, Wu L, Lou X, Liu S. Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model. J Proteomics 2016;132:31-40. [PMID: 26581642 DOI: 10.1016/j.jprot.2015.11.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
574 Kočevar N, Hudler P, Komel R. The progress of proteomic approaches in searching for cancer biomarkers. New Biotechnology 2013;30:319-26. [DOI: 10.1016/j.nbt.2012.11.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
575 Kim HY, Lee DH, Lee JH, Cho YY, Cho EJ, Yu SJ, Kim YJ, Yoon JH. Novel biomarker-based model for the prediction of sorafenib response and overall survival in advanced hepatocellular carcinoma: a prospective cohort study. BMC Cancer 2018;18:307. [PMID: 29558905 DOI: 10.1186/s12885-018-4211-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
576 Dhanapala L, Krause CE, Jones AL, Rusling JF. Printed Electrodes in Microfluidic Arrays for Cancer Biomarker Protein Detection. Biosensors (Basel) 2020;10:E115. [PMID: 32906644 DOI: 10.3390/bios10090115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
577 Chen S, Weddell J, Gupta P, Conard G, Parkin J, Imoukhuede PI. qFlow Cytometry-Based Receptoromic Screening: A High-Throughput Quantification Approach Informing Biomarker Selection and Nanosensor Development. Methods Mol Biol 2017;1570:117-38. [PMID: 28238133 DOI: 10.1007/978-1-4939-6840-4_8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
578 Zhu Q, Chai Y, Zhuo Y, Yuan R. Ultrasensitive simultaneous detection of four biomarkers based on hybridization chain reaction and biotin-streptavidin signal amplification strategy. Biosens Bioelectron 2015;68:42-8. [PMID: 25562732 DOI: 10.1016/j.bios.2014.12.023] [Cited by in Crossref: 89] [Cited by in F6Publishing: 73] [Article Influence: 12.7] [Reference Citation Analysis]
579 Gao J, Wang K, Ding T. Detecting early-warning signals for influenza A pandemic based on protein dynamical network biomarkers. Saudi J Biol Sci 2017;24:724-8. [PMID: 28386202 DOI: 10.1016/j.sjbs.2017.01.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
580 Ribeiro AC, Ferreira R, Freitas R. Plant Lectins: Bioactivities and Bioapplications. Elsevier; 2018. pp. 1-42. [DOI: 10.1016/b978-0-444-64056-7.00001-5] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
581 Jia G, Wang X, Li Q, Lu W, Tang X, Wistuba I, Xie Y. RCRnorm: An integrated system of random-coefficient hierarchical regression models for normalizing NanoString nCounter data. Ann Appl Stat 2019;13:1617-47. [PMID: 33564347 DOI: 10.1214/19-aoas1249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
582 Song N, Choi JY, Sung H, Jeon S, Chung S, Park SK, Han W, Lee JW, Kim MK, Lee JY, Yoo KY, Han BG, Ahn SH, Noh DY, Kang D. Prediction of breast cancer survival using clinical and genetic markers by tumor subtypes. PLoS One 2015;10:e0122413. [PMID: 25867717 DOI: 10.1371/journal.pone.0122413] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
583 Murakoshi Y, Honda K, Sasazuki S, Ono M, Negishi A, Matsubara J, Sakuma T, Kuwabara H, Nakamori S, Sata N, Nagai H, Ioka T, Okusaka T, Kosuge T, Shimahara M, Yasunami Y, Ino Y, Tsuchida A, Aoki T, Tsugane S, Yamada T. Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray. Cancer Science 2011;102:630-8. [DOI: 10.1111/j.1349-7006.2010.01818.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
584 Brooks JD. Translational genomics: the challenge of developing cancer biomarkers. Genome Res 2012;22:183-7. [PMID: 22301132 DOI: 10.1101/gr.124347.111] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 7.6] [Reference Citation Analysis]
585 Cho ES, Choi JY. MRI features of hepatocellular carcinoma related to biologic behavior. Korean J Radiol. 2015;16:449-464. [PMID: 25995679 DOI: 10.3348/kjr.2015.16.3.449] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
586 Chen JY, Chang YC. Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells. Adv Exp Med Biol 2017;994:43-66. [PMID: 28560667 DOI: 10.1007/978-3-319-55947-6_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
587 Zhang X, Wang J, He X, Chen L, Zhang Y. Tailor-Made Boronic Acid Functionalized Magnetic Nanoparticles with a Tunable Polymer Shell-Assisted for the Selective Enrichment of Glycoproteins/Glycopeptides. ACS Appl Mater Interfaces 2015;7:24576-84. [PMID: 26479332 DOI: 10.1021/acsami.5b06445] [Cited by in Crossref: 113] [Cited by in F6Publishing: 93] [Article Influence: 18.8] [Reference Citation Analysis]
588 Kanyong P, Rawlinson S, Davis J. Immunochemical Assays and Nucleic-Acid Detection Techniques for Clinical Diagnosis of Prostate Cancer. J Cancer 2016;7:523-31. [PMID: 26958088 DOI: 10.7150/jca.13821] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
589 Kowalczuk O, Burzykowski T, Niklinska WE, Kozlowski M, Chyczewski L, Niklinski J. CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes. Tumour Biol 2014;35:4619-28. [PMID: 24500664 DOI: 10.1007/s13277-014-1605-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
590 Yue T, Partyka K, Maupin KA, Hurley M, Andrews P, Kaul K, Moser AJ, Zeh H, Brand RE, Haab BB. Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases. Proteomics. 2011;11:3665-3674. [PMID: 21751362 DOI: 10.1002/pmic.201000827] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
591 Juurikka K, Butler GS, Salo T, Nyberg P, Åström P. The Role of MMP8 in Cancer: A Systematic Review. Int J Mol Sci 2019;20:E4506. [PMID: 31514474 DOI: 10.3390/ijms20184506] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
592 Guo J, Yang W, Wang C. Magnetic Colloidal Supraparticles: Design, Fabrication and Biomedical Applications. Adv Mater 2013;25:5196-214. [DOI: 10.1002/adma.201301896] [Cited by in Crossref: 121] [Cited by in F6Publishing: 104] [Article Influence: 15.1] [Reference Citation Analysis]
593 Williams R. Discontinued drugs in 2006: oncology drugs. Expert Opinion on Investigational Drugs 2008;17:269-83. [DOI: 10.1517/13543784.17.3.269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
594 Tang Z, Zhu Z, Mallikaratchy P, Yang R, Sefah K, Tan W. Aptamer-target binding triggered molecular mediation of singlet oxygen generation. Chem Asian J 2010;5:783-6. [PMID: 20340154 DOI: 10.1002/asia.200900545] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
595 Grünmüller L, Thierauf J, Weissinger SE, Bergmann C, Bankfalvi A, Veit J, Hoffmann TK, Möller P, Lennerz JK. Biopanel identifies expression status of targetable proteins in sinonasal melanoma. Per Med 2016;13:291-301. [PMID: 29749817 DOI: 10.2217/pme-2016-0023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
596 Diehl F, Diaz LA Jr. Digital quantification of mutant DNA in cancer patients. Curr Opin Oncol 2007;19:36-42. [PMID: 17133110 DOI: 10.1097/CCO.0b013e328011a8e7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
597 Pettitt D, Smith J, Meadows N, Arshad Z, Schuh A, Digiusto D, Bountra C, Holländer G, Barker R, Brindley D. Regulatory barriers to the advancement of precision medicine. Expert Review of Precision Medicine and Drug Development 2016;1:319-29. [DOI: 10.1080/23808993.2016.1176526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
598 Singh AN, McGuire MJ, Li S, Hao G, Kumar A, Sun X, Brown KC. Dimerization of a phage-display selected peptide for imaging of αvβ6- integrin: two approaches to the multivalent effect. Theranostics 2014;4:745-60. [PMID: 24883124 DOI: 10.7150/thno.7811] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
599 Zhang H. The Plasma Proteome: High Abundance versus Low Abundance: January 10–11, 2006, San Diego, CA, USA. Expert Review of Proteomics 2014;3:175-8. [DOI: 10.1586/14789450.3.2.175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
600 Ma R, Xu H, Wu J, Sharma A, Bai S, Dun B, Jing C, Cao H, Wang Z, She JX, Feng J. Identification of serum proteins and multivariate models for diagnosis and therapeutic monitoring of lung cancer. Oncotarget 2017;8:18901-13. [PMID: 28121629 DOI: 10.18632/oncotarget.14782] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
601 Dawood S. Novel biomarkers of metastatic cancer. Expert Rev Mol Diagn 2010;10:581-90. [PMID: 20629508 DOI: 10.1586/erm.10.35] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
602 Hong Y, Zhan Q, Zheng Y, Pu C, Zhao H, Lan M. Hydrophilic phytic acid-functionalized magnetic dendritic mesoporous silica nanospheres with immobilized Ti4+: A dual-purpose affinity material for highly efficient enrichment of glycopeptides/phosphopeptides. Talanta 2019;197:77-85. [DOI: 10.1016/j.talanta.2019.01.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
603 Blaschke CRK, McDowell CT, Black AP, Mehta AS, Angel PM, Drake RR. Glycan Imaging Mass Spectrometry: Progress in Developing Clinical Diagnostic Assays for Tissues, Biofluids, and Cells. Clin Lab Med 2021;41:247-66. [PMID: 34020762 DOI: 10.1016/j.cll.2021.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
604 Debald M, Franken S, Heukamp LC, Linke A, Wolfgarten M, Walgenbach K, Braun M, Rudlowski C, Gieselmann V, Kuhn W, Hartmann G, Walgenbach-brünagel G. Identification of specific nuclear structural protein alterations in human breast cancer. J Cell Biochem 2011;112:3176-84. [DOI: 10.1002/jcb.23249] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
605 Hou Q, Tan HT, Lim KH, Lim TK, Khoo A, Tan IB, Yeoh KG, Chung MC. Identification and functional validation of caldesmon as a potential gastric cancer metastasis-associated protein. J Proteome Res. 2013;12:980-990. [PMID: 23265641 DOI: 10.1021/pr3010259] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
606 Jiao XD, Ding LR, Zhang CT, Qin BD, Liu K, Jiang LP, Wang X, Lv LT, Ding H, Li DM, Yang H, Chen XQ, Zhu WY, Wu Y, Ling Y, He X, Liu J, Shao L, Wang HZ, Chen Y, Zheng JJ, Inui N, Zang YS. Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma. Transl Lung Cancer Res 2021;10:3236-50. [PMID: 34430361 DOI: 10.21037/tlcr-21-543] [Reference Citation Analysis]
607 Sardesai NP, Kadimisetty K, Faria R, Rusling JF. A microfluidic electrochemiluminescent device for detecting cancer biomarker proteins. Anal Bioanal Chem 2013;405:3831-8. [PMID: 23307128 DOI: 10.1007/s00216-012-6656-5] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 9.6] [Reference Citation Analysis]
608 Liu X, Zhang M, Go VL, Hu S. Membrane proteomic analysis of pancreatic cancer cells. J Biomed Sci 2010;17:74. [PMID: 20831833 DOI: 10.1186/1423-0127-17-74] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
609 Cao HH, Zheng CP, Wang SH, Wu JY, Shen JH, Xu XE, Fu JH, Wu ZY, Li EM, Xu LY. A molecular prognostic model predicts esophageal squamous cell carcinoma prognosis. PLoS One 2014;9:e106007. [PMID: 25153136 DOI: 10.1371/journal.pone.0106007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
610 Bendinelli B, Vignoli A, Palli D, Assedi M, Ambrogetti D, Luchinat C, Caini S, Saieva C, Turano P, Masala G. Prediagnostic circulating metabolites in female breast cancer cases with low and high mammographic breast density. Sci Rep 2021;11:13025. [PMID: 34158597 DOI: 10.1038/s41598-021-92508-1] [Reference Citation Analysis]
611 Easton JM, Harris LM, Viant MR, Peet AC, Arvanitis TN. Linked metabolites: a tool for the construction of directed metabolic graphs. Comput Biol Med 2010;40:340-9. [PMID: 20138614 DOI: 10.1016/j.compbiomed.2010.01.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
612 Cao Y, Wen L, Svec F, Tan T, Lv Y. Magnetic AuNP@Fe 3 O 4 nanoparticles as reusable carriers for reversible enzyme immobilization. Chemical Engineering Journal 2016;286:272-81. [DOI: 10.1016/j.cej.2015.10.075] [Cited by in Crossref: 80] [Cited by in F6Publishing: 63] [Article Influence: 16.0] [Reference Citation Analysis]
613 Essaghir A, Demoulin JB. A minimal connected network of transcription factors regulated in human tumors and its application to the quest for universal cancer biomarkers. PLoS One 2012;7:e39666. [PMID: 22761861 DOI: 10.1371/journal.pone.0039666] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
614 Wu S, Shen W, Yang L, Zhu M, Zhang M, Zong F, Geng L, Wang Y, Huang T, Pan Y, Cao S, Dai J, Ma H, Wu J. Genetic variations in miR-125 family and the survival of non-small cell lung cancer in Chinese population. Cancer Med 2019;8:2636-45. [PMID: 30843663 DOI: 10.1002/cam4.2073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
615 Whelan SA, He J, Lu M, Souda P, Saxton RE, Faull KF, Whitelegge JP, Chang HR. Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid. J Proteome Res 2012;11:5034-45. [PMID: 22934887 DOI: 10.1021/pr300606e] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
616 Umelo IA, Costanza B, Castronovo V. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies. Cancer Metastasis Rev 2018;37:125-45. [PMID: 29392535 DOI: 10.1007/s10555-017-9710-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
617 Li X, He Y, Ma Y, Bie Z, Liu B, Liu Z. Hybrid Approach Combining Boronate Affinity Magnetic Nanoparticles and Capillary Electrophoresis for Efficient Selection of Glycoprotein-Binding Aptamers. Anal Chem 2016;88:9805-12. [PMID: 27579807 DOI: 10.1021/acs.analchem.6b02907] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
618 Huang SH, Xu W, Waldron J, Siu L, Shen X, Tong L, Ringash J, Bayley A, Kim J, Hope A, Cho J, Giuliani M, Hansen A, Irish J, Gilbert R, Gullane P, Perez-Ordonez B, Weinreb I, Liu FF, O'Sullivan B. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. J Clin Oncol 2015;33:836-45. [PMID: 25667292 DOI: 10.1200/JCO.2014.58.6412] [Cited by in Crossref: 259] [Cited by in F6Publishing: 104] [Article Influence: 43.2] [Reference Citation Analysis]
619 Akkız H, Kuran S, Akgöllü E, Üsküdar O, Bekar A, Bayram S, Yıldırım S, Ülger Y, Kaya BY, Şansal M, Çınar E. Effect of PON1 gene polymorphisms in Turkish patients with hepatocellular carcinoma. Meta Gene 2013;1:93-101. [PMID: 25606379 DOI: 10.1016/j.mgene.2013.09.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
620 Zhang S, Tan IB, Sapari NS, Grabsch HI, Okines A, Smyth EC, Aoyama T, Hewitt LC, Inam I, Bottomley D, Nankivell M, Stenning SP, Cunningham D, Wotherspoon A, Tsuburaya A, Yoshikawa T, Soong R, Tan P. Technical reproducibility of single-nucleotide and size-based DNA biomarker assessment using DNA extracted from formalin-fixed, paraffin-embedded tissues. J Mol Diagn 2015;17:242-50. [PMID: 25746798 DOI: 10.1016/j.jmoldx.2014.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
621 de Almeida BP, Apolónio JD, Binnie A, Castelo-Branco P. Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers. BMC Cancer 2019;19:219. [PMID: 30866861 DOI: 10.1186/s12885-019-5403-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 18.5] [Reference Citation Analysis]
622 Bilgrami SM, Qureshi SA, Pervez S, Abbas F. Promoter hypermethylation of tumor suppressor genes correlates with tumor grade and invasiveness in patients with urothelial bladder cancer. Springerplus. 2014;3:178. [PMID: 24790823 DOI: 10.1186/2193-1801-3-178] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
623 Xie X, Wang C, Xiao Q, Zheng Y, Li Y, Feng B. Practical detection for simultaneous analysis of multiple antigens with Staphylococcal protein A as an intermediate. Anal Methods 2015;7:9018-25. [DOI: 10.1039/c5ay01808k] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
624 Li Y, Sokoll LJ, Rush J, Meany D, Zou N, Chan DW, Zhang H. Targeted detection of prostate cancer proteins in serum using heavy-isotope-labeled-peptide standards and MALDI-TOF/TOF. Prot Clin Appl 2009;3:597-608. [DOI: 10.1002/prca.200800197] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
625 Idikio HA. Galectin-3 and Beclin1/Atg6 genes in human cancers: using cDNA tissue panel, qRT-PCR, and logistic regression model to identify cancer cell biomarkers. PLoS One 2011;6:e26150. [PMID: 22039439 DOI: 10.1371/journal.pone.0026150] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
626 Timms JF, Cramer R, Camuzeaux S, Tiss A, Smith C, Burford B, Nouretdinov I, Devetyarov D, Gentry-Maharaj A, Ford J, Luo Z, Gammerman A, Menon U, Jacobs I. Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancer. Clin Chem 2010;56:262-71. [PMID: 20093557 DOI: 10.1373/clinchem.2009.133363] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
627 Abbas M, Ahmed A, Khan GJ, Baig MMFA, Naveed M, Mikrani R, Cao T, Naeem S, Shi M, Dingding C. Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer. Curr Probl Cancer 2019;43:5-17. [PMID: 30172422 DOI: 10.1016/j.currproblcancer.2018.08.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
628 Teale P, Barton C, Driver PM, Kay RG. Biomarkers: unrealized potential in sports doping analysis. Bioanalysis 2009;1:1103-18. [DOI: 10.4155/bio.09.87] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
629 Timms JF, Hale OJ, Cramer R. Advances in mass spectrometry-based cancer research and analysis: from cancer proteomics to clinical diagnostics. Expert Review of Proteomics 2016;13:593-607. [DOI: 10.1080/14789450.2016.1182431] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
630 Li T, Yang J, Ali Z, Wang Z, Mou X, He N, Wang Z. Synthesis of aptamer-functionalized Ag nanoclusters for MCF-7 breast cancer cells imaging. Sci China Chem 2017;60:370-6. [DOI: 10.1007/s11426-016-0159-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
631 Bakhtiar R. Biomarkers in drug discovery and development. J Pharmacol Toxicol Methods 2008;57:85-91. [PMID: 18024093 DOI: 10.1016/j.vascn.2007.10.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
632 Gajdosova V, Lorencova L, Kasak P, Tkac J. Electrochemical Nanobiosensors for Detection of Breast Cancer Biomarkers. Sensors (Basel) 2020;20:E4022. [PMID: 32698389 DOI: 10.3390/s20144022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
633 Bracaglia S, Ranallo S, Plaxco KW, Ricci F. Programmable, Multiplexed DNA Circuits Supporting Clinically Relevant, Electrochemical Antibody Detection. ACS Sens 2021;6:2442-8. [PMID: 34129321 DOI: 10.1021/acssensors.1c00790] [Reference Citation Analysis]
634 Liu J, Deng N, Xu Q, Sun L, Tu H, Wang Z, Xing C, Yuan Y. Polymorphisms of multiple genes involved in NER pathway predict prognosis of gastric cancer. Oncotarget. 2016;7:48130-48142. [PMID: 27340861 DOI: 10.18632/oncotarget.10173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
635 Zhang H, Loriaux P, Eng J, Campbell D, Keller A, Moss P, Bonneau R, Zhang N, Zhou Y, Wollscheid B, Cooke K, Yi EC, Lee H, Peskind ER, Zhang J, Smith RD, Aebersold R. UniPep--a database for human N-linked glycosites: a resource for biomarker discovery. Genome Biol 2006;7:R73. [PMID: 16901351 DOI: 10.1186/gb-2006-7-8-R73] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 5.6] [Reference Citation Analysis]
636 Huang SP, Chang YC, Low QH, Wu ATH, Chen CL, Lin YF, Hsiao M. BICD1 expression, as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas. Oncotarget 2017;8:113766-91. [PMID: 29371945 DOI: 10.18632/oncotarget.22667] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
637 Haab BB, Huang Y, Balasenthil S, Partyka K, Tang H, Anderson M, Allen P, Sasson A, Zeh H, Kaul K, Kletter D, Ge S, Bern M, Kwon R, Blasutig I, Srivastava S, Frazier ML, Sen S, Hollingsworth MA, Rinaudo JA, Killary AM, Brand RE. Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. PLoS One 2015;10:e0139049. [PMID: 26431551 DOI: 10.1371/journal.pone.0139049] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
638 Li D, Chen Y, Liu Z. Boronate affinity materials for separation and molecular recognition: structure, properties and applications. Chem Soc Rev 2015;44:8097-123. [PMID: 26377373 DOI: 10.1039/c5cs00013k] [Cited by in Crossref: 284] [Cited by in F6Publishing: 22] [Article Influence: 47.3] [Reference Citation Analysis]
639 Mortezai N, Harder S, Schnabel C, Moors E, Gauly M, Schlüter H, Wagener C, Buck F. Tandem Affinity Depletion: A Combination of Affinity Fractionation and Immunoaffinity Depletion Allows the Detection of Low-Abundance Components in the Complex Proteomes of Body Fluids. J Proteome Res 2010;9:6126-34. [DOI: 10.1021/pr100224y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
640 Wang Z, Ding Q, Li Y, Liu Q, Wu W, Wu L, Yu H. Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis. Tumour Biol 2016;37:14779-87. [PMID: 27633066 DOI: 10.1007/s13277-016-5369-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
641 Wang J, Kang QS, Lv XG, Song J, Zhan N, Dong WG, Huang WH. Simple patterned nanofiber scaffolds and its enhanced performance in immunoassay. PLoS One 2013;8:e82888. [PMID: 24340065 DOI: 10.1371/journal.pone.0082888] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
642 Zhu J, Wang F, Cheng K, Dong J, Sun D, Chen R, Wang L, Ye M, Zou H. A simple integrated system for rapid analysis of sialic-acid-containing N-glycopeptides from human serum. Proteomics 2013;13:1306-13. [PMID: 23335361 DOI: 10.1002/pmic.201200367] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
643 Padler-Karavani V, Hurtado-Ziola N, Pu M, Yu H, Huang S, Muthana S, Chokhawala HA, Cao H, Secrest P, Friedmann-Morvinski D, Singer O, Ghaderi D, Verma IM, Liu YT, Messer K, Chen X, Varki A, Schwab R. Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer. Cancer Res 2011;71:3352-63. [PMID: 21505105 DOI: 10.1158/0008-5472.CAN-10-4102] [Cited by in Crossref: 96] [Cited by in F6Publishing: 70] [Article Influence: 9.6] [Reference Citation Analysis]
644 Sallam RM. Proteomics in cancer biomarkers discovery: challenges and applications. Dis Markers 2015;2015:321370. [PMID: 25999657 DOI: 10.1155/2015/321370] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
645 Touat M, Duran-Peña A, Alentorn A, Lacroix L, Massard C, Idbaih A. Emerging circulating biomarkers in glioblastoma: promises and challenges. Expert Rev Mol Diagn 2015;15:1311-23. [PMID: 26394701 DOI: 10.1586/14737159.2015.1087315] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
646 Dedong H, Bin Z, Peisheng S, Hongwei X, Qinghui Y. The contribution of the genetic variations of the matrix metalloproteinase-1 gene to the genetic susceptibility of gastric cancer. Genet Test Mol Biomarkers 2014;18:675-82. [PMID: 25148204 DOI: 10.1089/gtmb.2014.0117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
647 Cummings J, Ranson M, Lacasse E, Ganganagari JR, St-Jean M, Jayson G, Durkin J, Dive C. Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br J Cancer. 2006;95:42-48. [PMID: 16804528 DOI: 10.1038/sj.bjc.6603220] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
648 Sahab ZJ, Semaan SM, Sang QA. Methodology and Applications of Disease Biomarker Identification in Human Serum. Biomark�Insights 2007;2:117727190700200. [DOI: 10.1177/117727190700200034] [Cited by in Crossref: 57] [Cited by in F6Publishing: 35] [Article Influence: 14.3] [Reference Citation Analysis]
649 Balayan S, Chauhan N, Chandra R, Kuchhal NK, Jain U. Recent advances in developing biosensing based platforms for neonatal sepsis. Biosens Bioelectron 2020;169:112552. [PMID: 32931992 DOI: 10.1016/j.bios.2020.112552] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
650 Jie J, Liu D, Zou X. A one-pot synthesis of hydrophilic poly(glycerol methacrylate) chitosan for highly selective enrichment of glycopeptides. Chem Commun (Camb) 2020;56:908-11. [PMID: 31850411 DOI: 10.1039/c9cc08016c] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
651 Jiao F, Gao F, Wang H, Deng Y, Zhang Y, Qian X, Zhang Y. Polymeric hydrophilic ionic liquids used to modify magnetic nanoparticles for the highly selective enrichment of N-linked glycopeptides. Sci Rep 2017;7:6984. [PMID: 28765562 DOI: 10.1038/s41598-017-07516-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
652 Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Critical Reviews in Clinical Laboratory Sciences 2011;48:155-70. [DOI: 10.3109/10408363.2011.599831] [Cited by in Crossref: 258] [Cited by in F6Publishing: 241] [Article Influence: 25.8] [Reference Citation Analysis]
653 Wang S, Kong H, Gong X, Zhang S, Zhang X. Multicolor imaging of cancer cells with fluorophore-tagged aptamers for single cell typing. Anal Chem 2014;86:8261-6. [PMID: 25054485 DOI: 10.1021/ac501657g] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
654 Han KC, Yang EG, Ahn DR. Elongated oligonucleotide-linked immunosorbent assay for sensitive detection of a biomarker in a microwell plate-based platform. Biosens Bioelectron 2013;50:421-4. [PMID: 23896521 DOI: 10.1016/j.bios.2013.07.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
655 Minelli C, Lowe SB, Stevens MM. Engineering nanocomposite materials for cancer therapy. Small 2010;6:2336-57. [PMID: 20878632 DOI: 10.1002/smll.201000523] [Cited by in Crossref: 193] [Cited by in F6Publishing: 165] [Article Influence: 19.3] [Reference Citation Analysis]
656 Zhang H, Ba S, Lee JY, Xie J, Loh T, Li T. Cancer Biomarker-Triggered Disintegrable DNA Nanogels for Intelligent Drug Delivery. Nano Lett 2020;20:8399-407. [DOI: 10.1021/acs.nanolett.0c03671] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
657 Guo X, Chen C, Liu B, Wu Y, Chen Y, Zhou X, Huang X, Li X, Yang H, Chen Z, Xing J. Genetic variations in monocarboxylate transporter genes as predictors of clinical outcomes in non-small cell lung cancer. Tumour Biol 2015;36:3931-9. [PMID: 25578492 DOI: 10.1007/s13277-014-3036-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
658 Hudler P. Genetic Testing, an Optimal Strategy for Lynch Syndrome Identification. In: Vogelsang M, editor. DNA Alterations in Lynch Syndrome. Dordrecht: Springer Netherlands; 2013. pp. 63-83. [DOI: 10.1007/978-94-007-6597-9_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
659 Vassilakopoulou M, Parisi F, Siddiqui S, England AM, Zarella ER, Anagnostou V, Kluger Y, Hicks DG, Rimm DL, Neumeister VM. Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time. Lab Invest 2015;95:334-41. [PMID: 25418580 DOI: 10.1038/labinvest.2014.139] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 4.9] [Reference Citation Analysis]
660 Rama EC, Costa-garcía A. Screen-printed Electrochemical Immunosensors for the Detection of Cancer and Cardiovascular Biomarkers. Electroanalysis 2016;28:1700-15. [DOI: 10.1002/elan.201600126] [Cited by in Crossref: 49] [Cited by in F6Publishing: 14] [Article Influence: 9.8] [Reference Citation Analysis]
661 Kim SG, Friedman K, Patel S, Hagiwara M. Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer. AJR Am J Roentgenol 2016;207:248-56. [PMID: 27163282 DOI: 10.2214/AJR.16.16265] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 3.4] [Reference Citation Analysis]
662 Rodriguez H. Proteomics: a long and winding road to medical diagnostics. Expert Opinion on Medical Diagnostics 2009;3:219-25. [DOI: 10.1517/17530050902794923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
663 Lee HJ, Na K, Kwon MS, Park T, Kim KS, Kim H, Paik YK. A new versatile peptide-based size exclusion chromatography platform for global profiling and quantitation of candidate biomarkers in hepatocellular carcinoma specimens. Proteomics 2011;11:1976-84. [PMID: 21500349 DOI: 10.1002/pmic.201100002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
664 Van Scherpenzeel M, Willems E, Lefeber DJ. Clinical diagnostics and therapy monitoring in the congenital disorders of glycosylation. Glycoconj J 2016;33:345-58. [PMID: 26739145 DOI: 10.1007/s10719-015-9639-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 8.4] [Reference Citation Analysis]
665 Zhan Q, Zhao H, Hong Y, Pu C, Liu Y, Lan M. Preparation of a hydrophilic interaction liquid chromatography material by sequential electrostatic deposition of layers of polyethyleneimine and hyaluronic acid for enrichment of glycopeptides. Microchim Acta 2019;186. [DOI: 10.1007/s00604-019-3712-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
666 Battersby B, Chen A, Kozak D, Trau M. Biosensors for disease biomarker detection. Biosensors for Medical Applications. Elsevier; 2012. pp. 191-216. [DOI: 10.1533/9780857097187.2.191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
667 Lee WK, Lee SY, Choi JE, Seok Y, Lee EB, Lee HC, Kang HG, Yoo SS, Lee MH, Cho S, Jheon S, Kim YC, Oh IJ, Na KJ, Jung CY, Park CK, Kim MH, Lee MK, Park JY. Development of a prognosis-prediction model incorporating genetic polymorphism with pathologic stage in stage I non-small cell lung cancer: A multicenter study. Thorac Cancer 2017;8:251-9. [PMID: 28371058 DOI: 10.1111/1759-7714.12434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
668 Olafsson S, Alexandersson KF, Gizurarson JGK, Hauksdottir K, Gunnarsson O, Olafsson K, Gudmundsson J, Stacey SN, Sveinbjornsson G, Saemundsdottir J, Bjornsson ES, Olafsson S, Bjornsson S, Orvar KB, Vikingsson A, Geirsson AJ, Arinbjarnarson S, Bjornsdottir G, Thorgeirsson TE, Sigurdsson S, Halldorsson GH, Magnusson OT, Masson G, Holm H, Jonsdottir I, Sigurdardottir O, Eyjolfsson GI, Olafsson I, Sulem P, Thorsteinsdottir U, Jonsson T, Rafnar T, Gudbjartsson DF, Stefansson K. Common and Rare Sequence Variants Influencing Tumor Biomarkers in Blood. Cancer Epidemiol Biomarkers Prev 2020;29:225-35. [PMID: 31666285 DOI: 10.1158/1055-9965.EPI-18-1060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
669 Valera VA, Walter BA, Yokoyama N, Koyama Y, Iiai T, Okamoto H, Hatakeyama K. Prognostic groups in colorectal carcinoma patients based on tumor cell proliferation and classification and regression tree (CART) survival analysis. Ann Surg Oncol. 2007;14:34-40. [PMID: 17024555 DOI: 10.1245/s10434-006-9145-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
670 Cao Q, Li Y, Li Z, An D, Li B, Lin Q. Development and validation of a radiomics signature on differentially expressed features of 18F-FDG PET to predict treatment response of concurrent chemoradiotherapy in thoracic esophagus squamous cell carcinoma. Radiother Oncol 2020;146:9-15. [PMID: 32065875 DOI: 10.1016/j.radonc.2020.01.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
671 Xu J, Yin Z, Shen H, Gao W, Qian Y, Pei D, Liu L, Shu Y. A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population. PLoS One 2013;8:e79135. [PMID: 24223174 DOI: 10.1371/journal.pone.0079135] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
672 Qi J, Qian C, Shi W, Wu X, Jing R, Zhang L, Wang Z, Ju S. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer. Clin Biochem 2013;46:64-9. [PMID: 22975639 DOI: 10.1016/j.clinbiochem.2012.08.026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
673 Guo XM, Zhu FF, Pan LW, Chen JL, Lai JC, Wu HX, Shu JC. Caprin-1 promotes HepG2 cell proliferation, invasion and migration and is associated with poor prognosis in patients with liver cancer. Oncol Lett 2020;20:1761-71. [PMID: 32724419 DOI: 10.3892/ol.2020.11712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
674 Good DM, Thongboonkerd V, Novak J, Bascands JL, Schanstra JP, Coon JJ, Dominiczak A, Mischak H. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res 2007;6:4549-55. [PMID: 17970587 DOI: 10.1021/pr070529w] [Cited by in Crossref: 177] [Cited by in F6Publishing: 165] [Article Influence: 12.6] [Reference Citation Analysis]
675 Suzuki S, Yamayoshi Y, Nishimuta A, Tanigawara Y. S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells. Proteome Sci. 2011;9:76. [PMID: 22206547 DOI: 10.1186/1477-5956-9-76] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
676 Bodelón G, Montes-García V, Fernández-López C, Pastoriza-Santos I, Pérez-Juste J, Liz-Marzán LM. Au@pNIPAM SERRS Tags for Multiplex Immunophenotyping Cellular Receptors and Imaging Tumor Cells. Small 2015;11:4149-57. [PMID: 25939486 DOI: 10.1002/smll.201500269] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 8.7] [Reference Citation Analysis]
677 Yoon AJ, Wang S, Kutler DI, Carvajal RD, Philipone E, Wang T, Peters SM, LaRoche D, Hernandez BY, McDowell BD, Stewart CR, Momen-Heravi F, Santella RM. MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at high-risk for cancer-specific mortality. Head Neck 2020;42:1699-712. [PMID: 31981257 DOI: 10.1002/hed.26089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
678 Kanzaki H, Chiba T, Ao J, Koroki K, Kanayama K, Maruta S, Maeda T, Kusakabe Y, Kobayashi K, Kanogawa N, Kiyono S, Nakamura M, Kondo T, Saito T, Nakagawa R, Ogasawara S, Suzuki E, Ooka Y, Muroyama R, Nakamoto S, Yasui S, Tawada A, Arai M, Kanda T, Maruyama H, Mimura N, Kato J, Zen Y, Ohtsuka M, Iwama A, Kato N. The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma. Sci Rep 2021;11:5303. [PMID: 33674622 DOI: 10.1038/s41598-021-84117-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
679 Végvári Á, Magnusson M, Wallman L, Ekström S, Bolmsjö G, Nilsson J, Miliotis T, Östling J, Kjellström S, Ottervald J, Franzén B, Hultberg H, Marko‐varga G, Laurell T. Implementation of a protein profiling platform developed as an academic‐pharmaceutical industry collaborative effort. Electrophoresis 2008;29:2696-705. [DOI: 10.1002/elps.200700816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
680 Peng W, Fan H. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma. Biomed Pharmacother 2015;72:113-8. [PMID: 26054684 DOI: 10.1016/j.biopha.2015.04.014] [Cited by in Crossref: 54] [Cited by in F6Publishing: 62] [Article Influence: 9.0] [Reference Citation Analysis]
681 Zhong L, Li C, Ren Y, Wu D. Prognostic value of 18F-fluorodeoxyglucose PET parameters and inflammation in patients with nasopharyngeal carcinoma. Oncol Lett 2017;14:5004-12. [PMID: 29085513 DOI: 10.3892/ol.2017.6816] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
682 Rusling JF, Forster RJ. Biosensors Designed for Clinical Applications. Biomedicines 2021;9:702. [PMID: 34206405 DOI: 10.3390/biomedicines9070702] [Reference Citation Analysis]
683 Xia WX, Zhang HB, Shi JL, Lu X, Wang L, Ye YF, Cao KJ, Qian CN, Guo X, Xiang YQ. A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classification. Eur J Cancer 2013;49:2152-60. [PMID: 23571148 DOI: 10.1016/j.ejca.2013.03.003] [Cited by in Crossref: 39] [